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SUMMARY OF FINDINGS 
  
This PhD sought to exploit the acute effects of exercise upon the kidneys to make tenable 
links to pathological states such as acute kidney injury (AKI) and chronic kidney disease 
(CKD). It is surprising that such associations with their potential clinical implications have 
received limited attention so far despite the ever-increasing number of healthy individuals 
participating in vigorous and physiologically challenging activities. The work herein has 
shown how experimental in-vivo exercise models may be used to simulate a “stressed” kidney 
with features that resemble diseased states. 
Summarising the key findings briefly, the first study (chapter 2) demonstrated that 
maximal-intensity exercise in the form of an 800 metre sprint resulted in increased urinary 
concentrations of an AKI biomarker (neutrophil gelatinase-associated lipocalin / NGAL), 
suggesting mild kidney stress or a concentrating effect. However, plasma NGAL 
concentrations decreased and urinary rises were independent of post-exercise proteinuria. 
There was also an inverse relationship between urinary volume and urinary NGAL 
concentrations – an observation that is also seen in oliguric AKI.  
The systematic review in the second study (chapter 3) found promise in post-exercise 
proteinuria as a predictor for CKD progression. Five studies (N = 351) that met inclusion 
criteria, examined prospective cohorts of Type I diabetics who were at risk of CKD. Through 
combining the results of the primary outcome in four studies (N = 318), the presence of post-
exercise proteinuria was highly associated with elevated resting proteinuria at follow-up (χ2 
test, P < 0.0001) and significant odds ratios (developing CKD following a positive exercise 
test vs. not developing CKD) were noted in each of these four studies (OR 2.3-52.0). 
However, there was great variability and questionable validity in the interventions that did not 
permit meta-analysis. It was evident that exercise interventions need to be refined and 
standardised before applying to other at-risk CKD populations. 
In the third study (chapter 4), it was demonstrated that a prior bout of muscle-damaging 
exercise established a pro-inflammatory state with elevated plasma interleukin-6 (IL-6) 
concentrations, and that with subsequent endurance-based exercise in the heat there was 
increased kidney stress as measured by increased urinary NGAL and plasma creatinine 
concentrations. The latter elevations met clincial criteria for AKI. Also, plasma IL-6 and 
plasma NGAL concentrations were positively correlated. 
 
 III 
Lastly, the final study (chapter 5) extended the findings of chapter 4 by isolating the role 
of pro-inflammatory IL-6 in AKI. Through infusion of recombinant IL-6 in healthy males to 
concentrations above 100 pg/ml, elevations in plasma NGAL concentrations were shown but 
not to AKI ranges. In addition, there were no changes to plasma concentrations of other AKI 
biomarkers such as creatinine or cystatin C. Overall, this suggests that IL-6 is able to 
modulate NGAL but is not responsible per se for AKI or kidney dysfunction. Thus, it is likely 
that additional physiological aberrations are needed.  
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definition of post-exercise proteinuria and primary outcomes are detailed in the Eligibility 
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Figure 4.1. Schematic detailing flow of study. Treatment (EIMD or CON) was performed at 
20 
o
C. Heat stress was performed at 33 
o
C. Baseline, before heat stress and after heat stress 
denote sampling time points. EIMD, exercise-induced muscle damage arm; CON, control 
arm; NGAL, neutrophil gelatinase-associated lipocalin. 
 
Figure 4.2. Left panel: urinary neutrophil gelatinase-associated lipocalin (NGAL) at baseline, 
before (preHS) and after (postHS) heat stress for control (CON; clear boxes) and exercise 
induced muscle damage (EIMD; shaded boxes) groups. Data are presented as median (solid 
line in box), quartiles (boxes) and ranges (whiskers) given non-parametric data. Circles and 
small stars indicate outliers. Dotted horizontal line on y-axis indicates upper limit of normal 
range for urinary NGAL (9.8 ng/ml). For EIMD and CON groups, there was a significant 
interaction between pre- and postHS (P = 0.005).  By post hoc test: *, significantly different 
from PreHS; †, significantly different from CON. Right panel: median difference and 95% 
confidence intervals between EIMD and CON for urinary NGAL at pre- and postHS.  A 
positive value indicates urinary NGAL was higher in the EIMD group.   
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before (preHS) and after (postHS) heat stress for control (CON; dotted line) and muscle 
damage (EIMD; solid line) groups. Data are means (SD). Dotted horizontal grey line crossing 
y-axis indicates upper limit of plasma NGAL (106 ng/ml). For EIMD and CON groups, there 
was a significant interaction between pre- and postHS (P = 0.04). By post hoc test: *, 
significantly different from PreHS; 
‡ 
trend (P ≥ 0.05 but ≤ 0.1) for difference with CON. 
Right panel: mean difference and 95% confidence intervals between EIMD and CON for 
plasma NGAL at pre- and postHS. A positive value indicates plasma NGAL concentration 
was higher in the EIMD group. 
 
Figure 4.4. Left panel: plasma creatinine at baseline, before (preHS) and after (postHS) heat 
stress for control (CON; dotted line) and muscle damage (EIMD; solid line) groups. Data are 
means (SD). Dotted horizontal grey line crossing y-axis indicates upper limit of plasma 
creatinine (1.2 mg/dl). For EIMD and CON groups, there was a significant interaction 
between pre- and postHS (P = 0.005).  By post hoc test: 
*
, significantly different from PreHS; 
 XX 
†
, significantly different from CON. Right panel: mean difference and 95% confidence 
intervals between EIMD and CON for plasma creatinine at pre- and postHS. A positive value 
indicates plasma creatinine was higher in the EIMD group. 
 
CHAPTER 5 – INFUSION OF RECOMBINANT IL-6 IN HEALTHY HUMANS ELEVATES PLASMA NGAL 
CONCENTRATIONS WITHOUT A REDUCTION IN RENAL FUNCTION.  
 
Figure 5.1. Schematic illustrating time points for primary and secondary measurements. The 
recombinant IL-6 infusion was given between 0 and 3 hours (h). All measurements were 
taken in the resting condition. 
 
Figure 5.2. Effect of recombinant IL-6 infusion upon plasma IL-6 concentrations. Data are 
medians (thick lines) and ranges. Open circles and asterixes are outliers. There was a 
significant effect of time (P = 0.007). #, difference compared to 0 hours sample point by 
planned comparisons. 
 
Figure 5.3. Effect of recombinant IL-6 infusion upon plasma NGAL concentrations. Data are 
means and standard deviations. Dotted line indicates upper limit of normal range for plasma 
NGAL (106 ng/ml). There was a significant effect of time (P = 0.025).  #, difference 
compared to 0 hours sample point by planned comparisons. 
 
CHAPTER 6 - SUMMARY OF STUDIES, GENERAL DISCUSSION AND FUTURE DIRECTIONS 
 
Figure 6.1. When considering urinary biomarker:creatinine ratios, the change of excretion of 
both biomarker and creatinine should be known. As creatinine excretion is unstable in AKI, 
changes in the ratio cannot be determined unless the directional change of each is known. 
This would also apply to other dynamic setting such as post-exercise. AKI, acute kidney 
injury; ∆, change. Adapted from Goldstein 2010. 
 
Figure 6.2. Immunohistochemistry results on frozen sections of mouse kidneys at 3 and 12 
hour reflow periods following experimentally-induced ischaemia using a vascular clamp. 
Induction of mouse kidney NGAL protein within tubules is demonstrated by cherry-red 
fluorescence when tissue samples were probed with a polyclonal antibody to NGAL. Con, 
representative sample obtained from control mice; G, glomerulus; HP, tissue sample at high 
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power 100× magnification (other panels are at 20× magnification). Adopted from Mishra et 
al., 2003. 
 
Figure 6.3. Arterial IL-6 concentrations at rest and during exercise during one hour on a cycle 
ergometer at a core temperature of 38
0
C (first bout) followed by a one hour rest period and 
then further exercise at 39.5
0
C (second bout). Both exercise trials were completed at a 
workload (170 ± 4 W) that corresponded to 50 % O2max. A similar pattern of plasma IL-6 
rise was also seen in study 4. Data are means of 8 subjects. * Significantly different from the 
resting value (P < 0.05). Adopted from Nybo et al. 2002. 
 
Figure 6.4. Changes in serum creatinine in fourteen male athletes before and at several time 
points following a 50km dualthon. The cohort was split into a damaged group (N = 7) 
consisting of individuals with renal tubular epithelium in their urine and a non-damaged 
group (N = 7) where this was absent. Damaged individuals met stage I AKIN AKI criteria 
immediately post-exercise and 90 minutes post-exercise based upon serum creatinine 
concentrations elevations (0.54 mg/dl or 1.66-fold increase from baseline and 0.36 mg/dl or 
1.44-fold rise from baseline, respectively). Legend: creatinine (Cr), pre-exercise (Pre), 
immediately post-exercise (0 h), 1.5 hour post-exercise (1.5 h) and 3 hour post-exercise (3 h) 
are sampling points. Statistics: * P < 0.05, ** P < 0.01, † P < 0.1. Adopted from Sugama et 
al. 2013. 
 
Figure 6.5.  Taylor et al. used a custom MR-compatible stationary cycle in a 0.5-T open 
magnet magnetic resonance scanner with cine phase-contrast techniques to measure blood 
flow velocities in the inferior vena cava of young healthy subjects at rest and during upright 
dynamic lower limb exercise. Subjects were strapped to an upright seat in the open magnet to 
allow full range of leg motion while positioning the abdomen in the centre of the magnet for 
optimal imaging. The cycle was then positioned and its resistance was adjusted to promote 
comfortable pedaling and minimize abdomen movement that could affect image capture and 
quality. Adopted from Taylor et al. 2002. 
 
Figure 6.6. Schematic illustrating the potential mechanism of acute kidney injury through 
heavy physical exertion. In this setting, kidney injury is likely to exist on a scale of severity 
where milder activity only results in temporary phenomena such as haematuria and 
proteinuria. However, more strenuous activity of a higher intensity and longer duration, 
V
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coupled with various adverse modifiable and non-modifiable factors increases the risk of 
developing significant AKI. It is at this point where “normal” physiological responses to 
exercise cross-over into a clinically-significant pathological state. AKI, acute kidney injury; 
NSAID, non-sterodial anti-inflammatory drug. 
 
Figure 6.7. Diagram summarising the key putative pathophysiological connections in the 
cardiorenal syndrome. Given the recent formal recognition of this syndrome, these potential 
routes of communication are now being investigated in more detail. RAAS, renin–
angiotensin–aldosterone system; VD/VDR, vitamin D/vitamin D receptor. Adopted from 
Darabian et al. 2011. 
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COMMONLY USED ABBREVIATIONS 
A:Cr albumin:creatinine ratio 
ADH - anti-diuretic hormone 
AKI - acute kidney injury  
AKIN - acute kidney injury network 
ANP - atrial natriuretic peptide 
CKD – chronic kidney disease 
Cr - creatinine 
CON – control (group) 
ELISA - Enzyme-linked immunosorbent assay 
EIMD  - exercise induced muscle damage (group) 
GFR - glomerular filtration rate 
IL- interleukin 
NGAL - neutrophil gelatinase-associated lipocalin 
NGAL:Cr - neutrophil gelatinase-associated lipocalin: creatinine ratio 
P:Cr – protein:creatinine ratio 
PeP – post-exercise proteinuria 
RBF – renal blood flow 
RPF – renal plasma flow 
TNF-α – tumour necrosis factor alpha 
O2max – maximal aerobic capacity 
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CHAPTER 1  
 
GENERAL INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2 
Compared to the vast scientific literature on cardiac responses during exercise, the kidneys 
have been relatively ignored. However, their contribution to the maintenance of homeostasis 
in the setting of strenuous exertion cannot be underrated. For example, they are essential to 
the diversion of blood flow to active musculature, maintainance of intravascular volume by 
limiting filtration processes, and regulating electrolyte concentrations, particularly sodium 
and potassium (Grimby 1965a; Refsum and Strömme 1975; Zambraski 1990).  
These and other concomitant physiological changes such as reduced kidney blood flow, 
reduced glomerular filtration rate (GFR) and the presence of blood and protein in the urine 
(haematuria and proteinuria, respectively), could also be described as stress phenomena 
(Poortmans 1984, Poortmans and Vanderstraeten, 1994). The incidences of these vary and 
range from 11-100% depending on various factors that are described below (Bellingheri et al., 
2008). 
Clinicians encounter such phenomena in the context of acute and chronic kidney disease 
(CKD) and these often serve as biomarkers of disease severity. In the acute setting a rapid 
progressive glomerulonephritis is characterised by a reduction in glomerular filtration and 
increased amounts of haematuria and proteinuria (Lewington 2008). Proteinuria is thought to 
be mechanistically important in CKD as it can directly contribute to further glomerular 
damage partly through activation of pro-inflammatory pathways (Abbate et al., 2006). 
However, when these phenomena present during and following exercise they are, in the 
majority of cases, not as profound and are short-lived (hours to days) (Poortmans 1984; 
Bellingheri et al., 2008). Consequently, physiologists and clinicians currently regard such 
alterations as harmless. 
Nevertheless, there are numerous anecdotal reports in the literature that have associated 
strenuous exercise with significant acute disruption in kidney function (cf. acute kidney 
injury), through conditions such as heat stroke and rhabdomyolysis. The precise incidence of 
this is unknown but estimates of prevalence have approached 30% when strenuous exercise is 
performed in adverse environmental conditions e.g. in military personnel (MMWR 1990; 
Bosch et al., 2009; MSMR, 2012). Usually individuals who succumb to disrupted kidney 
function with exercise are healthy and disease-free, but hospitalisation is often required and 
despite supportive treatments, there is a high risk of death or permanent disability 
(Sithinamsuwan et al., 2009). 
Thus, such phenomena that are shared between what are considered to be a physiological 
response from the kidneys and kidney disease, provides the impetus to investigate the 
potential mechanisms and risk factors that can convert healthy exercising individuals to a 
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state of ill health. Aside from furthering knowledge of kidney physiology during exercise, the 
findings gained from such endeavours could have important public health implications.  For 
example, is heavy exercise “harmful” for the kidneys in certain individuals? Already such 
concepts have been investigated in other organs e.g. exercise, cardiac function and troponin 
elevations (Shave et al., 2010). Additionally, any findings will be of interest to specific “at 
risk” populations who perform regular strenuous physical activity such as amateur and 
professional athletes, the military, and sectors of the public services (e.g. fire fighters).  They 
will also provide a platform for further research in patients with established CKD, for whom 
exercise is currently being promoted as part of management strategy with little regard for its 
impact upon kidney function (Heiwe et al., 2011). 
Prior to focussing upon the specific circumstances in which strenuous exercise can result 
in significant kidney dysfunction, it is essential to provide a detailed description of the key 
physiological alterations that occur to the human kidneys during exercise, and a criticial 
appraisal of their measurement. In so doing, the reader can then perceive how such alterations 
may lead to a diseased state. 
 
1.1. PHYSIOLOGICAL CHANGES TO KIDNEY FUNCTION DURING EXERCISE 
 
1.1.1. Kidney blood flow. Measurement of actual or real-time renal (kidney) blood flow 
(RBF) in humans is technically challenging – even under normal resting conditions. This is 
complicated further during dynamic situations such as exercise owing to body movement. 
Non-invasive imaging techniques such as ultrasound Doppler have been used to demonstrate 
a general reduction in blood flow to all abdominal viscera during exercise with re-distribution 
to active musculature (Osada et al., 1999). However, more specific measurements in each of 
the two renal arteries with this modality have proved to be difficult because of interference 
from intestinal gas (Delahunt et al., 1996). Additionally, there are other technical limitations, 
including anatomic variations between subjects, interference from subcutaneous fat tissue and 
operator bias. Other imaging techniques such as nuclear magnetic resonance imaging have 
been used (Taylor et al., 2002). 
As an alternative, renal plasma flow (RPF) is closely related to RBF and can be 
mathematically defined and measured during and after exercise (Chapman et al., 1948). If the 
arterial plasma (Pa), venous plasma (Pv) and urine (Ux) concentrations of a substance are 
known together with the urine flow rate (V), the following equation can be used: 
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𝑅𝑃𝐹 =
𝑈𝑥 .𝑉
𝑃𝑎 −  𝑃𝑣
 
 
This assumes that a non-metabolite entering the kidney via the renal artery will exit 
essentially intact through the renal vein and into urine via the ureters. Diodone and p-
aminohippuric acid are chemically inert compounds that can be administered intravenously 
and utilised for this purpose (Chapman et al., 1948; Philips and Hamilton, 1948; Wilson et 
al., 1970). The latter is freely filtered and not reabsorbed within the nephron, though a small 
proportion in the vasa recta does not cross the Bowman’s capsule. This fraction is reabsorbed 
and then secreted into the tubular lumen via the proximal convoluted tubule cells. Thus, an 
effective RPF can be calculated:  
𝑒𝑓𝑓𝑒𝑐𝑡𝑖𝑣𝑒 𝑅𝑃𝐹 =  
𝑈𝑥
𝑃𝑎
.𝑉 
 
At rest, the kidneys receive approximately 20% of the total cardiac output (Guyton 1981). 
In comparison, skeletal muscles receive 20%, the liver, 30%, and 14% is delivered to the 
brain. With respect to blood flow, this is 4 ml/min/g in renal tissue compared to 0.04 ml/min/g 
in resting muscle. During exercise, this is reversed and active muscle blood flow may be as 
high as 8 ml/min/g (Guyton and Hall, 2011). Vigorous exercise (60% of maximal aerobic 
capacity, O2max) results in a reduction of RPF of almost one-quarter of baseline values 
(figure 1.1; Kenney and Ho, 1995). While during more vigorous activity (> 80% O2max), 
falls in RPF can approach 50% from baseline (Walker et al., 1994). Thus, reduction in RBF 
appears to be intensity-dependent with higher activity levels resulting in more profound 
reductions. Considering that there is up to a 400% increase in cardiac output during exercise, 
such declines suggest potent (and multiple) mechanisms must be at play to limit RBF.  
 
 
 
 
 
 
 
 
 
V
.
V
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Figure 1.1.  Renal blood flow as measured by 
p-aminohippuric acid clearance in young 
males  (26 ± 2 yrs; solid circles; n = 6) at rest 
and during exercise at two different 
intensities. Values of the subjects fell by 24 ± 
2% from baseline when 60% of O2 peak was 
encountered demonstrating the profound 
effect of exercise intensity on renal blood 
flow. Values are means ± SE. Adopted from 
Kenney and Ho, 1995. O2 peak, peak aerobic 
capacity (highest O2 observed).  
 
 
V
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Conversely, the duration of activity appears to play a less prominent role: prolongation of 
a light exercise load from 45 to 90 minutes does not impact upon effective RPF (Castenfors 
1967a). Similarly, during prolonged heavy exercise there is a further, albeit small, reduction 
in RBF that does not have discernible impact upon maintaining haemodynamic stability. The 
reductions in RBF cease after exercise as evidenced by urinary clearance of p-aminohippuric 
acid returning to almost baseline levels within 60 minutes of ceasing both light and heavy 
intensity exercise (Grimby 1965b; Castenfors 1967a). 
Potent neurohormonal influences are responsible for the reductions in RBF during 
exercise. The increased sympathetic drive during exercise promotes efferent and afferent 
arteriolar vasoconstriction, leading to increased vascular resistance (Tidgren et al., 1991). 
Specifically, this is through release of noradrenaline and activation of the renin-aldosterone-
angiotensin axis. Beta-adrenergic stimulation of the juxtaglomerular cells lead to the release 
of renin, which is augmented during exercise once a sufficient intensity has been attained. 
Despite the powerful renal vasoconstrictive effects of noradrenaline and angiotensin, 
these are partly counterbalanced by the renal synthesis of prostaglandins such as 
prostaglandin E2, which vasodilates afferent arterioles in the aim of maintaining adequate 
renal perfusion (Therland et al., 2004). This is of particular importance for the continued 
functioning of deep medullary nephrons that survive at critical partial pressures of oxygen of 
no more than 10 kPa (Leonhardt and Landes, 1963). Cyclooxygenase-2 inhibitors such as 
non-steroidal anti-inflammatory drugs prevent prostaglandin synthesis and over-the-counter 
preparations such as ibuprofen are commonly used amongst athletes as an analgesic to treat 
minor musculoskeletal ailments (Warden, 2010). This may shift the balance of maintaining 
RBF during exercise towards vasoconstriction and contribute to further physiological stress 
and kidney dysfunction (figure 1.2; Walker et al., 1994; Sanders, 1995).  
 
 
 
 
 
 
 
 
 
1.1.2. Glomerular filtration rate.  
Figure 1.2.  Renal blood flow (as measured by 
p-aminohippuric acid) in eight healthy males 
who performed treadmill exercise for 30 min at 
80% maximal aerobic capacity. Following 
control bout (open circles), the group repeated 
exercise one week later having taken 250mg of 
the non-steroidal anti inflammatory  
(indomethacin) 36hr previously (filled circles). 
Indomethacin produced a greater reduction in 
renal blood flow post-exercise compared to 
control (P = 0.009).  Adopted from Walker et 
al., 1994. 
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1.1.2. Glomerular filtration rate. Glomerular filtration rate (GFR) is defined as the volume of 
fluid filtered from the glomerulus into Bowman’s capsule per unit time (Guyton and Hall, 
2011). Similar to RBF, determining GFR ideally requires a solute that is freely filtered and is 
neither secreted nor reabsorbed by the nephrons. Thus, with this principle in mind, the 
following equation can be derived for such a solute if its urine (Ux), plasma (P) concentrations 
and urine flow rate (V) are known 
1
: 
 
𝐺𝐹𝑅 =  
𝑈𝑥 .𝑉
𝑃
 
 
Inulin, a naturally occurring fructan polysaccharide, is filtered by glomeruli but does not 
undergo tubular secretion or reabsorption, and therefore can be used to determine GFR by the 
above method (Erd et al., 1969). In humans, this can be administered as a continuous 
intravenous infusion with measurements of plasma and urine concentrations and urinary flow 
rates taken at chosen time intervals. Iohexol, a contrast medium, can be utilised in a similar 
fashion but a single injected dose followed by several measurements of plasma clearance over 
time is required (Krutzén et al., 1984).  
Use of inulin is considered a “gold standard” for GFR estimation and was applied in 
many early studies of kidney physiology during exercise.  However, this method does present 
practical challenges, including insertion of intravenous and urinary catheters that may be 
uncomfortable for subjects during strenuous physical activity, and rare hypersensitivity 
reactions to intravenous inulin infusions (Bacchetta et al., 2008). 
A less invasive and labourious method involves determining a urinary creatinine 
clearance (Hayman et al., 1933). Creatinine (Cr) derived from creatine phosphate found in 
muscle. Typically, over a 24-hour period, urine is collected to determine the amount of Cr 
excreted. Similar to above, the Cr concentrations in urine (𝑈𝐶𝑟) and a single recording from 
plasma (𝑃𝐶𝑟)  together with a urine flow rate (𝑉 ) can be used to calculate a urinary Cr 
clearance (𝐶𝑟𝑐𝑙): 
𝐶𝑟𝑐𝑙 =  
𝑈𝐶𝑟 .𝑉
𝑃𝐶𝑟
 
                                                        
1 The GFR calculated is assumed to be the GFR for all nephrons within the kidneys. 
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Apart from the practical issues surrounding urine collection other drawbacks of urinary 
Cr clearance lie in the numerous factors that may influence Cr metabolism, including: age, 
sex, ethnicity and muscle mass (Stevens and Levey, 2005). Also, in the specific context of 
exercise, use of creatinine may be flawed (see below) and as the test is typically performed 
over a 24-hour period, this makes it less suitable for the study of the acute effects of exercise 
upon renal function.  
Kidney physiology studies in the last decade have moved away from such invasive and 
laborious measurements to using serum or plasma Cr concentrations-based equations that 
generate an estimated GFR to reflect acute changes in kidney function during exercise (Banfi 
et al., 2009). However, the application of estimated GFR here is questionable. Aside from the 
issues inherent in using Cr as a marker of kidney function, GFR-based equations have been 
derived from specific patient populations with stable CKD and not from healthy exercising 
populations (Levey et al., 1999). Also, the equations assume stable Cr metabolism (i.e. 
relatively constant rates of production and excretion), however, this is not the case when there 
is abrupt impairment in kidney function (e.g. an acute kidney injury), or during intense 
exercise when muscle breakdown leads to increases in blood Cr. Indeed, if blood Cr is 
measured too early, falsely low or normal readings could result as the time required for a new 
steady state of Cr metabolism can exceed 24 hours (Chiou and Hsu, 1975). Hence, GFR 
would be under-estimated in such circumstances (Hostetter et al., 2010).  
Despite these limitations, the ease of obtaining this approximation, its low cost and 
widespread use in many clinical and research settings has made it popular amongst exercise 
physiologists investigating kidney function. Most studies utilizing this method have shown 
that GFR is unchanged during light to moderate exercise (Grimby 1965b, Poortmans et al., 
2013). However, with increasing intensity (measured by % maximal heart rate or % O2max), 
there is a systematic decrease in GFR where up to a 30% reduction from baseline may be seen 
(figure 1.3; Poortmans and Vanderstraeten, 1994, Poortmans et al., 2013). The decrease in 
GFR appears to be maximal immediately following exercise and extends beyond 60 minutes 
post-exercise during endurance based-events. A return of GFR back towards baseline levels 
may take several hours (Neumayr et al., 2003; Lippi et al., 2008, Mingels et al., 2009).  
As with control of RBF during exercise, adjustment of GFR is dependent upon the 
relative vascular tone between the efferent and afferent arterioles. Accordingly, it follows that 
a reduction of RBF during exercise leads to a similar effect on GFR and that this phenomena 
is again intensity-dependent. However, there are some distinct differences between GFR and 
RBF. Post-exercise, GFR decreases relatively less than RBF. This latter observation is 
V
.
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important because if the kidneys do not excrete the accumulated nitrogenous waste products 
from protein catabolism during exercise, then a toxic uraemia may potentially develop 
(Haralambie and Berg, 1976; Priest et al., 1982, Lemon et al., 1989). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
An important concept related to GFR and RBF is the filtration fraction. This represents 
the proportion of fluid within glomeruli which passes through into the tubules. 
Mathematically, it can be represented as follows, where RPF is considered as a surrogate for 
RBF: 
 
𝐹𝑖𝑙𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 =
𝐺𝐹𝑅
𝑅𝑃𝐹
 
 
The resting filtration fraction is 0.2 / 20%. Due to the relative preservation of GFR to RPF, 
filtration fraction increases during exercise in an intensity-related fashion. Castenfors (1976b) 
demonstrated that a short severe bout of exercise could result in a filtration fraction of 0.45. 
Figure 1.3. Changes (expressed as % rest) in glomerular filtration rate (GFR) following 30 minutes of 
treadmill exercise at 80% maximal aerobic capacity as estimated by serum creatinine (Cr; open circles), 
cystatin C (Cyst C; open squares), and by Cr clearance (Cl-Cr; filled triangles). Exercise resulted in all 
three measures indicating a marked reduction in GFR post-exercise, but more so for Cl-Cr (-30.0%) 
compared to Cyst C (-19.8%) and Cr (-18.2%).  Values are means ± SD. GFR, glomerular filtration 
rate. * Denotes significant differences with rest values (P < 0.05). † Denotes significant differences 
with Cr and Cyst C (P < 0.05). Adopted from Poortmans et al., 2013. 
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Although good experimental evidence is lacking, there are some plausible explanations 
including a relatively greater increase in efferent compared to afferent vascular tone (thus 
increasing intraglomerular pressures), and sluggish transit through glomeruli permitting more 
time for passage of fluid and other metabolites into the tubular space (Hohimer and Smith, 
1979). This latter mechanism may have a significant role to play in the manifestation of post-
exercise proteinuria and haematuria. 
 
1.1.3. Urine production. Generally, urine production and flow falls during and after exercise 
(Poortmans 1984, Bellingheri et al., 2008). Indeed, this is one of the few post-exercise 
observations that is apparent to the subject (the other being visible haematuria), but seems 
physiologically appropriate, as the kidneys need to maintain intravascular volume and 
therefore blood pressure during heavy physical exertion. 
However, the magnitude, duration and rate of decrease of urinary flow are not readily 
predictable. Indeed, Kachadorian and Johnson (1970) found that low levels of exercise were 
associated with increases in urine flow and sodium excretion. However, once higher exercise 
intensities are performed there is a decrease in free-water clearance, and even hyperhydration 
prior to or during severe exercise does not prevent the decrease in urine flow post-exercise 
(Refsum and Strömme, 1975; Virvidakis et al., 1986). Anti-diuretic hormone (ADH) plays a 
significant role in these observations as a fall in plasma concentrations permits higher urinary 
flow rates during low intensity exercise, whereas concentrations can increase almost three-
fold during higher intensity activity (Freund et al., 1991). Furthermore, ADH release can be 
increased by emotional components such as pain, high fluid losses, high ambient temperature 
and other hormonal factors such as renin, aldosterone and atrial natriuretic peptide (ANP, 
Cuneo et al., 1987; Galperin et al., 2006).   
A strong positive correlation has been observed between urinary flow rates and GFR at 
low exercise intensities (e.g. ~25% O2max; Freund et al., 1991). Apart from low plasma 
ADH at such workloads, concomitant increases in plasma ANP have been suggested as a 
contributory factor (Sosa et al., 1986). Similar to above, once sufficiently high intensities of 
exercise are achieved (≥80% O2max), GFR, urine flow and urine osmolality actually 
decrease, counteracting the effects of ANP (Freund et al., 1988). Increased sympathetic 
activity and falls in RBF through afferent vasoconstriction are again implicated, but the 
excretion of dilute urine suggests that concentration mechanisms are also being impaired 
(figure 1.4.; Wade, 1984).  
 
V
.
V
.
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1.1.4. Post-exercise proteinuria. The presence of protein in human urine was first 
documented by Morner in 1895 who commented upon a “mucodahliche Substantz” in 
military recruits (Morner, 1895). It is now recognised that protein excretion in the urine of 
healthy resting subjects may be up to 150 mg / day (Franklin, 1959). The vast majority of this 
consists of Tamm-Horsfall mucoprotein produced by the thick ascending limb of the loop of 
Henle (Tamm and Horsfall, 1950; Pennica et al., 1987). This can present either as a monomer 
of approximately 68 kDa or more commonly as large aggregates of several million Da. 
Globulin fractions account for 5-10% of total urinary protein of which approximately 50% are 
not found in the plasma or are only detectable in trace amounts (Poortmans and Jeanloz, 1968, 
Poortmans and Vanderstraeten, 1994). These glycoproteins have a molecular weightof 10-40 
kDa and include amongst others: immunoglobulin kappa and lambda chains, β2-microglobulin 
and lysozyme.  
From a practical perspective, initial rapid detection normally involves use of urine 
dipsticks (“multistix”) that give an approximate quantitative indication of total proteinuria but 
are prone to false-negative and false-positive results (Bonnardeaux et al., 1994). Many early 
physiological studies expressed post-exercise proteinuria as an excretion rate in µg/min to 
account for a concentration effect. However, recent studies have moved to using urine 
protein-to-creatinine or albumin-to-creatinine ratio (P:Cr or A:Cr, respectively), which has 
superseded the need for 24-hour proteinuria collections in the clinical setting with only a spot-
urine sample required (figure 1.5; Poortmans and Vanderstraeten, 1994; Siu et al., 2011). 
Figure 1.4.  Changes in plasma anti-diuretic hormone (left panel) concentration and urine flow rates 
(right panel) in eight healthy male subjects who underwent a graded cycle ergometry at different 
workloads (25, 40, 60 and 80% O2max). As workload increased, urine flow rates fell and there was a 
concomitant increase in plasma anti-diuretic hormone concentrations which was particularly marked 
between 60 to 80% O2max. Values are means ± SD. ADH, anti-diuretic hormone; * Denotes 
significant differences with pre values (p<0.05). Adopted from Freund et al., 1991. 
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Regardless of widespread use, it is yet to be clarified whether this is a valid measure given the 
instability of creatinine handling by the kidneys during exercise as discussed above.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Post-exercise proteinuria is one of the more thoroughly investigated exercise-induced 
renal responses (Poortmans 1977, Bellingheri et al., 2008). Young individuals without any 
evidence of renal disease can increase resting urinary albumin excretion rates as high as 100-
fold following intense exercise (Poortmans et al., 1981; Poortmans 1985, Poortmans and 
Vanderstraeten, 1994). It does not appear to have a precise quantitative definition, but recent 
studies that utilised A:Cr have cited a rise of more than 3 mmol/mg from resting values i.e. 
within the range of pathologic proteinuria at rest (Heathcote et al., 2009).  Previous 
observational studies revealed a variable prevalence depending on the physical discipline: 
boxers (25%), wrestlers (100%), gymnasts (13-55%), footballers (80%) and oarsmen (100%), 
but factors such as intensity and duration of exercise were often uncontrolled (Bellinghieri et 
al., 2008). Regardless, runners consistently appear to excrete more protein than cyclists, 
swimmers and rowers despite having similarily high plasma lactate levels after exercise 
(Poortmans et al., 1982). Moreover, this phenomenon is not observed in all participants, even 
with strenuous exercise and individuals who already have indications of significant 
proteinuria at rest (e.g. nephrotic-range proteinuria - greater than 3g / 24 hours; Cruz et al., 
Figure 1.5.  There a strong positive correlation (r = 0.95; P < 0.0001) between spot urine protein-to-
creatinine (Pr/Cr) ratio and concurrent 24-hour urine protein excretion as demonstrated in 174 adult 
patients with chronic kidney disease. Similar findings have been noted in many other studies and 
consequently use of protein-to-creatnine ratio has supplanted the use of 24-hour proteinuria estimations 
in routine clinical and research settings. Adopted from Siu et al., 2011. 
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1989). Constitutional factors may be relevant as protein excretion for exhaustive bicycle 
ergometry is highly correlated in monozygotic but not dizygotic twins (Liljefors et al., 1969). 
As with other physiological phenomenon during exercise, post-exercise proteinuria is 
driven by exercise intensity (Poortmans, 1984). This is supported by increased proteinuria 
rates following sprints compared to longer endurance-based events (figure 1.6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The pattern of protein excreted in post-exercise urine differs to the normal resting 
condition (Poortmans and Jeanloz, 1968). Through urine electrophoresis of post-exercise 
urine, an increase in glomerular permeability is evidenced by the presence of albumin and 
other larger macromolecules such as immunoglobulin G, α1-acid glycoprotein and α1-
antitrypsin (figure 1.7; Poortmans and Lion, 1963; Poortmans and Jeanloz, 1968). Moreover, 
more plasma protein seems to pass through into the urine after exercise than at rest and this 
accounts for over 80% of total protein excretion after exercise (Poortmans and Jeanloz, 1968). 
For diseased states, the type of proteinuria encountered can vary according to aetiology. For 
example, in multiple myeloma (a disease characterised by an abnormal proliferation of B-
lymphocytes), excess synthesis of abnormal monoclonal immunoglobulins can spill-over into 
the urine and result in an overflow proteinuria. Conversely, in disease states where there is an 
excess loss of normal proteins from plasma into the urine (e.g. nephrotic syndromes), 
Figure 1.6. Mean albuminuria excretion rates at different absolute intensities of exercise as measured 
by running distance. Grey bars represent mean values at resting state. Black bars are mean values 
following exercise. A 800 metre sprint has the highest propensity for post-exercise proteinuria. This 
progressively falls as longer distances are encountered. However, very short-term exercise (e.g. 100 
metre sprint) has a lesser effect than longer runs. Adapted from Poortmans, 1994. 
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proteinuria can be highly selective as demonstrated by a high urinary IgG:transferrin ratio. 
However, regardless of the aetiology, excessive and persistent albuminuria is indicative of 
CKD (Heathcote et al., 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Several postulated mechanisms have been put forward to explain post-exercise 
proteinuria. Firstly, an acidic environment during exercise as evidenced by lactate elevations 
is thought to affect glomerular permeability (Poortmans and Labilloy, 1981). Suzuki and 
Ikawa (1991) demonstrated that increased lactate production following strenuous exercise 
resulted in excretion of both albumin and low-molecular weight proteins, but also observed 
that increased organic acids could change glomerular permeability by decreasing surface 
anionic charge and inhibiting tubular reabsorption. In animal studies, intravenous injection of 
hydrochloric acid with subsequent metabolic acidosis induced proteinuria in rodents 
(Poortmans 1977). Moreover, this observation is supported by studies in humans that have 
shown a decrease in exercise-induced proteinuria following infusion of sodium bicarbonate to 
correct lactic acidosis (Bellinghieri et al., 2008). 
Figure 1.7. Comparison between the molecular weight of proteins and their renal clearance under 
normal resting conditions (filled bars) and post-exercise (unfilled bars). The letter under each pair of 
columns indicates the plasma protein studied: A, β2-glycoprotein I; B, α1-acid glycoprotein; C. α1-
antitrypsin D, Gc-globulin; E, tryptophan-rich prealbumin; F, albumin; G, hemopexin; H, transferrin; I, 
haptoglobin; J, cerulplasmin; K, γA-globulin; and L, γG-globulin. It is clear that proteins of a higher 
molecular weight are excreted following exercise suggesting an increase in glomerular permeability. 
Adopted from Poortmans and Jeanloz, 1968. 
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Secondly, as discussed in the preceding section, the vasoconstriction of renal arterioles 
during exercise induces a more marked reduction of RBF compared to GFR and therefore 
increased filtration fraction (Castenfors 1967b). Indeed, inducing vasoconstriction 
experimentally though an infusion of noradrenaline in man at rest yields an approximately 20-
fold increase in proteinuria (Cantone and Cerretelli, 1960; Taylor 1960). The increased 
hydrostatic pressures that results (due to a relatively greater efferent to afferent arteriolar 
vasoconstriction), coupled with sluggish kidney blood flow is likely to enhance diffusion of 
macromolecules into the tubular lumen (Hohimer and Smith, 1979). 
Thirdly, upregulation of renin during exercise through heightened sympathetic activity 
and stimulation of the juxtaglomerular apparatus may also be influential, as proteinuria can be 
induced experimentally by intravenous renin injection (Pickering and Prinzmetal, 1940; 
Deodhar et al., 1962). Kallikrein, an enzyme of the kinin system, could also be involved, as 
proteinuria is provoked when kallikrein is injected into rabbits and several kinin-releasing 
enzymes are found in urine after healthy subjects perform proteinuria-inducing exercise 
(Murakami et al., 1968; Masamura et al., 1970). 
The final theory states that exercise proteinuria results from a loss of fixed negative 
charges on the capillary wall that leads to a loss of charge-dependent glomerular 
permselectivity (Deen and Satvat, 1981). This has been shown experimentally by infusing the 
polycation hexadimethrine that neutralises the polyanions of the glomerular basement 
membrane in rats and induces an acute reversible proteinuria (Hunsicker et al., 1981; Bridges 
Jr et al., 1991). However, this experimental glomerular injury is only observed in rats, as in 
exercising humans immunoelectrophoresis does not reveal any differences between the fixed 
charges of proteins in resting and post-exercise urines (Poortmans 1984). 
When higher intensity activity is encountered, tubular proteinuria becomes more 
prominent (up to 100-fold from baseline) with the appearance of lower molecular weight 
proteins (< 40 kDa) such as lysozyme and β2-microglobulin. This suggests impairment of 
tubular reabsorption due to saturation of reabsorptive mechanisms (Miyai and Ogata, 1990). 
Nevertheless, albumin still constitutes the majority of protein excreted. Thus, post-exercise 
proteinuria following severe exercise is of the mixed glomerular-tubular type (Poortmans et 
al., 1988; Poortmans and Vanderstraeten, 1994). 
Maximal proteinuria occurs 20-30 minutes following exercise (Poortmans and 
Vanderstraeten, 1994). Both urinary total and albumin excretion rates follow a logarithmic 
decline with a half-life of about one hour and resting levels achieved 24-48 hours after 
activity (Coye and Rosandich, 1960). Persistence beyond this time period should raise the 
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need for further investigation (Bellinghieri et al., 2008). To date, it has been assumed that 
post-exercise proteinuria is not associated with any long-term sequalae such as CKD. The 
evidence for this is almost non-existent and is partly derived from the benign nature of other 
forms of physiological proteinuria e.g. orthostatic proteinuria (Springberg et al., 1982). This 
is a tenuous association as individuals with post-exercise proteinuria may experience greater 
degrees of renal stress compared to those without (Bellinghieri et al., 2008). 
 
1.1.5. Post-exercise haematuria. The first description concerning the presence of blood in the 
urine may have been over 2000 years ago (Fine 1986). The incidence of haematuria in normal 
resting subjects varies between 13-38% depending on the population studied and the 
definition used as haematuria can denote the presence of erythrocytes per se or apparent 
haematuria such as myoglobinuria or haemoglobinuria (Rockall et al., 1996). Haematuria is 
properly defined as microscopic when greater than three erythrocytes per high power field or 
when 1000 erythrocytes / ml urine is noted (Froom et al., 1984; Mohr et al., 1986; Rockall et 
al., 1996). Haematuria may also present macroscopically, where blood and / or clots can be 
visible to the subject. The latter invariably leads to distress and often leads to physicians 
conducting further investigations. 
Phase-contrast microscopy can be used to determine their origin from the renal tract: 
dysmorphic erythrocytes transit through glomeruli and tubules leading to deformity of their 
membrane, whereas erythrocytes of a normal appearance are likely to have arisen post-
glomeruli e.g. from the bladder (figure 1.8; Pillsworth Jr et al., 1987).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8. Examples of normal and dysmorphic erythrocytes as seen by phase-contrast microscopy (at 
x400 magnification): A) normal erythrocyte; B) ghost erythrocyte (where haemoglobin has leached 
out); C) dysmorphic erythrocyte extruding small bleb from membrane; D) dysmorphic erythrocyte with 
ruptured membrane. Adopted from Pillsworth Jr et al., 1987. 
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Like proteinuria, initial detection commonly involves the use of a urine multistix that are 
readily available and allow rapid detection but may not be able to differentiate reliably 
between true and apparent (i.e. false-positive) haematuria (Doezema and Standefer, 1990). 
For haematuria, the urine multistix utilises a pseudoperoxidase in haemoglobin that catalyses 
a reaction between hydrogen peroxide and tetramethylbenzidine resulting in a green oxidised 
chromogen (Martin et al., 1984). Free haemoglobin produces a colour change from yellow 
(negative) to blue (strongly positive). In contrast, when whole erythrocytes make contact with 
the test strip, the liberated haemoglobin results in a speckled pattern with the the detection of 
haematuria. With this method, most studies have demonstrated 91-100% sensitivity, while the 
specificity is more variable at 65-99% (Gleeson et al., 1995; Worrall 2009). False positive 
and negative results may occur as the reagents react with a host of other substances and 
accounts for the variable specificity e.g. vegetable peroxide, Escherichia Coli and myoglobin 
(Gibson and Le Seve, 1986). Thus, any suspicion of true haematuria should be evaluated 
formally by a wet-slide examination from fresh urine (Schumann and Schumann, 1992). 
Ramazzini described haematuria following exercise in 1713 after studying the urine of 
runners, but the first formal description of exercise-induced hematuria is credited to Barach in 
1910, who detected erythrocytes through microscopy in the urine of 18 marathon runners after 
a 40-kilometre race (Barach 1910; Brieger 1980; Franco 1999). Postulated mechanisms for 
exercise-induced haematuria vary and are both intensity and duration-based (Jones and 
Newhouse, 1997). This can be partly explained through the type of physical activity where 
potentially different stresses are placed upon erythrocytes and the kidneys. 
With reference to intensity–based mechanisms, the reduction in RBF together with 
vasoconstricting effects promotes a relative hypoxia within the kidney (Helzer-Julin et al., 
1988). This may lead to increased fragility of spiral vessels that connect interlobular arteries 
to the capillary bed and following exercise their contents may leak into minor calyces for 
excretion when resting renal blood supply resumes (Baker, 1959). Catechoamines themselves 
may promote erythrocyte destruction by two means: i) through release of a haemolysing 
factor (lysolecithin) from splenic contraction, and ii) via a direct effect on erythrocytes which 
increases osmotic and mechanical susceptibility (Newhouse and Clement, 1988; Szygula, 
1990).  
Historically, the most commonly documented cause of exercise-induced haematuria is the 
footstrike haemolysis (march haemaglobinuria) that is noted in long-distance runners due to 
physical trauma of erythrocytes circulating close to the sole of the foot (Horder and Horder, 
1970; Dufaux et al., 1981; Eichner, 1985). The haemoglobin released from this form of 
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haemolysis usually complexes with plasma haptoglobin. However, when this mechanism 
becomes saturated then overspill into the urine occurs (Jones and Newhouse, 1997). This 
mechanism is further supported by haemolysis being greater in running compared to 
swimming, downhill running versus uphill running, and running in hard-soled relative to 
running in soft-soled shoes (figure 1.9; Buckle, 1965; Miller et al., 1988). Other potential 
mechanisms affecting erythrocyte membranes during exercise include peroxidation due to 
free radical production during exhaustive exercise, dehydration affecting erythrocyte 
osmolarity, increased circulation rate, and elevated core body temperature (Clement and 
Sawchuck 1984; Szygula, 1990; Sjodin et al., 1990). 
Potentially independent of intensity and duration, bladder and kidney trauma is another 
plausible mechanism by which haematuria can arise e.g. jostling of the bladder and kidneys 
during running. Cystoscopic examination in runners 48-hours post-exercise has demonstrated 
bladder wall contusions which can predispose to haematuria (Blacklock, 1977). Furthermore, 
direct trauma to the kidneys during traumatic sports such as boxing can yield haematuria. 
Aside from physical force, a crouched body positioning and a lack of cushioning perirenal fat 
may also be contributory (Kleiman, 1958).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9. Urine samples taken during a seven-mile run in an individual prone to march 
haemoglobinuria. Tubes 1, 2 and 3 represent urine taken before, 20 and 60 minutes after running with 
insoles, respectively. Tubes 4, 5 and 6 represent the same time points of urine sampling, but taken 
whilst running without insoles. With the insoles there was no detectable change in plasma haemoglobin 
or haptoglobin. Adopted from Buckle, 1965. 
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As discussed in section 1.1.1, non-steroidal anti-inflammatory medications are used often 
by athletes and can affect RBF adversely through prostaglandin inhibition and exacerbate any 
exercise-related reductions in RBF. As the renal papillae within the medullary region are 
especially dependent upon prostaglandin E2-dependent blood flow, this mechanism can 
partake in the development of a renal papillary necrosis with sloughing of papillae that 
presents with macroscopic haematuria, urinary obstruction and loin pain (Henrich 1998).  
 
1.1.6. Urinary sediments. Apart from erythrocytes, a variety of other cellular elements are 
found in post-exercise urine including white blood cells (leukocytes), epithelial cells, and 
casts. Under resting conditions, three leukocytes and epithelial cells of a normal population 
may be seen (Geyer 1993). Casts are usually hyaline and comprises of Tamm-Horsfall protein 
that originates from the dropout of distal convoluted tubular cells (Tamm and Horsfall, 1950; 
Pennica et al., 1987). Exercise leads to marked increases in other sediment elements: 
Poortmans (1977) found a mean urinary excretion of 280 erythrocytes, 900 leucocytes and 
365 epithelial cells per minute after strenuous exercise in 90 healthy young men. Most of the 
casts were hyaline. 
The presence of granular casts may also occur after heavy exercise and is associated with 
tubular damage and an acute disruption in kidney function (Geyer 1993). Howenstein (1960) 
performed renal biopsies in three marine recruits following intensive squat jumping exercise 
and reported adhesions between the Bowman’s capsule and the glomerular tuft, pigmented 
debris in the tubular lumens and dilated tubules whose lumens contained a granular cast.  
 
1.1.7. Electrolyte metabolism. Heavy exercise appears to generally inhibit electrolyte 
excretion – especially that of sodium (Grimby 1965a; Castenfors 1967a; Kachadorian 1972). 
This makes physiological sense if the exercising body is to maintain intravascular volume and 
blood pressure. Rather than being due to declines in GFR, increased tubular reabsorption is 
the major influence for reduced sodium loss. Sympathetic stimulation leading to activation of 
the renin-angiotensin-aldosterone axis and increased levels of aldosterone, promotes both 
sodium and water reabsorption from the collecting duct (Freund et al., 1991). The rise in 
plasma aldosterone activity is related to both intensity and duration of exercise and there is an 
inverse relationship between plasma aldosterone and urine output (Galbo 1982). Other 
electrolytes such as chloride, calcium and phosphorus also demonstrate similar reductions in 
excretion after exercise, although potassium excretion, in contrast to the other electrolytes, 
may vary (Poortmans, 1984). 
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With respect of urine osmolality, short-term exercise of moderate intensity is associated 
with an increase in urine osmolality of about 40 mOsm/l. However, as intensity of exercise 
increases, osmolality decreases implying a defect in tubular concentrating mechanisms.  
Generally, most urinary electrolyte changes during exercise do not have clinical 
consequences. However, the combination of exercise-related increases in aldosterone, and 
ADH, and regular fluid intake (including hyperhydration) during prolonged endurance 
activity, can lead to a progressive dilution of plasma and its sodium content (O’Connor 2006; 
Draper et al., 2009). Biochemically, this manifests as hyponatraemia with a low plasma 
sodium concentration, low plasma osmolality and comparatively higher urine osmolality. 
Exercise-induced hyponatraemia is potentially life-threatening when developed acutely. Non-
specific symptoms such as lethargy, nausea, vomiting can progress to reduced consciousness 
levels and fitting owing to the development of cerebral oedema; particularly when lower 
plasma sodium concentrations of less than 115 mmol/l are encountered (O’Connor 2006). 
Treatment involves a careful assessment of fluid balance upon presentation and in most cases 
a fluid restriction is sufficient. In instances of repeated fitting and reduced consciousness, 
ventilator support, benzodiazepines and hypertonic saline may be indicated (Hew-Butler et 
al., 2008).  
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1.2. EXAMINING THE BOUNDARY BETWEEN PHYSIOLOGICAL STRESS AND PATHOLOGICAL STATES 
DURING STRENUOUS PHYSICAL EXERTION. 
 
The preceding discussion has outlined the changes to kidney physiology during exercise in 
healthy humans and so far could be regarded as normal phenomena. Nonetheless, they clearly 
exhibit a potential to crossover into a pathological condition. For example, reductions in RBF, 
GFR, proteinuria and haematuria are all characteristic clinical features of acute and chronic 
kidney disease. If exercise-induced changes do not revert back to resting values shortly 
following activity, prolonged interruptions to RBF and GFR could manifest as nitrogenous 
waste accumulation, severe electrolyte disturbances, and hypervolaemic states – all of which 
are life-threatening. Likewise, chronic proteinuria can be damaging to the kidney in the long-
term as it contributes to a pro-inflammatory state associated with fibrotic changes of the renal 
parenchyma (Abbate et al., 2006).  
 
1.2.1. Endurance exercise and troponin elevation. The notion of physiological stress 
resembling a pathological state during heavy physical exertion has been investigated 
extensively in the heart. Like the kidneys, prolonged changes in normal physiological 
responses during exercise such as elevated cardiac output, heart rate and systolic blood 
pressure in conjunction with the physiologic milieu of endurance activity (e.g. elevations in 
reactive oxygen species, altered pH, and increased core temperature), could hypothetically 
damage cardiomyocytes (Shave et al., 2010). Interestingly, similar factors have also been 
found to influence acute and chronic cardiac diseases (Ono et al., 2004)  
The ever-growing number of participants in marathons and similar events has permitted 
investigation of this possibility largely through the measurement of troponin-I and T-
myocardial contractile proteins, which are sensitive and specific serum biomarkers of 
myocardial injury primarily used for the diagnosis of myocardial infarction (Thygesen et al., 
2007). Here, troponin is elevated post-endurance exercise to concentrations comparable to an 
established myocardial infarction (figure 1.10; Shave et al., 2005; Collinson et al., 2006; 
Shave et al., 2010).  
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The reported incidence of this phenomena has ranged from 0 to 78% over the last two 
decades and this variability is partly due to the development of troponin-T immunoassays 
with improved sensitivity and specificity and application of different cut-off criteria (Shave et 
al., 2005). Initial assays could not reliably discriminate between skeletal and cardiac muscle 
damage but the current 4
th
 generation high-sensitivity troponin-T immunoassay possesses less 
than 0.001% cross-reactivity with skeletal troponin-T (cf. 12% cross-reactivity with 1
st
 
generation troponin-T assay) (Wu et al., 1994b; Laslett et al., 1996; Michielsen et al., 2008). 
Compared to the large number of observational studies in the literature, laboratory-based 
studies examining troponin release during controlled exercise are relatively few. Of those 
identified, some reveal modest elevations in troponin (0.02-0.04 μg/l) as early as 30 minutes 
into exercise (Middleton et al., 2002). Similar to kidney-related phenomena, the highest 
elevations are encountered during exercise of the highest intensity (i.e. 100% ventilatory 
threshold) rather than prolonged duration (Fu et al., 2009). Indeed, it has been shown that 
troponin-T elevations correlate inversely with training distance, suggesting that adaptation of 
the heart to strenuous exercise may decrease cardiac myocyte injury (Nelian et al., 2006). 
This conclusion is supported by the similar kinetics of other biomarkers of cardiac stress such 
as proBNP (Shave et al., 2007). Age and training status may also have some bearing on the 
degree of troponin rise encountered (Neumayr et al., 2001; Fortescue et al., 2007).  
 
1.2.2. Mechanisms of troponin release during endurance exercise. The mechanism of 
troponin rise in endurance activity so far remains unclear. It could potentially reflect cardiac 
muscle stretch that results in cytosolic troponin leakage due to transient increases in myocyte 
Figure 1.10. Cardiac troponin T 
measured in individual competitors 
following the London Marathon in 
2005. Approximately 78% of runners 
demonstrated troponin T values above 
0.01 μg/l, 58% above 0.03 μg/l, 36% 
above 0.05 μg/l and 11% above 0.1 
μg/l. All cut-offs have been diagnostic 
of an acute myocardial infarction. 
cTnT, cardiac troponin T. Adopted 
from Shave et al., 2005. 
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membrane permeability from the stress-induced overload of free radicals, hypoxia or 
ischaemia (McNeil and Khakee, 1992; Koller and Schobersberger, 2009; Goette 2009). This 
purported mechanism has similarities with exertional rhabdomyolysis of skeletal muscle 
where leakage of specific proteins such as creatine kinase and myoglobin also occurs (Warren 
et al., 2002). Although this process is distinct from myocardial infarction where actual 
necrosis of the contractile apparatus occurs (Wu et al., 1994b).  
Another factor potentially contributing to troponin elevations is the decrease in GFR 
during exercise that may impact upon troponin excretion (see section 1.1.2.). Minor troponin 
rises in patients occur in patients with end-stage renal disease i.e. GFR of typically < 10 
ml/min/1.73 m
2
 (Wallace et al., 2006). However, in this specific clinical context such elevated 
concentrations portend an increased risk of a future acute cardiovascular event (Sommerer et 
al., 2007). 
 
1.2.3. Endurance exercise and cardiac imaging. Apart from blood-based biomarker sampling, 
concomitant measures of cardiac function through imaging suggests transient decreases in 
systolic function and diastolic filling with an overall immediate post-exercise reduction in the 
ejection fraction, systolic blood pressure/end systolic volume pressure and early-to-late 
diastolic filling ratio (figure 1.11; Mousavi et al., 2009; Middleton et al.; 2006). Even in the 
long term, diastolic abnormalities of the left and right ventricle may persist up to one month 
despite normalisation of systolic abnormalities (Neilan et al., 2006).  
 
 
 
 
 
 
 
Figure 1.11. Transthoracic echocardiogram images in a marathon participant with a troponin-T 
concentration that increased from 0.01 to 0.54 μg/l post-marathon. (A) Baseline image demonstrating normal 
right ventricular structure and function. (B) Post-marathon evidence of mild right ventricular dilatation (right 
ventricular end-diastolic diameter 38 mm) and a decrease in right ventricular fractional area change of 35%. 
(C) Post-marathon cine-image in the horizontal long-axis view confirming a decrease in the right ventricular 
ejection fraction of 44%. LA: left atrium; LV: left ventricle; RA: right atrium; RV: right ventricle. Adopted 
from Mousavi et al., 2009. 
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Nonetheless, the majority of non-invasive imaging data so far argue against an 
association of post-event troponin elevations and permanent myocardial injury (Siegel et al., 
1995; Shave et al., 2010). In addition, the kinetics of troponin release following heavy 
endurance exercise bears little resemblance to that of an acute myocardial infarction and does 
not support irreversible cell death (Middleton et al., 2008). The majority of troponin-T 
elevations post-exercise are short-lived and concentrations return back to normal within 24-48 
hours after a strenuous event, whereas in myocardial infarction, troponin release follows a 
biphasic pattern with an initial release at two hours and a later release due to degeneration of 
the contractile apparatus (Shave et al., 2010). 
Probably the most convincing evidence of the benign nature of this occurence is that a 
large proportion of people who partake in regular strenuous exercise will have repeated 
elevations in cardiac biomarkers without coming to harm or clinical attention (Shave et al., 
2010). However, until the precise nature of cardiac biomarker up-regulation is resolved, 
physicians will still be surrounded by much confusion to whether this phenomenon is 
physiological or pathological. This situation is furthermore complicated by the widespread 
incidence of abnormal resting electrocardiograms in athletes (Wu et al., 2006).  
In contrast to the heart, the kidneys demonstrate specific instances whereby there is a 
clearer transgression to a pathological state from prolonged physiological stress during heavy 
physical exertion. The physiological stress may be the cause or contributory factor of an acute 
kidney injury that leads to a significant disruption of kidney function and might require urgent 
medical attention. Before describing these specific conditions in turn, it is necessary to move 
discussion into the clinical setting to define acute kidney injury and its relationship to kidney 
physiology during exercise. 
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1.3. ACUTE KIDNEY INJURY 
 
Acute kidney injury (AKI), formally known as acute renal failure / insufficiency, is a clinical 
syndrome which can be simply defined as an abrupt or sudden insult to the kidneys with the 
end result being a reduction in kidney function (Webb and Dobb, 2007). The aetiology can be 
divided anatomically into three key areas: 1) pre-renal (disorders affecting perfusion to the 
kidneys); 2) renal (disorders affecting the kidney parenchyma); and 3) post-renal (disorders 
related to the structures post-kidney i.e. obstruction to ureters, bladder). The consequences of 
AKI can be life-threatening, particularly if dysfunction is prolonged and complications reflect 
an inability of the kidneys to maintain fluid, acid-base and electrolyte homeostasis e.g. 
hypervolaemic states, metabolic acidosis and hyperkalaemia (Mehta et al. 2007). 
There is scarce data on the incidence of AKI and this has been marred by the previous 
lack of consensus on a working definition. However, hospital-acquired AKI appears to be 
more prevalent than the community form (7.1% vs. 1%; Kaufman et al., 1991; Nash et al., 
2002). However, recent evidence suggests that community-acquired AKI, which can include 
AKI sustained from strenuous exercise, is at least as severe as hospital acquired AKI 
(Schissler et al., 2013). The severity may result in the need for intensive care support and data 
from the UK-based Intensive Care National Audit Research Centre (ICNARC) suggests that 
AKI alone accounts for nearly ten percent of all intensive care unit bed days (Simpson et al., 
2005). Mortality in this setting can exceed 50%. Thus, AKI following heavy exertional 
activity is potentially a real public health concern, particularly when populations involved in 
strenuous physical activity are considered, e.g. amateur and professional sports players, or 
public services (e.g. military, firemen). 
 
1.3.1. Development of AKI definition. The term AKI represents a recent development in 
terminology and has arisen through the need to standardise an operative definition that can be 
used in both clinical and research environments (Mehta et al., 2007). Previously, the 
definition varied according to the clinical environment; intensive care physicians, surgeons 
and emergency physicians all had unique definitions with differences based on their 
experience. This led to difficulties in determining the epidemiology and outcomes of AKI 
(Mehta et al., 2007). The term AKI now denotes a spectrum of disease from mild kidney 
impairment to a more severe phenotype requiring supportive therapies such as dialysis 
(Bellomo et al., 2004). Hence, a worldwide consortium was established to define stages of 
AKI that would indicate increasing severity of illness. The Acute Kidney Injury Network 
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(AKIN) criteria classifies AKI into three stages of progressive disease based upon elevations 
of serum / plasma Cr or decreased urine flow rates (table 1.1; Mehta et al., 2007; Molitoris et 
al., 2007). This has resulted in raising awareness of AKI amongst clinicians, allowing 
prognostication and facilitatation of a standardised approach to both audit and research. 
 
 
AKI Stage 
 
Serum creatinine (Cr)  
criteria 
 
 
Urine output criteria 
 
1 
 
Increase ≥ 26 μmol/L within 
48hrs or increase ≥ x 1.5 to x 
1.9 reference Cr. 
 
< 0.5 mL/kg/hr for > 6 
consecutive hrs. 
 
2 
 
 
Increase ≥ x 2 to x 2.9  
reference Cr. 
 
< 0.5 mL/kg/hr for > 12 hrs. 
 
3 
 
increase ≥ x 3 reference SCr 
or increase ≥354 μmol/L or 
commenced on renal 
replacement therapy 
irrespective of stage. 
 
< 0.3 mL/kg/hr for > 24 hrs 
or anuria for 12 hrs. 
 
 
 
 
 
 
1.3.2. Traditional biomarkers of AKI. Aside from Cr and urine output, there are other 
biomarkers that may be used to support or refine the diagnosis of an AKI. There is merit in 
performing smear examinations of a fresh urine samples to look for granular casts, as these 
are strongly suggestive of an acute tubular necrosis (Geyer 1993; Kanbay et al., 2010). 
Calculation of a fractional excretion of sodium or urea helps to differentiate between pre-renal 
AKI and acute tubular necrosis (Schrier 2011). Also, ultrasonography of the renal tract at the 
earliest opportunity is recommended to ensure that urinary tract obstruction is excluded as a 
cause of AKI (Kalantarina, 2009a). 
However, it should be noted that derangements of Cr, urine output are actually reflective 
of altered kidney function and not necessarily injury. Evidence for this comes from the 
observation that acute falls in GFR following kidney injury (i.e. as reflected by increased 
blood Cr), may take time to manifest until a new steady state in Cr metabolism becomes 
Table 1.1. Acute Kidney Injury Network criteria for acute kidney injury. Each stage indicates 
progressive severity of AKI. Either one of serum creatinine and urine output criteria has to be satisfied 
for each stage of AKI. It is envisaged that widespread introduction of this new system will enable 
healthcare professionals to consider the AKI as a spectrum of disease. Anuria, less than 100 mls urine / 
24 h. Renal replacement therapy includes all forms of dialysis. Adapted from Mehta et al., 2007. 
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established (Waikar and Bonventre, 2009). The situation is also complicated by the fact that 
serum Cr is insensitive to small changes in GFR (Slocum et al., 2012). Hence, the precise 
time of insult may predate GFR decline and subsequent blood Cr elevations by several hours 
or longer (Portilla et al., 2008). In the clinical setting, this implies that blood Cr 
concentrations could be “normal” in the face of AKI and reduced GFR, leading to 
misdiagnosis, delayed treatments and the added risk of progression to acute tubular necrosis 
with its associated complications. 
 
1.3.3. Novel biomarkers of AKI. From the above discussion, it is clear that the current AKIN 
criteria utilises changes in Cr and urine output as surrogates for an AKI despite these being 
insensitive, non-specific and late markers of disease (Slocum et al., 2012). Consequently, 
there has been intense research over the past decade to discover biomarkers reflective of 
kidney cell injury that could aid early diagnosis and treatment of AKI. This process of 
identification is costly and has recently involved use of spectrometry-based proteomic and 
metabolomic analyses as they have the advantage of utilizing blood and urine (Wang et al., 
2010). So far, this has yielded a number of potential biomarkers such as  interleukin-18, 
kidney injury molecule-1, liver fatty acid binding protein-1 and cystatin-C - the latter of 
which is not a kidney injury biomarker per se, but as a filtration biomarker demonstrates an 
earlier rise compared to Cr when detecting falls in GFR (Han et al., 2002; Herget-Rosenthal 
et al., 2004; Ichimura et al., 2004; Parikh et al., 2004; Yamamoto et al., 2007; Wu et al., 
2008). 
At the time of commencing this doctorate, of the numerous potential AKI biomarker 
candidates, neutrophil gelatinase-associated lipocalin (NGAL) has shown the most promise 
(Carrillo-Esper et al., 2011). NGAL is a 25 kDa protein encoded by the LCN2 gene. 
Originally isolated from neutrophil granules it is secreted by the epithelia of numerous organs 
where its functions include limiting bacterial growth by sequestering iron-containing 
siderophores (Flo et al., 2004; Mishra et al., 2005; Wang et al., 2010). It also participates in 
the motility of breast carcinoma cells and has been classed as a cytoprotective factor in 
conditions of oxidative stress (Roudkenar et al., 2008; Fougère et al., 2010). In the setting of 
AKI however, NGAL is up-regulated in high concentrations in the blood and urine. Rodent 
models of ischaemic AKI suggest the source of release to include the proximal and distal 
renal tubules (Mishra et al., 2003; Paragas et al., 2011). In humans, NGAL is elevated within 
two hours of renal insult and numerous studies have demonstrated superior sensitivity and 
specificity for AKI compared to blood creatinine in a variety of clinical settings e.g. intensive 
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care, emergency room, post-cardiac surgery and post-kidney transplantation (figure 1.12.; 
Mishra et al., 2003; Mishra et al., 2006; Nickolas et al., 2008; de Geus et al., 2011; Parikh et 
al., 2011).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Furthermore, NGAL elevations are proportional to the severity of the AKI. This has 
prognostic value with high concentrations associated with a greater incidence of renal 
replacement therapy and in-hospital mortality, both in the presence and the absence of a blood 
Cr rise (Hasse et al., 2011). Such favorable characteristics have led to the development and 
availability of turbimetric and rapid point-of-care NGAL immunoassay kits for clinical use, 
but at present the cost-effectiveness of this approach remains debatable (Han et al., 2009; 
Koch et al., 2011). 
 
 
 
 
 
Figure 1.12. One of the seminal studies demonstrating the clinical utility of NGAL as an AKI 
biomarker in children who underwent open-heart surgery with cardiopulmonary bypass. In the 20 
patients who sustained AKI (N = 20), serum NGAL concentrations were elevated at two hours (P = 
0.001) whereas those without AKI (N = 51) did not demonstrate any discernable rise (P > 0.05). Those 
with AKI had serum creatinine elevations (> 50% from baseline) 22 hours after NGAL. Adopted from 
Mishra et al., 2005. 
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1.4. DOES AKI OCCUR DURING STRENUOUS PHYSICAL ACTIVITY? 
 
At the very least, the numerous changes to kidney physiology during heavy exercise calls into 
question whether a kidney injury (albeit temporary) is occurring. The bulk of laboratory-
based and observational work examining kidney function during exercise predates current 
AKIN criteria. However, if AKIN criteria were applied, they would satisfy stage one serum 
creatinine elevations in many instances, especially during endurance-based activity (Neumayr 
et al., 2003; Mingels et al., 2009). An AKI in this setting seems plausible as the aetiology of 
the majority (> 70%) of AKI cases encountered in the clinical setting are pre-renal i.e. 
involving a sudden reduction in RBF (Hou et al., 1983). This and falls in GFR are phenomena 
clearly shared with strenuous exercise.  
However, there are some caveats. Firstly, in the majority of cases, urine flow rates does 
not usually remain depressed for more than six hours post-exercise (the time period of 
oliguria as stated in AKIN criteria). Secondly, increases in blood Cr may be confounded by 
increased muscle damage sustained through exercise, combined with the effect of a decrease 
in GFR. Thirdly, as mentioned earlier, the use of estimated GFR to document acute variation 
in renal function during exercise could be flawed, as such equations are derived from 
populations with CKD and are not valid in acute settings such as AKI and other experimental 
circumstances where there is brief manipulation of kidney function. Indeed, there is 
suggestion that GFR criteria should be developed for athletes as these may significantly differ 
between different disciplines depending on the phenotype required for the sport e.g. rowers 
versus rugby players (Lippi et al., 2011). Finally, although GFR falls during intensive 
exercise, this is maintained with no further decrements if exercise is performed over a longer 
period at a similar intensity (Poortmans et al., 1996). This is not the case in instances of AKI 
requiring hospital admission, where GFR may continue to decrease, especially if the stressor 
is prolonged or maintained e.g. by infection and / or nephrotoxic medication use (Nash et al., 
2002).  
Few studies have investigated the application of molecular AKI biomarkers, such as 
NGAL, following exercise. These have been observational and focussing only on endurance 
activity and not the high-intensity exercise which elicits more profound changes in kidney 
physiology (McCullough et al., 2011). Additionally, since endurance events can last several 
hours, use of these makes it difficult to determine how early NGAL is up-regulated by 
exercise. Additionally, urinary concentrating effects have not been taken into account and 
little comparisons has been made to other traditional biomarkers of kidney injury. NGAL 
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concentrations in both blood and urine are elevated post-event but are short-lived and so far 
do not approach ranges associated with AKI as seen in clinical settings (McCullough et al., 
2011). Thus, there is considerable scope here for further research. 
Regardless, in the real-world setting, most healthy people who regularly perform 
strenuous exercise will not be labelled with a diagnosis of AKI, because: 1) physiological 
changes to kidney function during exercise are considered by the medical community to be 
“normal” and temporary; and 2) most individuals do not come to the attention of a clinician 
for further investigation following heavy exercise unless it is incidental or a harmful event 
occurs e.g. collapse post-marathon. There are nonetheless specific instances following heavy 
physical exertion where a prolonged derangement to kidney function arises that becomes 
directly responsible for hospitalisation, intensive monitoring and specific therapies that may 
extend towards a severity requiring dialysis and fulfilling stage three AKIN criteria (Mehta et 
al., 2007). The outcomes here are not always favourable and death can result, particularly 
when multi-organ failure ensues. These will now be discussed. 
 
1.4.1. Exertional rhabdomyolysis.  
 
1.4.1.1. Definition. Exertional rhabdomyolysis represents the rapid breakdown of striated 
muscle through strenuous physical activity (Cervellin et al., 2010). Following muscle fibre 
necrosis, leakage of intracellular calcium activates cellular proteases with the release of 
numerous intracellular muscle proteins such as myoglobin, creatine kinase and lactate 
dehydrogenase (Warren et al., 2002). Apart from well-recognised symptoms such as delayed-
onset muscle pain, soreness and weakness, AKI associated with rhabdomyolysis is a life-
threatening complication (Bywaters and Beall, 1941). 
 
1.4.1.2. Incidence. There is a variable incidence of AKI associated with rhabomyolysis due to 
the different settings which this is experienced, but estimates range from 13 up to 50% (Bosch 
et al., 2009). In a law enforcement training class where 50 participants exhibited laboratory 
evidence of rhabdomyolysis, 13 (26%) were admitted to hospital with evidence of “renal 
failure” (serum Cr > 176.8 mmol/l): of which, six received dialysis and one died of kidney 
and liver failure from combined rhabdomyolysis and heat stroke (MMWR, 1990). In contrast, 
cases appear to be infrequent in marathon runners. Between 1969 and 1986, Seedat et al. 
(1990) reported only 19 cases of acute renal failure reported in the South African Comrades 
marathon; even when participants were averaging 2,000 to 10,000 per year over this time 
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period. There are now probably fewer reports in the literature of this occurrence as it is no 
longer considered novel and there is greater awareness of precautionary measures (Clarkson 
2007). 
 
1.4.1.3. Pathophysiology. Overwhelming myoglobin precipitation within renal tubules is the 
principle cause of AKI following exertional rhabdomyolysis. Myoglobin is a single peptide 
protein of 153 amino acids with a molecular weight of 17.8 kDa (Kagen 1979). A small (0.01-
5%) but constant proportion of filtered myoglobin is excreted into the urine under resting 
conditions and most is reabsorbed by the proximal tubules where it is catabolised though 
endocytosis and proteolysis (Beetham 2000). However, in exertional rhabdomyolysis the 
filtered myoglobin load can exceed the reabsorptive capacity of the tubule, and myoglobinuria 
(cola-coloured urine) can result once its concentration surpasses 100 mg/dl (or plasma 
concentration > 1.5 mg/dl) (Knochel 1982). 
There are two key factors that promote myoglobin precipitation. Firstly, a low urinary pH 
(< 5.6) is likely to cause myoglobin to dissociate to globulin and toxic haematin (Ellenhorn, 
1997). In murine models, acidic urine is required to promote renal impairment when 
myoglobin concentrate is intravenously infused (Zager 1989). This leads to several potential 
mechanisms of injury, including renal vasoconstriction by activation of the cytokine cascade, 
intraluminal cast formation and retention with Tamm-Horsfall protein which physically 
blocks tubules (Zager 1996). There is also evidence for direct haem-protein induced 
cytotoxicity through free-radical formation (Salahudeen et al., 1996).  The second factor is 
hypovolaemia which impacts upon RBF and promotes reduced urinary flow rates, enabling 
myoglobin to remain within tubules and exert toxicity (Beetham 2000). 
 
1.4.1.4. Diagnosis. To determine the extent of rhabdomyolysis, usually blood creatine kinase 
(skeletal muscle isoform) is measured since it is regarded as the most sensitive measure of 
myocyte injury (Moghtader et al., 1997). Blood creatine kinase concentrations in humans are 
typically 45-260 U/l and elevations due to rhabdomyolysis typically occur within 12 hours 
from the onset of muscle injury, peaking at one to three days post, and declining after three to 
five days (Huerta-Alardin et al., 2005). In exercise involving a significant eccentric 
component, substantial rises in creatine kinase are expected (Clarkson and Hubal, 2002). 
Additionally, exercise intensity rather than duration is the most important determining factor 
for muscle enzyme release as endurance-type exercise generates creatine kinase 
concentrations < 5000 U/l and peak approximately 24 hours post-exercise (Clarkson 2007). 
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While myoglobin is a direct marker of muscle damage, it is rarely used in the diagnosis of 
rhabdomyolysis. Firstly, myoglobin concentrations may not fully reflect progressive muscle 
damage given its shorter half-like in plasma compared to creatine kinase (two to three hours 
vs. 1.5 days, respectively) (Poels and Gabreels, 1993). Also, myoglobin is rapidly 
metabolised to bilirubin and excreted in the urine with concentrations returning to normal by 
24 hours, thus making it difficult to monitor the evolution of muscle damage (figure 1.13, 
Huerta-Alardin et al., 2005).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The creatine kinase concentration at which AKI is seen with exertional rhabdomyolysis is 
not well defined. Overall, there appears to be a poor correlation between creatine kinase and 
plasma Cr concentrations (Clarkson and Eichner, 2006). Very high creatine kinase 
concentrations may be encountered without any significant rise in plasma Cr or fall in urine 
output (Clarkson et al., 2006). Sinert et al. (1994) reported on 35 cases of exertional 
rhabdomyolysis with mean admission creatine kinase of 40,471 U/l though a retrospective 
chart analysis over a five-year period. None of their cohort developed renal impairment (as 
defined by plasma Cr > 2 mg/dl or urea > 25 mg/dl) or other related metabolic consequences 
such as hyperkalaemia, hyperphosphataemia, hypocalcaemia, or acidosis. However, if the 
AKIN criteria are applied then six out of their 35 patient cohort would have satisfied stage 
Figure 1.13. Kinetics of plasma myoglobin and creatine kinase (CPK) elevations following 
rhabdomyolysis. Myoglobin is the first protein to increase, but owing to its rapid clearance from plasma 
concentrations, rapidly return to normal within 24 hours. Conversely, CPK is elevated a few hours later 
than myoglobin but reaches its peak value within the first 24 hours and can remain as such for up to 
three days. This characteristic enables CPK to be a more practical marker for the severity and evolution 
of muscle injury.  Adopted from Giannoglou et al., 2007.  
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one AKI (Mehta et al., 2007). Another study of 477 rhabdomyolysis cases found a highly 
significant association between serum Cr and creatine kinase concentrations (R
2 
= 0.12, P < 
0.0001), but the predictive value of creatine kinase determining the variance of serum Cr in 
this model was low and there were only three exertional rhabdomyolysis cases noted over an 
eight year period (Melli et al., 2005). A previous study has also confirmed this lack of 
predictive correlation (Gabow et al., 1982). 
Such findings have contributed to the lack of clear guidance to when individuals, based 
on creatine kinase concentrations, should be monitored and hospitalised for the potential 
development of AKI (Clarkson and Eichner, 2006). Nonetheless, most authorities advocate 
that creatine kinase concentrations of greater than five to ten-times the upper limit of normal 
or between 5,000 to 10,000 U/l should at least warrant observation of urine output, 
myoglobinuria and daily measurement of plasma Cr, whereas treatment should be instigated 
prophylactically at 20,000 U/l (Huerta-Alardin et al., 2005; Terpilowski and Cridddle, 2004; 
Clarkson and Eichner, 2006a, Cervellin et al., 2010).  
Urinary concentrations of myoglobin have been investigated as alternative predictors of 
AKI onset (Rodriguez-Capote et al., 2009). However, this has been hampered by the reasons 
discussed above regarding myoglobin analysis and the paucity of well-designed trials. A 
recent systematic review concluded that the sensitivity of urine myoglobin in patients with 
AKI due to rhabdomyolysis was 100% from eight studies, but specificity was much lower and 
varied between 15-91%. This was partly due to marked differences in study design, disease 
spectrum, reference standard and test methodology (Rodriguez-Capote et al., 2009). There is 
a suggestion that serum myoglobin together with a low urine myoglobin (indicating low 
clearance) may indicate a high risk for developing AKI in the clinical setting, but the cost-
effectiveness of this approach is doubtful (Wu et al., 1994a; Rodriguez-Capote et al., 2009). 
Moreover, in the context of physical activity, serum myoglobin concentrations do not 
necessarily correlate with the occurrence of kidney injury: after a 99 km ultramarathon 25 out 
of 44 runners had elevated serum myoglobin but none developed kidney injury (Schiff et al., 
1978). The usefulness of other muscle damage markers and their relationship with AKI has 
not been established to justify their routine clinical use (Cervellin et al., 2010).   
Given the variability in the relationship between biomarkers of muscle damage to predict 
AKI, it is clear that other factors must be involved. These include: a lack of preconditioning to 
strenuous exertion, heat stress, preceding viral infection, use of non-steroidal anti-
inflammatory drugs, alcohol, cocaine, heroin, hyperuricaemia, diuretics, latent myopathy (e.g. 
McArdle’s syndrome), urate metabolism, sickle cell trait and possibly a genetic predisposition 
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involving polymorphisms of the myosin light chain kinase gene (Huerta-Alardin et al., 2005; 
Clarkson et al., 2006b). The latter may be particularly significant as there is wide inter-
individual variability in the magnitude and time course of plasma creatine kinase response 
related to exercise-induced muscle damage, and this in turn leads to a classification of low, 
medium and high creatine kinase responders (Chen 2006). Thus, it is likely that a “perfect 
storm” of factors may be required for an AKI to develop (Clarkson 2007). 
 
1.4.1.5. Treatment and prognosis of AKI in exertional rhabomyolysis. Treatment of AKI from 
exertional rhabomyolysis primarily involves aggressive intravenous overhydration (Huerta-
Alardin et al., 2005). A forced diuresis when started within six hours of diagnosis has been 
reported to minimize the risk of AKI developing (Zager 1996). The choice of intravenous 
fluid is currently debatable. Given the evidence of myoglobin precipitation in renal tubules at 
a low urinary pH, dilute sodium bicarbonate (e.g. 1.26%) solutions are advocated to achieve 
alkaline urine (pH above 7.5) and a solute diuresis (Eneas et al., 1979; Ozgüç et al., 2005). 
But despite its widespread use, superiority to 0.9% saline solutions is so far lacking (Homsi et 
al., 1997; Brown et al., 2004; Huerta-Alardin et al., 2005; Scharman and Troutman, 2013). 
There are theoretical benefits of diuretics such as mannitol and furosemide that would 
maintain urine flow rates and reduce the likelihood of tubular myoglobin deposition, but good 
randomised controlled data is lacking (Karajala et al., 2009). 
In the majority of cases, the above treatments result in resolution of AKI within days 
(Huerta-Alardin et al., 2005; Cervellin et al., 2010). Occasionally, damage to tubules may be 
more extensive and result in an acute tubular necrosis characterised by increasing blood 
creatinine and urea, variable urine output, progressive metabolic acidosis and severe 
hyperkalaemia despite intravenous fluids. In such instances, prolonged supportive treatment 
dialysis may be required for weeks to months, but despite this the outcome for complete 
recovery in renal function remains good (Uberoi et al., 1991). With respect to preventative 
strategies, modifiable risk factors should be addressed e.g. good hydration prior to exercise, 
limited use of non-steroidal anti-inflammatory drugs, and pre-conditioning, which is known to 
reduce myoglobin release from myocytes after exercise (Byrnes et al., 1985). 
 
1.4.2. Exertional Heat Stroke  
 
1.4.2.1. Definition. Exertional heat stroke is a life-threatening condition where central nervous 
system abnormalities (e.g. confusion, seizures, coma) occur following physical activity in hot 
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environments where excessive heat generated from cannot be dissipated effectively 
(Bouchama and Knochel, 2002). A core body temperature of typically > 40
o
C has often been 
stated as being part of the definition, but lower values satisfying hyperthermia (i.e. > 37.5
o
C) 
may also be associated with heat stroke. Other organ dysfunction may also develop and this 
includes AKI, which may or may not be associated with exertional rhabdomyolysis (Schrier 
et al., 1967; Schrier et al. 1970; Raju et al. 1973).  
 
1.4.2.2. Incidence. The incidence of AKI in exertional heat stroke appears to be variable and 
depends upon the population studied and the presence of risk factors such as sex (women > 
men), geographical region of origin (hotter > cooler climates) and ethnicity (Caucasians > 
Afro-Carribean) (Carter et al., 2005). Incidence rates are better described in the military 
literature and have varied between 10-25%. This is partly reflective of the various definitions 
of heat stroke employed (Schrier et al., 1967; Clowes and O’Donnell, 1974; Chapman 1995). 
In one of the largest epidemiological studies of heat illness in US military personnel involving 
5246 soldiers, Carter and colleagues placed the incidence of AKI in heat stroke at 16% 
(Carter et al., 2005). However, once heat stroke victims are admitted into the intensive care 
unit, AKI almost invariably seen within 24 hours of presentation (Pease et al., 2009). 
 
1.4.2.3. Pathophysiology. The kidneys act as both victim and villain to the multi-organ 
dysfunction that typifies exertional heat stroke. The pathophysiology is complex and is 
believed to involve interplay between heat cytotoxicity, disseminated intravascular 
coagulation, and a systemic inflammatory response syndrome (Perchick et al., 1975; Shieh et 
al., 1995; Willatts et al., 1995; Heled et al., 2013).  
Hyperthermia may lessen cell survival through a direct effect on membrane integrity, 
increased enzymatic reactions rates, and generation of harmful reactive oxygen species (Leon 
and Helwig, 2010). However, this may vary amongst individuals as conditioned athletes can 
tolerate hyperthermia without side-effects due to the training-induced heat acclimatization 
effects on cellular protective mechanisms (McClung et al., 2008). Furthermore, the increase 
in skin blood flow in hyperthermic states is accompanied by a compensatory fall in 
splanchnic blood flow to maintain blood pressure (Nybo, 2007). Such haemodynamic 
alterations could compromise the kidneys further when already up to 50% of RBF is 
redirected during intense exercise (Walker et al., 1994).  
Thermal injury to the vascular endothelium is regarded as the primary initiating event 
that leads to disseminated intravascular coagulation (Mustafa et al., 1985). In vitro studies 
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have shown that exposure to temperatures of 43-44
o
C causes platelet activation and 
aggregation (Gader et al., 1990). Together with the excess deposition of fibrin, this leads to 
microvascular thromobosis. Organ dysfunction ultimately results and hypoperfusion is further 
exacerbated by blood loss due to excessive intravascular consumption of coagulation 
products. Compounding this, endotoxin can activate cytokines and endothelial cells to 
amplify the coagulation cascade (Huisse et al., 2008).  
The contribution from systemic inflammatory response syndrome in heat stroke is thought 
to result from the translocation of gastrointestinal bacteria into the systemic circulation when 
splanchnic blood flow to the gut is compromised (Leon and Helwig, 2010). This 
endotoxaemia in turn activates numerous pro- and anti-inflammatory intracellular peptides 
including cytokines interleukin (IL)-1, IL-1, IL-1 receptor antagonist, IL-6, soluble IL-6 
receptor, IL-8, IL-10, IL-12, interferon-, tumor necrosis factor-; all of which are commonly 
observed following collapse from heat stroke (Leon 2007). The function of these molecules is 
very complex and different interactions are observed depending upon the clinical or 
experimental model studied e.g. plasma IL-8 concentration is elevated in exertional heat 
stroke but unchanged following exercise in the heat (Heled et al., 2013). Additionally, there 
may be different sources cytokine production. For example, IL-6 is secreted by active 
musculature but can also be derived from the renal tubules and epithelia in the setting of AKI 
with heat stroke (Lu et al., 2004; Lee et al., 2011; Pedersen 2013). Therefore, as a source of 
cytokine synthesis, the kidneys may serve to propagate the pathophysiological processes 
underlying heat stroke.  
Environmental factors that contribute to exertional heat stroke evolution are many and 
include: a heat stressed environment, dehydration, obesity and over clothing (Adams et al., 
2012). A history of exertional heat illness, recent or current viral illness and fever have only 
been anecdotally associated. Genetic factors involving polymorphisms in genes that encode 
proteins associated with the acute phase response to heat could interact with environmental 
triggers leading to the development of organ dysfunction (Protasi et al., 1995). 
Aside from the cytokine milieu, circulating vasoconstrictive and vasodilatory hormones 
are present in exertional heat stroke. These are recognised to play a role in the pathogenesis of 
ischaemic and septic models of AKI in both humans and animals (Cumming et al., 1988). In 
brief, during the acute phase of exertional heat stroke, marked elevations of renin, 
aldosterone, plasma catecholamines and endothelin-1 result in a predominantly 
vasoconstrictive environment in the kidney (Lin et al., 2003). However, the concurrent 
reductions in prostaglandin E2 with rise in nitric oxide concentrations fail to counterbalance 
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this. The resultant renal haemodynamic status is likely to lead to extensive endothelial injury 
and tubulointerstitial damage to the kidneys. Co-existent rhabdomyolysis can also exacerbate 
the clinical picture (Shieh et al., 1992).  Lin et al. (2003) attempted to summarise the factors 
and complex interactions that lead to AKI during exertional heat stroke (figure 1.14). 
 
 
 
 
 
 
 
 
 
 
 
 
1.4.2.4. Diagnosis. Hyperthermia can be reliably assessed by using an oesophageal or rectal 
probe that determines core temperature, and central nervous system abnormalities can be 
defined by the Glasgow Coma Scale or characterised by seizure activity (Adams et al., 2012). 
Following this, heat stroke victims need to be observed assiduously for development of organ 
dysfunction. This can be monitored through regular assessment of blood biomarkers 
concentrations. However, these may not be sensitive or specific enough to detect damage as 
they can also be released from other organs and tissues altered by heat and exhaustive 
exercise e.g. up-regulation of creatine kinase may suggest rhabdomyolysis or myocardial 
infarction (Goddard and Warnes, 1992; Wallimann and Hemmer, 1994). In addition, there is 
suggestion that over-reliance of these traditional biomarkers may result in misdiagnosis of 
heat stroke and its recovery: rat models of heat stroke show dissociation between temperature 
profiles, urea, aspartate transaminase and alanine transaminase, with histological  damage to 
kidney and liver at 10 days post-heat stroke recovery (Leon and Helwig, 2010).  This implies 
that traditional biomarkers expected to be reflective of organ damage in heat stroke are not 
Figure 1.14. A proposed mechanism elucidating the complex relationship between vasoactive 
mediators, inflammatory responses and renal haemodynamics in exertional heat stroke. NO: nitric 
oxide; PG, prostaglandin; GFR, glomerular filtration rate; ARF, acute renal failure i.e. AKI. Adopted 
from Lin et al., 2003. 
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specific enough and strengethens calls for investigation of novel biomarkers in heat-stroke 
mediated organ injury, such as NGAL. 
 
1.4.2.5. Treatment and prognosis. Apart from immediate resuscitative measures, rapid whole-
body ice-cold water immersion is one of the recognised evidence-based treatments for 
lowering core temperature and preventing the downstream effects on thermal injury upon 
organ function (Smith 2005; Casa et al., 2012). Others include evaporative cooling, ice cold 
packs in axillae and more invasive procedures such as gastric and peritoneal ice lavage.  
There is no role for dantrolene and anti-pyretic agents such as paracetamol, and no 
randomised-controlled trials have assessed the effectiveness of non-steroidal anti-
inflammatory drugs (Smith 2005; Leon and Helwig, 2010). If immersion is delayed, the risk 
of permanent organ damage is increased (Bouchama and Knochel, 2002). Once multi-organ 
failure ensues, supportive management in the intensive care setting e.g. invasive ventilation 
techniques and vasopressors, correction of coagulation derangements and renal replacement 
therapy. Compared to standard haemofiltration, trials utilising high cut-off haemofiltration 
techniques or plasma exchange may be beneficial for the removal of cytokines involved in 
heat stroke (Raj et al., 2013; Atan et al., 2013). 
Potential therapies for severe sepsis have also been trialled in heat stroke. These include 
anti-cytotoxin, anti-endotoxin and anti-coagulation therapies, but results are not promising 
and multicentre trials involving over 6000 severe sepsis patients have shown no benefit on 
all-cause mortality (Redl et al., 1998). There are several reasons for this including limited 
understanding of the precise roles of cytokines in heat stroke, failure to neutralise target 
proteins, compensatory increase of other mediators with similar activities, and inappropriate 
timing or duration of therapy (Remick, 2003). The latter may be relevant in terms of the lack 
of ability to precisely define the start of organ injury, and again injury specific biomarkers 
such as NGAL could assist in this regard and lead to re-evaluation of promising cytokine-
targeted treatment.  
Multi-organ failure in heat stroke carries a mortality of greater than 20% (Casa et al., 
2012). Additionally, 30% of survivors experience permanent reductions in organ or tissue 
function that in turn increase the risk of mortality during the subsequent recovery period 
(Argaud et al., 2007). Military heat stroke patients have also shown a two-fold increased 
mortality from cardiovascular risk, kidney, and liver failure within 30 years of hospitalisation 
for a non-heat related illness (Wallace et al., 2007). Heat stroke is currently more preventable 
than treatable. Strategies include acclimiatization to heat, reduction in duration and intensity 
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of physical activity, rescheduling of activities to cooler times of the day, adequate hydration, 
appropriate clothing, and removing vulnerable populations from the heat stressed 
environment, e.g. those with an infection (Leon and Helwig, 2010; Adams et al., 2012). 
 
1.4.3. Acute Renal Failure with Severe Loin Pain and Patchy Renal Ischaemia after 
Anaerobic Exercise. 
 
1.4.3.1. Definition. This is a less well-recognised form of AKI that occurs following 
anaerobic exercise e.g. short track sprints. Symptoms are characterised by a prodrome of 
nausea and vomiting followed by loin or abdominal pain that is typically sharp and 
lancinating in nature (Ishikawa et al., 1982). The pain is thought to be due to vasospasm 
(renal angina), but given the condition’s association with use of analgesics, flank pain due to 
concurrent use of non-steroidal anti-inflammatory drugs and papillary necrosis may be 
difficult to distinguish (Johnson and Wen, 1995). The patchy renal ischaemia refers to the 
typical appearance of contrast enhancement following computer-aided tomography imaging 
(Ishikawa et al., 1981). 
 
1.4.3.2. Incidence. Less than 200 cases have been reported in the literature so far, with over 
90% occurring in young males (Ishikawa 2002). There also appears to be a preponderance of 
this condition in Japan, possibly a reflection of increased awareness and recognition, and 
hence, diagnosis, of the syndrome in Japan.  
 
1.4.3.3. Pathophysiology. It is believed that during anaerobic exercise, the rapid re-diversion 
of blood flow to musculature is responsible for significant kidney ischaemia and acute loin 
pain (Ishikawa 2002). However, as discussed above, this is a physiological adaptation that 
would not normally cause clinically significant ischaemia. Therefore, an additional insult 
must be necessary. Given that approximately half of affected individuals have a low serum 
uric acid concentration together with a high fractional excretion of urinary uric acid, renal 
hypouricaemia has a likely pathological role (Ishikawa 2002). The lack of uric acid through 
its increased excretion prevents the neutralisation of reactive oxygen species that are formed 
during anaerobic activity (Murakami 1995). Such free radicals can inhibit the action of 
cyclooxygenase, which catalyses a critical step in the production of Prostaglandin E2, and as 
mentioned is an important mediator of renal vasodilation during times of reduced RBF 
(section 1.1.1.). In recent years, this purported mechanism has gained support from genetic 
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studies of affected individuals that revealed mutations in the urate anion exchange gene 1 that 
is responsible for increased urate excretion (Tanaka et al., 2003). A previous theory of a uric 
acid crystallopathy leading to tubular obstruction is not supported by renal biopsies that 
instead consistently demonstrate an acute tubular necrosis (Ishikawa 2002).  
 
1.4.3.4. Diagnosis. Apart from biochemical evidence of kidney injury, a key diagnostic 
feature is patchy wedge-type enhancement of the kidneys following contrast-aided computer 
tomography (figure 1.15). This reveals itself in a delayed fashion over hours to a few days and 
the contrast enhancement appears to be more diffuse when the AKI is more severe (Ishikawa 
2002). 
 
 
 
 
 
 
 
 
 
 
Furthermore, creatine kinase and myoglobin only demonstrate mild elevations in serum 
(upper normal of creatine kinase and myoglobin less than seven and nine-times upper limits, 
respectively) (Ishikawa 2002). These lower elevations are thought to be in part due to the 
predominantly type II muscle fibre damage that ensues following performing anaerobic 
exercise bouts  (repeated short sprints); type II fibre having lower amounts of myoglobin than 
type I fibres (Berchtold et al., 2000).   
 
1.4.3.5. Treatment and prognosis. AKI in this condition is typically mild and treated with 
conservative measures (e.g. intravenous fluids), although cases requiring dialysis have been 
reported (Ishikawa 2002). Given the non-oliguric nature of this AKI, prognosis appears to be 
good in most cases despite dialysis, but in a significant proportion (around 20%), this 
condition recurs on performing exercise (Ishikawa 2002). 
 
Figure 1.15. A schematic illustration of wedge-shaped contrast enhancement following acute renal 
failure with severe loin pain and patchy renal ischaemia after anaerobic exercise. Initially, contrast 
media is not taken up by the wedge-shaped diseased area but appears later on. The size of the wedge-
shape appears to be proportional to the degree of kidney injury. Adopted from Ishikawa, 2002. 
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1.5. AIMS OF PHD STUDY 
 
In the preceding sections, the key alterations to kidney physiology that occur through heavy 
physical exercise has been described in detail and their stressful nature appears to resemble 
pathological states. The discussion then progressed to defining AKI and attempting to apply 
this to the marked perturbations that the kidneys experience during exercise. Finally, taking a 
step further into the clinical setting, three specific instances where severe AKI is encountered 
in exercise were described in detail. The clinical significance of these settings highlights the 
need for further research to dissect the interactions between exertional activity and AKI. 
Understanding why apparently healthy individuals can rapidly develop life-threatening 
pathology may have far-reaching public health implications and permit prediction of 
individuals who are at risk. To this end, the subsequent four chapters represent studies 
exploring specific areas of this relationship.  
Chapter 2 aims to determine if the presence of post-exercise proteinuria indicates a mild 
transient exercise-induced kidney injury. This is conceivable as there is physiological stress 
during exercise and proteinuria per se is known to be damaging to the kidney (section 1.1.4.). 
Through a short duration but high-intensity bout of proteinuria-inducing exercise, a biomarker 
of kidney injury (NGAL) is measured post-exercise to determine whether kidney injury or 
stress occurs. Such efforts would allow further insights into site-specific renal stresses during 
exercise and may provide a novel and more sensitive method of assessing the acute effects of 
exercise on the kidney than blood Cr. Additionally, any changes in NGAL concentrations 
post-exercise may have implications in biomarker interpretation within the clinical 
environment (cf. troponin, section 1.2.1.). 
Further investigation of post-exercise proteinuria is pursued in chapter 3. Using a 
systematic review of available literature, the acute phenomena of post-exercise proteinuria is 
explored as a risk factor for the onset or progression of CKD. Persistent proteinuria is a 
biomarker of CKD, and is pathogenic if left untreated i.e. it can accelerate the progression of 
CKD. However, there is currently no consensus on whether exercise-induced proteinuria 
represents a potentially useful test to predict the onset or progression of CKD. This is an 
important question as such a diagnostic tool could potentially provide a non-invasive method 
of determining the onset of nephropathies at various stages, or act as an adjunctive or triage 
assessment before more risky invasive procedures such as renal biopsy. Additionally, it could 
allow for early proactive measures to prevent disease progression. Previous work in this area 
is scarce and has generally focused on diabetics with or without nephropathy.  
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By using an exercise-induced muscle damage model followed by heat stress, chapter 4 
probes the inflammatory component of AKI. Exercise-induced muscle damage, heat stress 
and AKI are each typified by a pro-inflammatory state. Moreover, the cytokine IL-6 is 
released by exercising muscle and also plays a crucial role in the initiation and development 
of inflammation in AKI. By exposing healthy individuals to a prior bout of muscle-damaging 
exercise followed with endurance exercise in the heat, novel and traditional AKI biomarkers 
are measured to determine whether increased kidney stress occurs. Such findings would have 
implications for at-risk populations including amateur and professional athletes, military 
personnel and firefighters, as well as offering insights into the pathophysiology of heat illness 
and AKI. 
Chapter 5 attempts to further isolate the relationship between plasma IL-6 and 
biomarkers of kidney injury and function. Despite its perceived importance as a mediator of 
AKI, the experimental manipulation of IL-6 in animal models yields variable findings 
depending on type of AKI studied. Such disparities could be due to variable degrees of insult, 
experimental time course, definitions of AKI used, or be reflective of pleiotropism exhibited 
by IL-6. The impact of IL-6, in humans upon biomarkers of AKI is currently unknown. 
Hence, recombinant IL-6 is infused into healthy humans to simulate concentrations 
experienced in an ischaemic model of AKI, and assessed the behaviour of biomarkers of 
kidney injury and function.  
Finally, chapter 6 concludes the thesis with a summary of the key findings arising from 
the four studies. Links are made between the studies and current literature. Aside from 
discussing the limitations of the methodologies used in the studies, clinical applications and 
future directions of research are also discussed. 
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CHAPTER 2  
 
DOES PROTEINURIA-INDUCING PHYSICAL ACTIVITY INCREASE 
BIOMARKERS OF ACUTE KIDNEY INJURY? 
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2.1. ABSTRACT 
 
It was determined if an acute kidney injury biomarker, neutrophil gelatinase-associated 
lipocalin (NGAL), would be up-regulated by high intensity proteinuria-inducing exercise. 
Through a prospective cohort design, 90 healthy, active adults (mean age 24 ± 4 (SD) years) 
were screened for post-exercise proteinuria (PeP); 10 PeP positive and 10 PeP negative 
participants then completed a high-intensity exercise protocol involving an 800 metre sprint.  
Plasma and urinary NGAL, urinary creatinine, urinary albumin and urine volume were 
obtained at the following time points: pre-run, immediately post-, 25 minutes, one hour and 
two hours post-run. Following maximal exercise, 64% of participants had urinary NGAL 
concentrations above the normal range, particularly at 25 minutes post (P = 0.002). However, 
there was no difference in NGAL response between PeP positive and negative groups and 
plasma NGAL was decreased, not elevated, following exercise (P = 0.002). In some 
individuals normalizing urinary NGAL for urinary creatinine attenuated elevations. Urinary 
NGAL was also negatively correlated with urine volume (r = -0.701, P = 0.005). In 
conclusion, proteinuria susceptibility did not influence an acute injury biomarker response to 
exercise.  Nevertheless, urinary NGAL is likely to be elevated by exercise, possibly due to 
increased production by the proximal tubule, increased plasma clearance (given the decrease 
in plasma NGAL) and / or a concentrating effect of exercise-induced oliguria. Until correct 
normalisation of urinary biomarkers is determined, NGAL should be interpreted cautiously in 
exercise and acute kidney injury-induced oliguria. The inter-individual NGAL response to 
exercise also warrants further investigation.  
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2.2. INTRODUCTION 
 
During exercise, the kidneys maintain homeostatic composition of extracellular fluid, thus 
enabling regulation of vascular volume and preservation of cardiac output. However, high-
intensity physical activity is associated with marked perturbations in kidney function 
(Poortmans 1984). In fact, 30 - 40% decreases in kidney blood flow have been observed as 
blood is diverted to other metabolically demanding tissues such as the active musculature 
(Guyton and Hall, 2011). In addition, enhanced proteinuria and haematuria, reductions in 
glomerular filtration rate (GFR), impaired handling of electrolytes and amino acids are also 
apparent (Kadachorian and Johnson, 1970). 
When chronic, such perturbations are usually associated with kidney pathology 
(Mookerje et al., 2001). However, in exercise models these changes are interpreted as 
harmless as they typically resolve within 24 to 72 hours (Cianflocco et al., 1992). 
Nevertheless, such derangements can indicate and progress to more serious acute kidney 
pathology. For example, in U.S. military members, acute kidney injury (AKI) / acute renal 
failure has been recognized as a significant threat during physical exertion, particularly under 
heat stress (Carter et al., 2005). A delay in diagnosis of AKI is not uncommon and 
haemodialysis may be required.
 
One of the most commonly observed disturbances to kidney function with exercise is 
post-exercise proteinuria (PeP), but this shows large inter- and intra-individual variation 
(Poortmans et al., 1982; Poortmans 1984, Poortmans and Vanderstraeten, 1994). Why such 
variability exists in renal responses to exercise, and why and some individuals progress to 
more serious kidney pathology remains unclear. Until recently, one obstacle has been a lack 
of sensitive biomarkers of kidney injury. Serum or plasma creatinine (Cr) is the most widely 
utilized measure of kidney function. At present, it forms the basis for a diagnosis of AKI and 
has also been repeatedly used to demonstrate the declines in renal function during exercise 
(Poortmans 1984; Ronco et al., 2007). Despite its convenience, Cr is not a kidney injury 
biomarker per se and has its deficiencies such as a delayed response to an AKI (Waikar et al., 
2010). Thus, there has been avid interest in identifying molecular biomarkers which are 
capable of detecting kidney injury (and therefore impaired kidney function) much earlier than 
blood Cr. One promising biomarker is neutrophil gelatinase-associated lipocalin (NGAL; 
Mishra et al., 2005). However, the behaviour of this and other novel biomarkers to exercise 
has only recently been examined (McCullough et al., 2011). Responses to exercise protocols 
of varying intensity or duration remain unknown and whether individuals who are susceptible 
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to PeP also experience greater up-regulation in NGAL due to nephron-related stress has also 
not been determined.   
Given the physiological aberrations to kidney function known to occur during exercise, 
their unexplained inter-individual response, and the recent development of more sensitive 
biomarkers of kidney injury, the aim of this study was to determine if NGAL is up-regulated 
following a short duration high-intensity bout of proteinuria-inducing exercise (800 metre 
sprint). In this model, it was hypothesized that: i) NGAL would show a significant but 
transient rise above normal ranges (but not approaching levels seen in AKI); and ii) the 
elevations would be greater in those with PeP compared to those without. If supported, this 
would reveal further insights into site-specific kidney stresses during exercise and provide a 
novel and more sensitive method of assessing the acute effects of exercise upon kidney 
function. Additionally, any elevations in NGAL post-exercise may have implications in 
biomarker interpretation within the clinical environment. 
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2.3. MATERIALS AND METHODS.  
 
Study design and participants. An observational prospective cohort design was employed 
(figure 2.1.).  In the first stage of the study, 90 potential participants (mean age ± SD, 24 ± 4 
years; 38 female; 52 male) were approached via university and local sports clubs between 
September 2010 and July 2011 and were screened for presence of PeP.  Subsequently, 10 PeP 
positive and 10 PeP negative participants, who were conveniently sampled and not 
purposefully matched, completed the second stage of the study. This involved collection of 
blood and urine samples following an experimental exercise protocol designed to induce 
proteinuria. All participants provided written informed consent and ethical approval was 
provided by the College of Health and Behavioural Sciences, Bangor University ethics 
committee. 
Screening protocol for exercise proteinuria. All participants had no significant medical 
conditions nor took medications that could potentially influence kidney function (e.g. non-
steroidal anti-inflammatory drugs). Screening for PeP was conducted through the following 
methods: rested individuals (i.e. who had not performed strenuous exercise in the last 72 
hours) were asked to provide a urine sample prior to the start of their normal exercise routine. 
Approximately 30 minutes following this exercise a further urine sample was taken. Both 
samples were stored in ice boxes during transportation and auto-analysed for 
albumin:creatinine ratio (A:Cr) estimation within 24 hours of collection (both by Olympus 
AU2700 analyser; creatinine reagent OSR6178, Beckman Coulter, California, USA (kinetic 
Jaffe method); Microalbumin reagent MA2426, Randox Laboratories, Crumlin, UK). A 
baseline estimated GFR was also calculated by the CKD-EPI (Chronic Kidney Disease 
Epidemiology Collaboration) equation (Levey et al., 2009).  
There are no official guidelines to the acceptable A:Cr limits for post-exercise proteinuria 
in healthy subjects, although literature exists regarding provocation of PeP in diabetics as part 
of a risk assessment of future diabetic nephropathy (Agarwal et al., 1998). Therefore, to 
define whether an individual was PeP positive, the well-established criteria for significant 
microalbuminuria in diabetics was adopted and applied to the A:Cr difference between pre to 
post-exercise. Thus, participants were defined as PeP positive if their A:Cr rise was greater 
than 2.5 mg/mmol (male) or 3.5 mg/mmol (female; Jefferson et al., 1985). Those not 
fulfilling such increases were deemed PeP negative.  
Experimental protocol for proteinuria-inducing exercise. All PeP positive and randomly 
selected PeP negative participants were invited to complete the full experimental protocol. 
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Eventually twenty participants completed the protocol, performing an 800 metre sprint at the 
University athletic track between September 2010 and August 2011 (figure 2.1.). This form of 
high intensity, lactate-generating exercise is recognised as an optimal protocol for inducing 
PeP (Poortman et al., 1996).  
A day prior to any sampling of urine and blood, all participants were required to drink 
two litres of water (in addition to normal fluid intake) to ensure adequate hydration. 
Hydration status was assessed by using a portable meter (Pocket Pal-Osmocheck, Vitech 
Scientific, Partridge Green, UK) to assess urine osmolality immediately prior to completing 
the experimental protocol. If the value exceeded 700 mOsmols/KgH20, individuals were 
asked to re-attend when adequately hydrated (Sawka et al., 2007).
 
Participants were also 
asked to refrain from heavy exercise for at least four days and not to eat during the two hours 
before testing.  
Participants ran in groups of two or three to encourage competition and to elicit maximal 
effort. As a measure of exercise intensity (anaerobic energy production) during exercise, 
blood lactate was measured pre- and immediately post-run (Lactate Pro Lt-1710, Arkray, 
Kyoto, Japan; Jacobs et al., 1986).  
 
 
 
 
 
Figure 2.1.  Study design flowchart. ACR, albumin:creatinine ratio. 
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Following the run, participants were rested. Venous blood and urine specimens were 
collected prior to, immediately post- (0 minutes), 25 minutes post-, one hour post- and two 
hour post-run. These time points were selected to maximise the chances of early detection of 
PeP and NGAL, as elevations in PeP have been shown to be maximal 20-30 minutes after 
exercise, while NGAL increases have been confirmed as early as two hours after the onset of 
AKI (Poortmans 1984; Mishra et al., 2005). Urine volume was also recorded at each time 
point. Haemoglobin (β-Haemoglobin Hemocue AB photometer, Hemocue Ltd, Dronfield, 
UK) and haematocrit (Hawksley and sons Ltd, Sussex, UK) were also measured for 
subsequent plasma volume shift calculations (Dill and Costill, 1974). Following this, all blood 
specimens were centrifuged; plasma and urine aliquots were stored at -80ºC for subsequent 
biochemical analysis.  
Ascertainment of albumin:creatinine and urine and plasma NGAL. A:Cr assessments 
were performed as described above. NGAL concentrations were determined using a 
commercially available enzyme-linked immunosorbent assay (NGAL Rapid ELISA, 
Bioporto, Gentofte, Denmark). Absorbances were read at a wavelength of 450 nm by a 
microplate reader (Opsys MR, Dynex Technologies, Worthing, UK). The normal ranges 
quoted by the kit manufacturer for urinary NGAL and plasma NGAL concentrations were 
0.7-9.8 ng/ml and 37-106 ng/ml, respectively (NGAL, Bioporto Diagnostics). According to 
the kit insert, intra-assay variation was determined by measurement of NGAL in two urine 
and two plasma samples with eight replicates each. The coefficients of variation for both 
urine samples were 3.4% and 4.3%, and for plasma, 2.9% and 1.9%, respectively. Inter-assay 
variation was calculated through a similar process with two dilute urine and two dilute EDTA 
plasma samples in two replicates. The coefficients of variation for both urine samples were 
4.7% and 22.7%, respectively, and for plasma, 11.4% and 12.4%. 
As with A:Cr, urinary NGAL concentrations were corrected for urine Cr to account for 
changes in urinary concentration or dilution. Therefore, Cr corrected urinary NGAL (urinary 
NGAL:Cr) was expressed as ng NGAL / mmol urine Cr (x10
-3
). Additionally, plasma NGAL 
concentrations were corrected for plasma volume change (Dill and Costill, 1974).  
Statistical analysis. SPSS version 18.0 (IBM, Chicago, IL) was used for all statistical 
analysis. Statistical significance was accepted at P ≤ 0.05. Data for all dependent variables 
were examined for normality through three methods: 1) Shapiro-Wilk tests; 2) skewness  
beyond the limits of +3 to -3; and 3) visual inspection of histogram plots. In the case of 
descriptive data and plasma NGAL, mean ± SD are stated.  However urine volume, A:Cr, 
urinary NGAL and urinary NGAL:Cr were not normally distributed and remained markedly 
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skewed despite attempts at data transformation. Thus, these non-parametric data are presented 
as median {25
th
 percentile, 75
th
 percentile}. Nonetheless, in the interests of consistency, all 
results were graphically presented as boxplots. 
Descriptive data were examined by Student’s t-test.  Correlations between variables were 
determined using Pearson’s (r) or Spearman’s rank (ρ) correlation coefficient, as appropriate.  
For plasma NGAL, to examine the interaction between proteinuria group (PeP positive or PeP 
negative) and time (pre, post 0 minutes, 25 minutes, 1 hour, and 2 hours-post) a parametric 
two-way repeated measures analysis of variance was used with post hoc Tukey’s tests.  
For urine volume, A:Cr, urinary NGAL and urinary NGAL:Cr a Friedman’s test (a non-
parametric alternative to repeated measures analysis of variance) was performed to examine 
the effect of time. The main effects of proteinuria group and the interaction between 
proteinuria group and time were examined using a two-way non-parametric analysis of 
covariance as outlined by Quade (Quade 1967). Significant differences were examined further 
using post hoc Wilcoxon Signed-Ranks with Bonferroni corrections for multiple comparisons.  
For the primary outcome measure of urinary NGAL, a power calculation revealed that six 
participants were needed per group to detect a smallest important change in means of 4.6 
ng/ml (the increase required to elevate urinary NGAL above the normal range), assuming a 
within subject error of 1.7 ng/ml, and allowing for a 5 and 20% chance of making a Type I or 
Type II error, respectively (Hopkins 2006). 
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2.4. RESULTS  
 
Descriptive data. All participants were Caucasian (figure 2.1.). Estimated GFR was similar in 
both groups (PeP positive: 121 ± 8; PeP negative: 115 ± 13 ml/min/1.73m
2
; P = 0.3) and 
within healthy ranges for all participants. In the PeP positive group, mean age was slightly 
higher (PeP positive: 24 ± 5; PeP negative: 20 ± 2 yrs; P = 0.04) and there were more females 
(PeP positive: 5 females; PeP negative: 2 females).  
As there were no differences between groups for hydration status and exercise intensity 
by independent t-tests, data from both groups were combined. Pre-800 metre run urine 
osmolality was 173 ± 119 mOsmols/kgH20, indicating good hydration status prior to testing. 
There was the expected elevation of serum lactate between pre- and 0 hours post-run (1.2 ± 
0.4 and 8.3 ± 3.1 mmol/l, respectively; P < 0.001), indicating physical exercise was 
completed at a high intensity. 
Albumin:creatinine. Despite identification of PeP positive and PeP negative subjects 
during screening, the experimental protocol yielded a rise in A:Cr post-exercise in all 
participants who provided urine samples by 25 minutes. At this time point, mean A:Cr peaked 
at 27.6 {11.7, 50.5} mg/mmol
 
before returning close to pre-exercise levels of 1.2 {0.9, 1.4} 
mg/mmol, by two hours with a significant effect of time (P < 0.001; post-hoc analyses, pre to 
25 minutes: P = 0.001; pre to two hours: P = 0.4). There was a trend for a positive correlation 
between percentage change in serum lactate and percentage change in A:Cr (between pre and 
25 minutes; r = 0.493; P = 0.07). 
 
As all participants unexpectedly developed PeP at 25 minutes, a new A:Cr cut-off criteria 
was applied to examine the quantitative effects of proteinuria upon NGAL release. Therefore, 
the participants were divided into macroproteinuria (A:Cr > 30 mg/mmol; N = 6) and non-
macroproteinuria (A:Cr < 30 mg/mmol; N = 8) groups by assessing their peak A:Cr value at 
25 minutes (Poortmans 1984). Baseline estimated GFR and age were not significantly 
different between these two newly defined groups (data not shown). Consequently, and by 
design, for A:Cr there was a time × macroproteinuria status interaction (figure 2.2a). 
Examination of individual plots clearly showed that most peaks in A:Cr occurred at 25 
minutes, but there were five individuals who peaked earlier immediately post-exercise (figure 
2.2b). 
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Figure 2.2a.  Effect of an 800 metre run on albumin:creatinine ratio in non-macro and 
macroproteinuria subgroups. Data are medians (thick lines) and interquartile ranges (boxes). Open 
circles are outliers. There was a significant interaction between time and macroproteinuria status (P = 
0.001 by Quade’s test). #, difference between non-macro and macroproteinuria groups by post hoc 
test. 
Figure 2.2b.  Individual plots for albumin:creatinine ratio following an 800 metre run. 
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Urine volume. Only 14/20 participants (70%) were able to provide urine samples at all 
time points following the 800 metre run. Thus, subsequent reporting of results and statistics 
refers only to this cohort. This observation was accounted for by an exercise-induced anti-
diuretic effect that was most pronounced at 25 minutes, when only 38 {28, 99} ml of urine 
could be produced. This oliguria recovered by two hours to 420 {204, 586} ml. Overall, there 
was a significant effect of time (P = 0.001; post-hoc analyses, pre to 0 hours: P = 0.004; pre 
to 25 minutes: P = 0.001; pre to two hours P = 0.5; figure 2.3). Response in urine volume was 
similar between macroproteinuria and non-macroproteinuria groups (no interaction effect: P = 
0.5); therefore both groups are combined in figure 2.3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Urinary NGAL. There were increases in urinary NGAL following exercise which peaked 
at 12.8 {6.2, 23.2} ng/ml at 25 minutes before decreasing below baseline levels to 0.8 {0.02, 
3.3} ng/ml at two hours (significant effect of time: P = 0.002; post-hoc analyses, pre to 25 
minutes: P = 0.04 (not significant after Bonferroni correction); pre to two hours post: P = 
0.004; figure 2.4a). At 25 minutes and two hours, urinary NGAL was negatively correlated 
with percentage change in urine volume (pre to 25 minutes; ρ = -0.701; P = 0.005; 25 minutes 
to two hours; ρ = -0.552; P = 0.04). Response in urinary NGAL was similar between 
Figure 2.3.  Effect of an 800 metre run on urine volume. Data are medians (thick lines) and ranges. 
Open circles and asterixes are outliers. There was a significant effect of time (P = 0.001 by 
Friedman’s test). #, difference compared to pre-exercise sample point by post hoc test. 
 
# # 
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Figure 2.4a. Effect of an 800 metre run on urinary NGAL concentration. Data are medians (thick 
lines) and interquartile ranges (boxes). Open circles and asterixes are outliers. Dotted line indicates 
upper limit of normal range for urinary NGAL. There was a significant effect of time (P = 0.002 by 
Friedman’s test).  #, difference compared to pre-exercise sample point by post hoc test; ¥, difference 
compared to pre-exercise sample point by post hoc test but not significant after Bonferroni correction.  
 
macroproteinuria and non-macroproteinuria groups (no interaction effect; P = 0.6); therefore 
both groups are combined in figure 2.4a. Individual data plots suggested a cluster of urinary 
NGAL peaks occurring at 0 and 25 minutes post although there was marked inter-individual 
variation (figure 2.4b).  Throughout the entire post-exercise period, nine individuals (64%) 
showed an elevation above the normal range at one or more time points, with one subject 
attaining a concentration of 145 ng/ml (figure 2.4b).  
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Urinary NGAL:creatinine. Although median urinary NGAL:Cr appeared to be relatively 
stable at pre, 0 hours and 25 minutes, it fell significantly at two hours to 0.42x10
-3 
{0.02x10
-3
, 
0.1x10
-3
} ng/mmol with a significant effect of time (P = 0.002; post-hoc analyses, pre to two 
hours: P =  0.004; figure 2.5a). Response of urinary NGAL:Cr was similar between macro- 
and non-macroproteinuria groups (no interaction effect; P = 0.241); therefore both groups are 
combined in figure 2.5a. When individual data were inspected, there were clusters of urinary 
NGAL:Cr peaks occurring at 0 and 25 minutes although there was marked inter-individual 
variation (figure 2.5b).  
Plasma NGAL. Baseline plasma NGAL was 73.0 ± 17.0 ng/ml and there was a significant 
effect of time (P = 0.002). However this was due to a decrease in plasma NGAL 
concentration from baseline at 25 minutes to 68.8 ± 15.0 ng/ml and at one hour to 64.5 ± 16.7 
ng/ml (post-hoc analyses, pre and 25 minutes: P < 0.001; pre and one hour: P = 0.007; pre 
and two hours: P = 0.03 (not significant after Bonferroni correction); figure 2.6). Similar to 
urinary NGAL and urinary NGAL:Cr, there was no interaction with type of proteinuria for 
plasma NGAL (P = 0.7). Throughout the entire post-exercise period, no individual went 
above or below the normal range for plasma NGAL at any time. 
 
 
 
Figure 2.4b.  Individual plots for urinary NGAL concentration following an 800 metre run. 
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Figure 2.5a. Effect of an 800 metre run upon urinary NGAL:creatinine ratio. Data are medians (thick 
lines) and interquartile ranges (boxes). Open circles and asterixes are outliers. There was a significant 
effect of time (P = 0.002).  #, difference compared to pre-exercise sample point by post hoc test. 
Figure 2.5b. Individual plots for urinary NGAL:creatinine ratio following an 800 metre run.  
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Figure 2.6.  Effect of 800 metre run upon plasma NGAL level over time. For the sake of consistency, 
data are presented as boxplots whereas data in results section are mean (±SD). Data are medians 
(thick lines) and interquartile ranges (boxes). Open circles are outliers. Dotted line indicates upper 
limit of normal range for plasma NGAL. There was a significant effect of time (P < 0.002).  #, 
difference compared to pre-exercise sample point by post hoc test. 
# # 
 57 
2.5. DISCUSSION  
 
This is the first study to examine NGAL kinetics and its association with proteinuria 
following short duration high-intensity exercise. These data partly supports upregulation of 
NGAL with a trend for a transient elevation in urinary NGAL concentrations following an 
acute bout of high-intensity exercise (pre to 25 minutes, P = 0.04; not significant after 
Bonferroni correction). However, this response was not uniform and demonstrated large inter-
individual variation. Furthermore, there was a negative correlation between urinary NGAL 
and percent change in urine volume, and median increases in urinary NGAL were attenuated 
when expressed relative to urinary Cr. Taken together these data suggest that elevations in 
urinary NGAL following exercise may in part be due to a concentration effect. In addition, 
statistically significant decreases in plasma NGAL only occurred 2 hours post-exercise (figure 
2.5b.).  
The current data do not support the hypothesized association between NGAL response 
and the extent of post-exercise proteinuria. Nevertheless, these data provide important 
information on the site-specific renal stress experienced during high-intensity exercise, and 
have implications for interpretation of NGAL within the clinical environment. 
Although the functions of NGAL have yet to be fully elucidated, there is an early and 
dramatic upregulation of NGAL in AKI (Allen et al., 1989; Goetz et al., 2002; Mishra et al., 
2003; Mishra et al., 2005). More than half of participants in the current study had urinary 
NGAL elevations above the normal range at 25 minutes post-exercise, but unsurprisingly 
none of the participants reached the currently used cut-off diagnostic for AKI (250ng/ml) 
(NGAL Rapid ELISA kit, Bioporto, Gentofte, Denmark). However, this cut-off has been 
derived from a diseased population and whether more modest elevations indicate a milder 
form of kidney stress or injury has not been investigated.  
At the time of writing, there was only one published study which reported the effect of 
exercise upon NGAL kinetics. McCullough et al. measured urinary NGAL in 25 individuals 
during and after a marathon (McCullough et al., 2011).
  
These subjects demonstrated a 
significant mean elevation, from 8 ± 4 ng/ml pre-marathon to 47 ± 29 ng/ml immediately post 
marathon (P < 0.05). The peak median urinary NGAL value observed in our investigation 
was considerably lower at 13 (interquartile range 17) ng/ml. Thus, if group averages are 
compared, prolonged exercise likely results in greater NGAL release compared to short-
duration higher-intensity activity. However, similar to the current findings, McCullough et al. 
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also noted wide variation for peak urinary NGAL with values in some individuals above 100 
ng/ml.  
Such urinary NGAL elevations could be a result of increased inflammatory injury to 
nephron units, specifically at the proximal tubule, with subsequent impairment in function 
(Poortman et al., 1988; Mishra et al., 2004; Mishra et al., 2005; Mishra et al., 2006). This 
may affect tubular reabsorption of NGAL as reabsorption of other small molecular weight 
proteins, such as lysozyme and β2 – microglobulin, are known to be inhibited by exercise 
(Kozlowski et al., 1967; Poortmans 1984; Poortmans et al., 1997). Leucocytouria has also 
been noted as a source of urinary NGAL elevations in the absence of AKI (e.g. in urinary 
tract infection) and analysis of urinary sediments following exercise has demonstrated that 
long duration activity is more likely to result in an increased leucocytouria (and haematuria), 
albeit this finding is not universal (Poortmans 1984; Decavele et al., 2011). Detection of 
dimeric urinary NGAL isoforms from neutrophils may distinguish release of urinary NGAL 
from tubular epithelium, as these are predominantly monomeric (Mårtensson et al., 2012). In 
the present study, urine samples for leukocyte quantification were not collected and the 
ELISA kit utilized in this study only detected monomeric urinary NGAL. Whilst the possible 
contribution from this source merits further investigation, the urinary data suggests that even 
short exercise bouts induce a mild kidney stress.  
The present findings also highlight the difficulties of interpreting urinary biomarkers. 
Currently, there is no clear agreement on how renal biomarkers values from urine should be 
expressed and the assay kit utilized in this study bases interpretation of urinary results on raw 
values which fail to consider specific correction factors (Waikar et al., 2010). For example, 
the elevation in median urinary NGAL at 25 minutes may in part be explained by the oliguria 
at that same time point, a conclusion supported by the significant negative correlation with 
percentage change in urine volume between pre and 25 minutes. Exercise is known to exert an 
anti-diuretic effect with numerous studies demonstrating a decrease in free water clearance in 
both dehydrated and hyperhydrated states (Kozlowski et al., 1967; Poortmans 1984). It is also 
plausible that the significant decrease in median urinary NGAL at two hours is due to relative 
polyuria following a period of anti-diuresis; this is supported by correlation with percentage 
change in urine volume. This situation is analogous to the shortcomings of measuring AKI 
biomarkers in urine during oliguric AKI (Waikar et al., 2010). Therefore, in an attempt to 
circumvent the issues surrounding changes in urinary concentration, urinary NGAL 
concentrations were normalized to urinary Cr. Although this correction resulted in the 
dissipation of median NGAL rises and correlations with changes in urinary volume, it is 
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noteworthy that some individuals continued to show substantial rises in urinary NGAL:Cr 
(particularly at 25 minutes).  
As Cr generation is not constant during exercise, normalisation of urinary NGAL to 
urinary Cr could also be considered inappropriate. However, it is interesting to note that 
previous studies have utilised A:Cr to demonstrate post-exercise proteinuria. Instead, 
observed urinary NGAL concentrations could be normalised to urinary flow rate, hence 
permitting determination of a biomarker excretion rate (Waikar et al., 2010).  Unfortunately 
flow rates could not be calculated in the present study.  As the first urine collection was done 
at pre-exercise and time the subject had micturated prior was not recorded, a baseline urinary 
NGAL flow rate could not be calculated. Of course, flow rates could be calculated subsequent 
to this but these would be uninterpretable without a baseline. There has also been suggestion 
that urine osmolality and conductivity could be used as an alternative normalization measures 
(Tomonaga et al., 2012). Assuming a steady state, it could be useful. However, in short-term 
acute exercise of moderate intensity there is an increase in urine osmolality of around 40 
mOsmols/KgH20 (Freund et al., 1991). In addition, high-intensity exercise as in the study’s 
protocol may result in further decreases in tubular function. Thus, it is not certain that in a 
dynamic state such as exercise (or indeed AKI), these normalisation techniques would be 
helpful. Nevertheless, as normalisation of urinary NGAL remains problematic, this is an area 
that merits further investigation. Overall, the current data suggest that elevations in urinary 
NGAL should be interpreted with caution in both research and clinical settings, as elevated 
NGAL may in part be due to urinary concentration.  
Measurement of plasma NGAL largely avoids the confounding factors affecting 
interpretation of its urinary equivalent. After correcting for plasma volume shifts, the current 
study showed no significant elevation in plasma NGAL. In contrary there was a minor yet 
statistically significant decline in plasma NGAL from 25 minutes that coincided with the peak 
urinary NGAL concentration. Thus, it is plausible that urinary NGAL elevations may arise 
from the plasma due to increased clearance into the Bowman’s capsule via the glomerular 
capillaries. This may involve exercise-related reductions in renal blood flow to catecholamine 
surges with corresponding falls in GFR and increases in filtration fraction (Kadachorian and 
Johnson, 1970; Poortmans 1984).  
The present study did not demonstrate any relationship between NGAL and the degree of 
PeP, nor between NGAL and any descriptive characteristics. Thus participants with post-
exercise macro-proteinuria reassuringly appear to be no more susceptible to exercise-induced 
kidney stress or injury than those without macro-proteinuria. Admittedly, with the small 
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sample size a type II statistical error is possible. However, the study was powered to detect a 
minimally important clinical change (NGAL elevations above the normal range). 
Additionally, distinct mechanisms seem to be responsible for post-exercise macro-proteinuria 
and NGAL up-regulation in nephron units. It is of note that 100% of individuals tested in the 
current study presented with PeP (as initially defined) following maximal exercise, supporting 
previous findings that when exercise is of sufficient intensity, all individuals will have some 
degree of PeP (Kozlowski et al., 1967; Poortmans et al., 1997).  
Limitations of this study include a lack of bladder ultrasound or urinary catherization.  
Although double voiding was encouraged, gold standard measurements of urine volume and 
therefore urine flow were not made, meaning biomarker production rate could not be 
calculated. To mitigate this limitation, participants arrived well hydrated, urinary data were 
presented relative to Cr concentration, and NGAL was also obtained as a plasma 
concentration, expressed relative to plasma volume shifts. Study strengths include the use of a 
“real-world” exercise protocol and selection of non-elite athletes; both of which support the 
applicability of these results to a young active healthy population. The repeated measures 
design and the conservative approach to statistical analyses, using non-parametric analyses on 
data which is characteristically skewed, is also well-suited to the study’s small cohort.  
In summary, for the first time it has been shown that an acute bout of high intensity 
exercise results in transient urinary NGAL elevations that are independent of proteinuria. 
Sources of NGAL may include the proximal tubule but also increased plasma clearance. 
However, absolute urinary values need to be interpreted with caution due to the anti-diuretic 
state exerted by exercise. Normalizing urinary NGAL to urinary Cr appeared to attenuate 
absolute rises. Given such phenomena, further work needs to be undertaken to determine the 
most suitable means of NGAL expression, e.g. biomarker excretion rate. Finally, given the 
large inter-individual response to urinary NGAL up-regulation, more research is needed to 
determine the factors responsible for large increases in some individuals and their clinical 
implications. These endeavours are essential if NGAL and other promising renal biomarkers 
are to be validated as measures of renal injury following exercise or oliguric AKI and to avoid 
erroneous interpretation. 
 
ACKNOWLEDGEMENTS 
 
We would like to thank Steve Jones (Caretaker at the Treborth Athletics Track, Bangor, 
UK) for use of training facilities, and Dominique Mauger for her technical assistance. 
 61 
CHAPTER 3 
 
CAN EXERCISE-INDUCED PROTEINURIA PREDICT THE ONSET OR 
PROGRESSION OF CHRONIC KIDNEY DISEASE IN HUMANS? A 
SYSTEMATIC REVIEW 
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3.1. ABSTRACT 
  
Background: Proteinuria is a biomarker of chronic kidney disease (CKD). Post-exercise 
proteinuria (PeP) shares certain characteristics with proteinuria of CKD including generation 
through increased intraglomerular pressures, a predilection for albumin excretion and 
reductions in glomerular filtration rate. Objective: To determine if PeP can predict the onset 
or progression of CKD. Data sources: A systematic review of English, human subject-based 
articles published between 1946 and 2014 in Ovid Medline (R), Ovid Medline in process, 
AMED, EMBASE, Pubmed, Cochrane Library and Web of Science. Search terms included 
exercise, exercise test, proteinuria, albuminuria, post-exercise proteinuria, post-exercise 
albuminuria, exercise induced-proteinuria and exercise induced-albuminuria, chronic kidney 
disease and nephropathy. Study eligibility criteria: Participants were individuals with or at-
risk of CKD. Intervention was an exercise test designed to yield PeP. The comparator 
population were individuals who did not develop PeP after exercise testing. Outcomes 
included biomarkers of CKD (e.g. high resting proteinuria or rise in blood creatinine) from a 
follow-up period of at least three months. Study types examined: randomized controlled trials 
and prospective observational cohort studies. Study appraisal and synthesis methods: 
Independent extraction of articles and data items by two authors using predefined data fields 
including study quality indicators. Discrepancies identified were resolved through a co-
investigator. Risk of bias and applicability was asessesed by the QUADAS-2 tool. Results: A 
narrative synthesis was performed. Five studies (N = 351) met inclusion criteria, all of which 
examined prospective cohorts of Type I diabetics who were at risk of CKD. Meta-analysis 
was not possible as interventions and post-exercise measurements varied markedly between 
studies. However, when combining the results of the primary outcome in four studies (N = 
318), the presence of PeP was highly associated with elevated resting proteinuria at follow-up 
(χ2 test, P < 0.0001) and significant odds ratios (developing CKD following a positive 
exercise test vs. not developing CKD) were noted for each of four studies (OR 2.3-52). 
Limitations: findings are only applicable to a population of young type I diabetics at risk of 
CKD. Interventions were a source of bias with variance in exercise intensity and duration 
between studies. Primary outcomes did not factor confounding variables such as use of 
angiotensin-receptor antagonists and the development of other nephropathies. Conclusion and 
implications: Despite the limited number of studies in the literature and their shortcomings, 
PeP shows promise as a predictor for CKD progression. However, there is a need to refine 
exercise testing for this purpose. PROSPERO registration number: CRD42014008686. 
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3.2. INTRODUCTION 
 
Through experimental study of chronic kidney disease (CKD), long-standing proteinuria 
resulting from glomerular hypertension is an independent predictor for CKD progression 
(Abbate et al., 2006). At a cellular level, podocytes exposed to an excessive protein load 
release transforming growth factor beta, ultimately inducing differentiation of mesangial cells 
into myofibroblasts (Yard et al., 2001; Abbate et al., 2002). Further along the nephron, 
protein overload in the tubules induces the release of cytokines, chemokines and growth 
factors that lead to abnormal interstitial accumulation of inflammatory cells, extracellular 
matrix collagen, fibronectin and other components that are responsible for interstitial fibrosis; 
a histopathological hallmark of CKD (Kriz and LeHir 2005; Abbate et al., 2006). Typically 
through the use of renin-angiotensin-aldosterone system inhibitors that lower blood pressure 
and intraglomerular pressures, proteinuria and its adverse effects can be halted (Brenner et al., 
2001). Thus, the detection and treatment of proteinuria asserts great importance in CKD 
management strategies (Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work 
Group, 2013).  
In contrast, proteinuria in the context of exercise is a well-recognised but transient 
physiological phenomenon that is currently thought to be benign, even when encountered on 
repeated occasions (Poortmans 1985; Poortmans and Vanderstraeten, 1994). However, 
convincing evidence for this is lacking, although long-term data on other so-called 
“physiological proteinurias” (e.g. orthostatic proteinuria) does not demonstrate any 
detrimental effects upon renal function (Glassock 1981; Springberg et al., 1982). Nonetheless, 
both proteinuria resulting from CKD and post-exercise proteinuria (PeP) share certain 
characteristics including potential mechanisms of generation such as increased 
intraglomerular pressures, a predilection for albumin excretion, and reductions in glomerular 
filtration rate (GFR; Refsum and Strömme, 1975; Poortmans 1984, Bellinghieri et al., 2008).  
Given the above similarities, the notion of whether proteinuria provocation through 
physical exertion could be used as a kidney stress test to predict the onset or prognosis of 
nephropathies is of particular interest.  Exercise stress tests are already utilised for cardiac 
disease risk stratification e.g. through use of the Bruce protocol (Lauer et al., 2005; 
Bourdillon 2010). Physical exertion as a kidney stress test potentially fulfils a number of 
desirable characteristics for a useful disease biomarker, including: ease of performing 
investigation (treadmill exercise protocols are routinely completed in cardiac patients and 
established proteinuria assays are readily available), ease of obtaining sample (spot urine 
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collection), rapid throughput and result generation (due to routine and commonly available 
biochemistry); and ability to offer treatment (anti-proteinuric agents).  
Already, there is evidence that analysis of the urinary proteome could offer important 
prognostic information about specific nephropathies (Mullen et al., 2011; Santucci et al., 
2013). However, there is presently no consensus on whether PeP could be a useful diagnostic 
tool to predict the onset or progression of CKD. This is an important question as such a test 
would provide a useful means of diagnosing the onset of nephropathies at various stages and 
may provide an adjunctive or triage assessment before more risky invasive procedures such as 
renal biopsy. Additionally, it could allow for early proactive measures to prevent disease 
progression. Therefore, the aim of this study was to perform a systematic review and assess 
all existing literature to determine if proteinuria provocation following exercise testing can 
predict onset or progression of CKD in humans.  
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3.3. MATERIAL AND METHODS 
 
Study registration. The study was registered under PROSPERO – the international 
prospective register of systematic reviews. For full online entry, the reader is directed to: 
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42014008686.Eligibility 
criteria. The research question was formulated into the PICOS format. Participants: this 
comprised of three eligible groups: 1) individuals with CKD; defined as abnormalities of 
kidney structure and function present for no less than three months (table 3.1.); 2) those with 
diseases that confer a risk of CKD e.g. diabetics; or 3) healthy individuals with a family 
history of inherited renal disease in first-degree relatives e.g. polycystic kidney disease. 
Intervention: an exercise tolerance test or similar bout of exercise likely to yield PeP 
(Poortmans 1984; Junglee et al. 2012). Comparator: participants listed above that did not 
develop PeP as per study limits following an exercise tolerance test or similar bout of 
exercise. Outcomes: primary outcomes were indicators of CKD progression after a follow-up 
period of at least three months including: 1) increased blood creatinine (Cr) concentration of 
25% from baseline; 2) a drop in estimated GFR category accompanied by a 25% or greater 
drop in estimated GFR from baseline (table 3.2.); or 3) resting proteinuria greater than 3 
mg/mmol albumin:creatinine ratio (A:Cr), 30 mg/g protein:creatinine ratio (P:Cr), 20 ug/min 
albumin excretion rate or other contempory measures of pathological resting proteinuria as 
recognized by a consensus group (Junglee et al., 2012; Kidney Disease: Improving Global 
Outcomes (KDIGO) CKD Work Group, 2013). Secondary outcomes (i.e. not a prerequisite 
for inclusion in the systematic review but were reported if studied), included any biomarkers 
associated with CKD progression e.g. worsening hypertension (blood pressure > 140/90 
mmHg) or glycaemic control (glycosylated haemoglobin, HbA1c) in diabetics. Study type: 
randomized controlled trials and prospective observational cohort studies. 
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Markers of 
kidney damage  
(one or more) 
Albuminuria (albumin excretion rate >30 mg/24 hours; A:Cr >30 
mg/g [>3 mg/mmol]) 
Urine sediment abnormalities 
Electrolyte and other abnormalities due to tubular disorders 
Abnormalities detected by renal biopsy 
Structural abnormalities detected by imaging 
History of kidney transplantation 
Decreased GFR GFR <60 ml/min/1.73 m
2 
 
 
 
 
 
 
 
GFR category GFR (ml/min/1.73m
2
) 
1 ≥ 90 
2 60-89 
3a 45-59 
3b 30-44 
4 15-29 
5 < 15 
 
Thus, primary studies, published in English and containing human participants of any 
age, sex, or ethnicity were sought. Animal studies, in-vitro studies and those not written in 
English language were rejected as data only relevant to exercise testing as applied to humans 
was required and there would be economical and time constraints in translating studies 
written in other languages.  
Information sources. With the assistance of a medical librarian, a search of the following 
electronic databases restricted to publications from 1946 to November 2014, was performed: 
Ovid Medline (R), Ovid Medline in process, AMED, EMBASE, Pubmed, Cochrane Library 
Table 3.1. Criteria for definition of CKD based upon the KDIGO Clinical Practice Guideline for the 
Evaluation and Management of Chronic Kidney Disease 2012. Either of the key features (left-hand 
side in bold) need to be satisfied for a period of no less than three months to fulfil a diagnosis of 
CKD. A:Cr, albumin creatinine ratio; GFR, glomerular filtration rate. Adapted from Kidney Disease: 
Improving Global Outcomes (KDIGO) CKD Work Group, 2013. 
 
 
Table 3.2. Stage of chronic kidney disease as defined by the KDIGO Clinical Practice Guideline for 
the Evaluation and Management of Chronic Kidney Disease 2012. GFR, glomerular filtration rate.  
Adapted from Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013. 
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and Web of Science. The search was performed on the 7
th
 of November 2014. Relevant 
review, case reports and commentaries were hand-searched for other potentially relevant 
references. Reference lists of all selected papers were also hand-searched for other relevant 
references missed from electronic database enquiries. Also, where appropriate, main authors 
of studies meeting eligibility criteria were contacted to identify additional studies. Grey 
literature was not searched.  
Search strategy. Using OvidSP (https://ovidsp.uk.ovid.com), electronic databases 
including Ovid Medline (R), AMED and EMBASE were searched using the following 
Medical Sub-Heading terms separately and / or in combination: exercise, exercise test, 
proteinuria, albuminuria, chronic kidney disease and nephropathy (for example of search 
enquiries see appendix 1). Non-MESH terms including: post-exercise proteinuria, post-
exercise albuminuria, exercise induced-proteinuria and exercise induced-albuminuria were 
also searched for separately. Limits applied included studies involving humans and in the 
English language. For each database, the search strategy had to be adjusted to ensure the 
optimum number of hits.  A similar process was conducted for: Pubmed 
(http://www.ncbi.nlm.nih.gov/pubmed); Cochrane Library 
(http://onlinelibrary.wiley.com/cochranelibrary/search); and Web of Science 
(http://apps.webofknowledge.com).  
Study selection. Following the removal of duplicate entries from the database searches, 
two review authors (Naushad Ali Junglee & Jamie Hugo Macdonald), using pre-defined 
criteria, independently evaluated each potential study through evaluation of the title and 
abstract (figure 3.1.). Reviewers compared their assessments and any disagreements were 
resolved by discussion with a co-investigator (Andrew Bruce Lemmey).  
Data collection process. A standardized, pre-piloted form was used to extract data from 
the selected studies for assessment of study evidence and quality synthesis. The two review 
authors extracted data independently. Any discrepancies identified were resolved through 
discussion with a co-investigator and attempts were made to retrieve missing data from study 
authors. 
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Figure 3.1. Flowchart used to select papers into systematic review. Specific values for definition of 
post-exercise proteinuria and primary outcomes are detailed in the Eligibility Criteria section. 
Inclusion of secondary outcomes were not an essential prerequisite for study inclusion. CKD: chronic 
kidney disease. 
 
 
 
 
 
 
 
 
 
Data items. Extracted information included: study design; type of nephropathy examined;  
study population characteristics; comparator population characteristics; exercise intervention 
employed; definition of exercise proteinuria; pre- and post-exercise proteinuria 
concentrations; follow-up time period; primary outcomes and any association with post-
exercise proteinuria; secondary outcomes and any associations with post-exercise proteinuria; 
and information for assessment of the risk of bias. 
Risk of bias assessment of individual studies and across studies. For each selected study, 
risk of bias and quality assessment was evaluated independently by both review authors 
through application of the QUADAS2 tool (see appendix 2; 
http://www.bris.ac.uk/quadas/quadas-2/), which has been validated for primary diagnostic 
accuracy studies. This assessment focuses upon four key domains: 1. patient selection; 2. 
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index test; 3. reference standard; and 4. flow and timing. Each domain incorporated signaling 
questions with additional anchoring statements specific to the review question and permits the 
reviewer to make an overall assessment of bias (appendix 2 and 3). The proportion of studies 
with differing degrees of bias and applicability was also determined to reflect the risk of bias 
across studies. Bias was not used as a study exclusion tool. 
Summary measures. From each selected study, the principle summary measures for the 
population under study and the comparator were collated in a tabular format. 
Synthesis of results. It was anticipated that there would be limited scope for meta-analysis 
because of the great variation in the interventions used across the small number of existing 
trials. Therefore, a narrative synthesis of the findings from the included studies was 
conducted. This was structured around the type of CKD investigated, populations selected, 
chosen exercise test to induce proteinuria, follow-up period and primary / secondary outcome 
measures. In addition, risk ratios were calculated.  
Additional analyses. No additional analyses were performed.  
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3.4. RESULTS 
 
Study selection. Of 69 potential studies identified in electronic searches, only 5 studies (N = 
351) met the inclusion criteria as outlined in figure 3.1. Figure 3.2. details the results of the 
search process with justifications at each review stage for study exclusion. 
Study characteristics. The five studies that met inclusion criteria were: Bognetti et al. 
(1994), Dash and Torffvit (2003), Garg et al. (1990), O’Brien et al. (1995) and Watts et al. 
(1989). The data extracted for each study are summarised in table 3.3.  
Risk of bias assessment of individual studies and across studies. Each study underwent a 
QUADAS-2 assessment – the results of which were used to generate summary charts to 
determine the risk of bias and concerns regarding applicability across studies (appendix 2 and 
3; table 3.4, figure 3.3). 
  
Figure 3.2. Flowchart detailing results of electronic database searches with reasons for 
exclusion at each stage.  
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Bognetti et al. (1994) Dash and Torffvit (2003)  Garg et al. (1990) 
e O'Brien et al. (1995) Watts et al. (1989) 
Study type Prospective Prospective Prospective Prospective Prospective 
Nephropathy  Type 1 diabetes Type 1 diabetes Type 1 diabetes Type 1 diabetes Type 1 diabetes 
Number of subjects 66 
a No microalbuminuria: 17 
b 
Microalbuminuria: 16 
Group 1: 102 
Group 2: 20 
Group 3: 9 
Group 4: 20 
Group 5: 23 
Group 6: 9 
Group 7: 4  
32 33 
Mean ± sd or 
median {range} age 
in years 
15.3 ± 3.1 
No microalbuminuria: 27.0 ±  6.0 
Microalbuminuria: 30.0 ± 7.0 
Group 1: 20.3 ± 0.3 
Group 2: 21.3 ± 0.6 
Group 3: 21.0 ± 0.6 
Group 4: 20.0 ± 0.6 
Group 5: 21.6 ± 0.6 
Group 6: 18.7 ± 0.4  
Group 7: 19.5 ± 1.2  
28.7 ± 9.8 29.0 {17.0-49.0} 
Male:female ratio  
(N) 
  
40:26 
  
  
No microalbuminuria: 17:0  
Microalbuminuria: 16:0 
  
Group 1: 49:53 
Group 2: 10:10  
Group 3: 4:5  
Group 4: 9:11  
Group 5: 12:11  
Group 6: 7:2  
Group 7:4  
  
25:7 
  
  
26:7 
  
Mean ± sd or 
median {range} 
body mass index 
kg/m2 
NS NS NS 
  
24 ± 2.8 
  
  
24.2 {17.1-27.6} 
  
Mean ± sd or 
median {range} 
duration of 
diabetes 
  
8.9 ± 3.0 
  
  
No microalbuminuria: 13.0 ± 4.0 
Microalbuminuria: 14.0 ± 4.0 
  
 Group 1: 11.9 ± 0.4 
Group 2: 14.8 ± 0.9 
Group 3: 11.2 ± 1.2 
Group 4: 13.0 ± 1.0 
Group 5: 13.3 ± 0.8 
Group 6: 13.0 ± 0.8 
Group 7: 14.3 ± 2.6  
  
15.5 ± 9.8 
  
  
18.0 {3.0-34.0} 
  
Mean ± sd or 
median {range} 
glycosylated 
haemoglobin / 
Hba1c 
NS 
 
No microalbuminuria: 7.9 ± 1.2 
Microalbuminuria: 8.7 ± 1.6 
  
Group 1: 11.2 ± 0.2 
Group 2: 13.1 ± 0.3 
Group 3: 12.4 ± 0.7 
Group 4: 12.7 ± 0.4 
Group 5: 12.2 ± 0.4 
Group 6: 12.8 ± 0.7 
Group 7: 12.8 ± 0.8  
  
10.1 ± 2.2 
  
  
10.2 {6.7-16.6} 
  
Number with 
retinopathy (%) 
NS 
 
 
No microalbuminuria: 8 (47) 
Microalbuminuria: 12 (75) 
NS 7 (22) 25 (76) 
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Bognetti et al. (1994) Dash and Torffvit (2003)  Garg et al. (1990) 
e O'Brien et al. (1995) Watts et al. (1989) 
 
Exercise test 
workload 
 
5 km/hr on treadmill 
Fixed workload: 150W bicycle at 60 rpm 
(N= 22)  
Fixed heart rate: maintained at 80% of 
max heart rate on bicycle (N = 20) 
c
 
Vigorous pedalling on exercise 
bike  
Treadmill with 12% gradient 
achieving double resting heart 
rate 
Treadmill with 12% gradient 
achieving double resting heart 
rate 
Exercise test 
duration (mins) 
15  
 
 30  
 
 20 20  20  
Definition of post-
exercise 
proteinuria 
Albumin excretion rate > 20.1 
ug/min 
NS 
Albumin excretion rate > 41 
ug/min 
Albumin excretion rate > 30 
ug/min 
f
 
Albumin excretion rate > 15 
ug/min 
Mean ± sd or 
median {range} 
pre-exercise 
proteinuria of 
cohort 
4.7 {0.1-15.7} ug/min 
No microalbuminuria: 1.9 {1.0-60.0} mg/l 
Microalbuminuria: 7.3 {1.0-115.0} mg/l 
Group 1: 5.5 ± 0.3 ug/min 
Group 2: 230.4 ± 56.9 ug/min 
Group 3: 9.3 ± 1.8 ug/min 
Group 4: 7.2 ± 0.9 ug/min 
Group 5: 8.5 ± 1.1 ug/min 
Group 6: 19.0 ± 5.1 ug/min 
Group 7: 9.0 ± 2.3 ug/min 
0.4 {0.1-1.9} mg/mmol 4 {0.5-9.4} ug/min 
Mean ± sd or 
median {range} 
PeP of cohort 
7.8 {1.3-93.0} ug/min 
For fixed workload: 
No microalbuminuria: 50 {11-281} ug/min 
Microalbuminuria: 102 {17-357} ug/min 
For fixed HR: 
No microalbuminuria: 158 {44-2811} 
ug/min  
Microalbuminuria: 36 {7.9-496} ug/min 
 
Group 1: 8 ± 0.4 ug/min 
Group 2: 399 ± 111.7 ug/min 
Group 3: 82.1 ± 13.6 ug/min 
Group 4: 15 ± 3.2 ug/min 
Group 5: 63.4 ± 9.3 ug/min 
Group 6: 52.7 ± 24.5 ug/min 
Group 7: 72.7 ± 66.1 ug/min 
NS 6.2 {0.6 -96.2} ug/min 
Number of subjects 
with PeP (%) 
21 (25) 
 
NS 
d
 
 
61 (33) 
 
6 (19) 
 
 
10 (30) 
 
Follow up period 
mean ± sd or 
median {range} 
years 
 
5.9 ± 1.3  
 
 
13.1 ± 3.2 
 
4.0 
 
10.0 
 
 
2 {1.5-2.9} 
g 
 
Definition of follow 
up primary 
outcome 
 
Resting overnight albumin 
excretion rate between 20-200 
ug/min 
 
 
Early morning microalbuminuria 
persistently > 30 mg/l  
OR need for haemodialysis 
 
Elevated overnight albumin 
excretion rate of > 30 ug/min 
on at least two urine samples 
Early morning resting albumin 
excretion rate >15 ug/min on 
three separate days 
f
 
 
Resting overnight albumin 
excretion rate > 1 mg/mmol 
compared to baseline 
 
Result of follow up 
primary outcome in 
PeP positive. 
3/15 (20%) had higher resting 
albumin excretion rate 
 
14/33 (42%) had raised early morning 
microalbuminuria 
2/33 required haemodialysis 
 
9/61 (15%) had elevated 
overnight albumin excretion 
rate  
 
4/6 patients (80%) had a high 
resting A:Cr  
4/10 (40%) had > 1mg/mmol in 
A:Cr 
Result of follow up 
primary outcome in 
PeP negative. 
5/46 (11%) had higher resting 
albumin excretion rate 
NS 
0/122 (0%) had elevated 
overnight albumin excretion 
rate 
 
1/27 (4%) had a high resting 
A:Cr  
0/23 (0%) had > 1mg/mmol in 
A:Cr 
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Table 3.3. Data extracted for studies that met criteria for systematic review. 
a 
Original cohort was 83 but 12 patients lost at follow-up. There were no baseline or PeP 
differences between lost and follow-up populations, however. Also 5 patients were excluded from the start as pre-exercise proteinuria was >20 ug/min. Therefore, group for 
final analysis consisted of 66 subjects. 
b 
Cohort was split into two groups: with or without microalbuminuria at baseline. 
c 
As part of study aim, fixed workload and fixed 
heart rate exercise tests were compared. Diabetics were all tested together: 12/22 with no microalbuminuria on fixed workload, 13/20 with no microalbuminuria on fixed 
heart rate. 
d  
Unable to determine number who developed PeP as no cut-off was defined. 
e 
Authors split cohort into seven groups depending on their exercise and overnight 
albumin excretion rate values. Only group 6 exhibited PeP and elevated resting albumin excretion rate on follow-up. See Garg et al. (1990) for further details. 
f 
Authors 
considered PeP and rest A:Cr as >4.3 and >2.1 mg/mmol as equivalent to  >30 ug/min and 15 ug/min, respectively.
 g
 Follow-up on focussed on PeP cohort’s results. h 
 
Where 
there was 0 participants in a category for cacluation of odds ratio, this was replaced by 0.5 (Glas et al., 2003). NS, not specified; PeP, post-exercise proteinuria; A:Cr, 
albumin-to-creatinine ratio.  
 
 
  
 
 
Bognetti et al. (1994) Dash and Torffvit (2003)  Garg et al. (1990) 
e O'Brien et al. (1995) Watts et al. (1989) 
 
Odds ratio for 
development of 
CKD if PeP 
positive 
h 
 
2.3 Unable to calculate 42.2 52 30.7 
Associations with 
primary outcome 
Nil 
PeP higher in fixed heart rate compared to 
fixed workload in those who developed 
nephropathy at follow up (16/33; 49%) 
NS 
PeP was positively correlated 
with change in A:Cr at 10 
years (r = 0.37; P = 0.017);  
PeP was a good predictor of 
resting A:Cr at 10 years  
(P = 0.005; r2 = 0.31) 
 
Nil 
 
Follow up 
secondary outcome 
Systolic/diastolic blood 
pressure and Hba1c 
Systolic/diastolic blood pressure and 
Hba1c 
Hba1c 
 
Systolic blood pressure and 
Hba1c 
 
 
Nil 
 
 
Results of 
secondary outcome 
 
Hba1c was positively 
correlated to change in 
albumin excretion rate  
(r = 0.293; P < 0.05) 
Maximum systolic blood pressure post-
fixed heart rate test was higher in group 
with microalbuminuria at baseline 
Nil 
Baseline Hba1c significant 
predictor of follow up A:Cr  
(P = 0.02) 
Nil 
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Bognetti et al. (1994) Dash and Torffvit (2003) Garg et al. (1990) O'Brien et al. (1995) Watts et al. (1989) 
Methods of patient selection 
described Y Y Y Y Y 
Consecutive or random sampling N N N Y N 
Case-control design avoided N N Y Y N 
Excluded patients described N N N N Y 
Avoid inappropriate exclusions U Y Y Y Y 
Selection of patients bias 
     Concern that included patients 
do not match review question      
Index test described Y Y N Y Y 
Index test results independently 
interpreted without reference test Y Y N Y Y 
Threshold pre-specified Y N Y Y Y 
Enough information to repeat 
test in independent study N N N Y Y 
Index test interpretation bias 
     Concern that index test does 
not match review question      
Reference standard described Y Y Y Y Y 
Reference standard correct for 
target condition Y Y Y N N 
Reference standard results 
independently interpreted Y Y Y Y Y 
Enough information to repeat 
reference test in independent 
study 
Y Y Y Y Y 
Reference standard 
interpretation bias      Concern that target condition 
does not match review question      Appropriate interval between 
index and reference tests N N N Y N 
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Table 3.4. Bias assessment using QUADAS-2 tool for all studies meeting criteria for systematic review. Extra signalling questions were included (see appendices 2 and 3 for 
elaboration). Green boxes denote low risk of bias/ concerns regarding applicability. Red boxes denote high risk of bias/concerns regarding applicability. N, no; Y, yes; U, 
unsure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Dash and Torffvit (2003) Garg et al. (1990) O'Brien et al. (1995) Watts et al. (1989) Bognetti et al. (1994) 
Reference standard for all 
patients Y Y Y Y Y 
Same reference standard for all Y Y Y Y Y 
All patients included in analysis N Y N Y Y 
Patient flow bias 
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Figure 3.3. Bar graphs summarising risk of bias and concerns of applicability across studies included for systematic review following assessment 
with QUADAS-2 tool. Green boxes denote low risk of bias/ concerns regarding applicability. Red boxes denote high risk of bias/concerns regarding 
applicability. 
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Narrative synthesis. Type of CKD investigated: All studies only examined prospective 
cohorts with type I diabetes that were at risk of diabetic nephropathy as evidenced by sub-
optimal long-term diabetic control (Hba1c ranging from 7.9 to 13.1%). Population 
demographics: All but one study (Garg et al., N = 187) included less than 100 subjects but no 
study performed power calculations to determine the sample size required for their primary 
outcome measure of CKD progression. The age of subjects was in the younger spectrum with 
the average age ranging from around 15 to 30 years old. Male sex featured predominantly in 
most studies: only Garg et al. demonstrated an approximately equal split between males and 
females (table 3.3.). Ethnicity was not stated in any study. Although body mass index (BMI) 
was not specified for three studies, of the remaining two (O’Brien et al. and Watts et al.) BMI 
averaged 24 kg/m
2
. The duration of diabetes ranged between 8.9 to 18 years. Microvascular 
complication in the form of retinopathy was accounted for in three studies (Dash and Torfvitt, 
O’Brien et al. and Watts et al.) and ranged between 22 to 76% of cohorts.  
Exercise test: The exercise intervention used to yield proteinuria varied greatly between 
all five studies. Except for one study (Dash and Torfvitt), all took into account exercise 
waterloading to maximise diuresis post-exercise to facilitate proteinuria estimation. This took 
the form of a single bolus of water (e.g. 500 mls post-exercise) or several boluses evenly 
spread over a specified time-period prior to commencing exercise. Despite this, no study 
measured the effectiveness of waterloading upon hydration status (e.g. through urine 
osmolality, specific gravity or urine colour). For their exercise protocol, two studies (Dash 
and Torfvitt and Garg et al.) used exercise ergometers and the remaining three used 
treadmills. There was little information on how exercise was tailored to the patient with 
respect to intensity: Bognetti et al. stated that their protocol was of “moderate exercise” whilst 
Garg et al. used 20 minutes “vigorous pedalling on an exercise bike”, with neither author 
providing quantification on how these exercise intensities were determined. The remaining 
three studies used increments of resting heart rate as a measure of intensity and Dash and 
Torfvitt compared intensity prescriptions by comparing fixed workload and fixed heart rate 
regimes. The duration of exercise varied between 15 to 30 minutes.  
With regards to post-exercise measurements, two studies (Dash and Torfvitt, Garg et al.) 
took proteinuria measurements immediately following the exercise bout. Bognetti et al. chose 
the highest value of several measurements post-exercise while O’Brien et al. took a sample 20 
minutes post-exercise. Watts et al. did not specify when their measurement(s) was / were 
taken. The cut-off for significant PeP was generally defined as above the limit for significant 
(pathological) albuminuria at rest as set by contemporary consensus guidelines in diabetic 
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nephropathy. This predated KDIGO guidance in all cases, but Dash and Torfvitt did not state 
any limit for significant PeP. The proportion of inidividuals with PeP from the cohort varied 
between 19 to 33%.  
Follow-up: The follow-up period for all studies was beyond three months and ranged 
between 2 to 13.1 years. Primary outcome: For all studies, primary outcomes concentrated on 
CKD progression as defined by higher-than-resting values of albuminuria at follow-up. Only 
one study (Dash and Torfvitt), measured serum Cr pre exercise and at follow-up and noted 
that the median concentration was lower at follow-up (80 {65-102} umol/l vs. 75 {53-317} 
µmol/l, respectively). Estimated GFRs were not calculated however. The proportion of 
individuals with PeP with significant albuminuria at follow-up varied between 5 to 80%, 
though no study clarified if follow-up measurements were taken in a steady-state period with 
other medical conditions potentially contributing to proteinuria being excluded. Moreover, 
during the follow-up period in one study (Dash and Torfvitt), it was noted that 10 patients had 
commenced proteinuria-modifying medications (e.g. angiotensin-converting enzyme 
inhibitors). There was no information to support a similar finding in the remaining studies. 
Only O’Brien et al. concluded that over a 10-year follow-up period, PeP was a good predictor 
of resting A:Cr at follow-up and used regression analysis to take into account confounding 
factors affecting proteinuria (r
2
 = 0.31; P = 0.005). The remaining four studies did not 
individually demonstrate any statistically significant associations between PeP and proteinuria 
at follow-up. However, when combining the results of the primary outcome in four studies 
(Bognetti et al., Garg et al., O’Brien et al. and Watts et al.), the presence of PeP was highly 
associated with elevated resting proteinuria at follow-up (χ2 test, P < 0.0001).  Moreover, 
significant odds ratios (developing CKD following a positive exercise test vs. not developing 
CKD) was found for each of the four studies, ranging between 2.3-52.0. Secondary outcomes: 
Four studies (Bognetti et al., Dash and Torfvitt, Garg et al. and O’Brien et al.) also 
investigated secondary outcomes that included other modifiable CKD risk factors related to 
diabetic nephropathy such as Hba1c and hypertension: with respect to the primary outcome 
measure, Bognetti et al. noted that Hba1c was positively correlated to change in albumin 
excretion rate (PeP to follow-up resting proteinuria). 
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3.5. DISCUSSION 
 
Summary of evidence. This is the first systematic review to investigate whether exercise-
induced proteinuria can predict the onset or progression of CKD in humans, and demonstrated 
a paucity of studies in this area as assessed over a 60-year period. Of the small number of 
studies that do exist, the focus was on young (predominantly male) cohorts with insulin-
dependent (type 1) diabetes at-risk of incipient nephropathy. Comparison by meta-analysis 
was deemed not feasible given the great variability in the interventions used to generate PeP 
and timing of measurements. Despite these issues, results for the primary outcome of 
progression to CKD from four studies were pooled together. From this, chi-squared analysis 
and odds ratios for the development of CKD given presence of PeP were both found to be 
highly significant, suggesting that exercise testing could be a useful predictive tool for CKD 
progression. Additionally, of the five studies included for review, one study demonstrated a 
positive association between the presence of PeP and development of CKD (as defined by 
elevated resting albuminuria) over a 10-year period.   
Limitations. Study limitations: Given the viewpoint that diabetic nephropathy is the 
leading cause of end-stage renal disease in the Western World, it is not unexpected that all 
eligible studies focussed on diabetic patients at-risk of secondary nephropathy (Harjutsalo and 
Groop, 2014). Other plausible explanations for an emphasis on diabetics includes ease of 
sampling and familiarity as previous work examining PeP in diseased states has largely 
focussed on populations with diabetes (Poortmans 1984). Thus, all studies were rated as 
having low concern regarding applicability of the patient selection to the review question. 
Nonetheless, to determine if exercise-testing will be a useful predictor of CKD in general, 
future studies must focus on populations regardless of their primary disease or their cause of 
CKD. From a biological perspective this is plausible as the biochemical and cellular 
aberrations that drive CKD towards advancing glomerulosclerosis and the treatments used to 
prevent its progression (e.g. angiotensin-receptor blocking agents) are similar regardless of 
the underlying aetiology of CKD (Oite 2011). Using general CKD populations would also 
serve to increase sample size and are more likely to confidently achieve power calculations 
for primary outcome measurements.  
The studies examined also had a heavy bias towards a younger population (average age 
ranging from 15 to 30 years). However, it is well known that the prevalence of CKD is greater 
in people over 60 years: between the 1988 to 1994 National Health and Nutrition 
Examination Survey (NHANES) study and the 2003 to 2006 NHANES study, the prevalence 
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of CKD in people 60 years and above rose from 18.8 to 24.5%, whereas during the same 
period, the prevalence of CKD in people between the ages of 20 and 39 remained consistently 
below 0.5% (de Boer et al., 2011). Moreover, renal responses to exercise are blunted with 
advancing age (Walker et al., 1994). Thus, he older age groups are set to benefit the most 
from such a test and the results (and thus exercise protocol) of the current studies are of 
questionable applicability to this population. Future study designs should take these factors 
into account.  
As reflected by the QUADAS-2 scores, the interventions (index test) used across studies 
harbour a significant source of study bias with some concerns of applicability (figure 3.3.). 
The intensity and duration of exercise are two key determinants in yielding PeP (Poortmans 
1984). For example, Poortmans et al. (1982) remarked that an 800 metre sprint had the 
highest propensity for exercise proteinuria and this can reliably yield exercise proteinuria in 
healthy individuals (Junglee et al. 2012).  Thus, high-intensity and short duration routines are 
likely to maximise post-exercise proteinuria. The studies examined used exercise routines, 
which although convienent for a clinical setting, varied in intensity and duration. Addtionally, 
hydration to ensure diuresis and the timing for measurement of PeP was also variable despite 
previous work showing that hydration status could affect baseline measurements and that 
maximal proteinuria occurs 20-30 minutes post-exercise (Poortmans 1984; Junglee et al. 
2012). These factors introduce interpretation bias and make fair comparison between studies 
(and hence meta-analysis) difficult. Future studies require replicable and comparable exercise 
interventions that are tailored to patients using a well-established and robust measure of 
intensity (e.g. O2max). This and other important factors are summarised in table 3.5. Diseased 
individuals may show exaggerated responses to exercise and if all participants experienced 
PeP, they could potentially be further catagorised depending on their level of PeP (i.e. 
microalbuminuric versus macroalbuminuric). 
 
 
 
 
 
 
 
 
V
.
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Outcome limitations: All studies chose follow-up periods upto an average of 13 years, 
though within a recognised time-frame where diabetic nephropathy type I diabetics may 
develop (15-25 years from diagnosis; Mauer et al., 1997). Nevertheless, such lengthy follow-
up testing for CKD could be subject to confounding by a number of factors such as 
introduction of proteinuria-modifying treatments (e.g. angiotensin-receptor antagonists) and 
the development of other nephropathies (e.g. IgA nephropathy). This is reflected by the large 
proportion of high bias risk across studies for the flow and timing domain of QUADAS-2 
(figure 3.3.).  
In most studies, there was consideration given for changes in diabetic control with Hba1c 
measurements at baseline and follow-up, but only O’Brien et al. made an attempt to correct 
for a range of confounders by regression analysis and they demonstrated a positive 
association of post-exercise proteinuria and elevated resting proteinuria after a 10-year 
follow-up. Although it is appreciated in the real-life setting such factors are difficult to control 
for, it is recommended that future study should consider appropriate statistical correction to 
account for these analysis (e.g. multiple regression).  
Factors to consider when developing  
an exercise proteinuria provocation test 
 
Intensity of exercise determined with valid subject specific 
measure (e.g. % O2max). 
Short duration activity e.g 5 to 10 minutes. 
Adequate pre-hydration and checked using urine osmolality 
or colour. 
Robust methods to ensure significant resting proteinuria is 
excluded prior to testing e.g. 3 consecutive early-morning 
urine samples negative for proteinuria.  
Cut-off for significant proteinuria is based upon pathological 
criteria. 
Methodology is replicable and inexpensive. 
V
.
Table 3.5. Some of the factors that should be considered when developing an exercise test for 
proteinuria provocation.  
 
 
 
 82 
With respect to the primary outcome measure, definitions of pathological proteinuria at 
rest were generally acceptable with contemporary consensus opinions – largely in keeping 
with later KDIGO guidance (Kidney Disease: Improving Global Outcomes (KDIGO) CKD 
Work Group, 2013). However, it was surprising to find only one study documenting use of 
serum Cr as a primary outcome measure for CKD progression. Serum Cr is the most 
commonly used biomarker of CKD and would have been accessible in the time period when 
all five studies were conducted (1989 to 2003; Levey et al., 1999). Although arguably more 
invasive than a urine sample, it would be subject to less variability / labour-cost compared to 
A:Cr ratio estimations (which have to be repeated on three morning occasions) and can be 
incorporated into estimated GFR calculations. Additionally, all studies did not clarify 
explicitly that follow-up measurements were taken in a steady state period as the presence of 
intercurrent illness and previous exercise can influence proteinuria. 
Review limitations: A drawback of the review process includes the lack of grey-area 
searching and exclusion of non-English language literature. However, key electronic 
databases were searched, a broad scope in terminology was permitted to maximise hits and a 
medical librarian was utilised. Despite attempts, it was not possible to retrieve missing 
information from study authors (e.g. from Dash and Torfvitt), but regardless it is likely this 
would not significantly change the key findings of this review. Meta-analysis was not 
possible given the high degrees of bias in most studies and the variability in the interventions. 
The results from this systematic review are only applicable to type I diabetics at risk of CKD 
progression and cannot be used to make generalisations to the CKD population as a whole.  
 
3.6. CONCLUSION 
 
Despite the limited number of studies in the literature and their shortcomings, post-exercise 
proteinuria shows promise; as currently evidenced in a type I diabetic population. This is 
supported by highly significant odds ratios for four studies included in the systematic review. 
However, there is a need to refine exercise interventions and such findings should provide 
enough impetus for this before applying them to wider at-risk CKD populations. 
 
3.7. FUNDING 
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CHAPTER 4  
 
EXERCISING IN A HOT ENVIRONMENT WITH MUSCLE DAMAGE: EFFECT 
ON ACUTE INJURY BIOMARKERS AND KIDNEY FUNCTION 
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4.1. ABSTRACT 
 
Unaccustomed strenuous physical exertion in hot environments can result in exertional heat 
stroke and acute kidney injury (AKI). Both exercise-induced muscle damage and AKI are 
associated with the release of interleukin-6 (IL-6), but whether muscle damage causes AKI in 
the heat is unknown. It was hypothesized that muscle damaging exercise, prior to exercise in 
the heat would increase kidney stress. To test this hypothesis, ten healthy, euhydrated males 
underwent a randomized, crossover trial involving both a 60 minute downhill muscle-
damaging run (EIMD), and an exercise intensity-matched non-muscle damaging flat run 
(CON), in random order, separated by two weeks. Both treatments were followed by heat 
stress elicited by a 40 minute run at 33
o
C. Urine and blood were sampled at baseline, after 
treatment (EIMD or CON), and immediately after running in the heat. As expected, EIMD 
induced higher plasma creatine kinase and IL-6 than CON (P < 0.001 and P = 0.005, 
respectively). EIMD elevated kidney injury biomarkers (e.g. urinary NGAL after running in 
the heat: EIMD–CON, mean difference [95% CI]: 12 [5, 19] ng/ml) and reduced kidney 
function (e.g. plasma creatinine after running in the heat: EIMD–CON, mean difference [95% 
CI]: 0.2 [0.1, 0.3] mg/dl). Plasma IL-6 was positively correlated with plasma NGAL (r = 0.9, 
P = 0.001). Moreover, following EIMD, 5 of 10 participants met Acute Kidney Injury 
Network criteria for AKI.  Thus, for the first time it is shown that muscle damaging exercise 
prior to running in the heat results in greater inflammation and kidney stress compared to non-
muscle damaging exercise. Muscle damage should therefore be considered a risk factor for 
AKI when performing exercise in hot environments.  
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4.2. INTRODUCTION 
 
Unaccustomed strenuous exercise in the heat may lead to exertional heat injury (Adams et al., 
2012). This has been reported in athletes, military personnel, and those in other hazardous 
occupations such as firefighters (Carter et al., 2005; Howe and Boden, 2007; Wallace et al., 
2007). Exertional heat illness exists as a spectrum, which ranges from relatively mild 
exertional heat injury to life-threatening heat stroke with reduced consciousness and multi-
organ failure (Carter et al., 2005). In 2011, there were approximately 3000 cases of exertional 
heat injury in US military soldiers with over 10% sustaining heat stroke (MSMR, 2012).   
An association between heat stroke and kidney dysfunction has long been recognized, 
and although not universal, this combination appears to exacerbate the risk of severe acute 
kidney injury (AKI). This itself portends significant mortality and may require supportive 
treatment in the form of renal replacement therapy e.g. haemofiltration (Schrier et al., 1967; 
Raju et al., 1973; Lin et al., 2003). Treatment for severe AKI can be protracted and full 
recovery is not guaranteed: survivors of this catastrophic condition may be left with chronic 
kidney disease which itself represents a significant morbidity (Okusa et al., 2009).  
Observations, mainly from longitudinal studies and case reports, suggest that there are a 
number of factors that are potentially associated with the development of heat illness 
including a hot environment, dehydration, use of non-steroidal anti-inflammatory agents, and 
poor fitness levels (Lin et al., 2003; Carter et al., 2005; Howe and Boden, 2007; Leon and 
Helwig, 2010; Adams et al., 2012; Fortes et al., 2013). Some theories also propose that 
immune dysregulation is partly responsible for the development of heat stroke. In this context, 
immune dysregulation involves an elevation of pro-inflammatory cytokines including the 
pleiotropic cytokine interleukin-6 (IL-6) and vasoconstricting mediators (Fortes et al., 2013).  
There is also evidence that AKI per se represents a pro-inflammatory condition with 
cytokines released by leukocytes and renal tubular cells in the injured kidney. These 
molecules are believed to be important components of both the initiation and extension of 
kidney injury (Lee et al., 2012). Recent findings suggest that IL-6 plays a pivotal role in the 
development of AKI, by promoting its early development via an injurious inflammatory 
reaction (Nechemia-Arbely et al., 2008; Lee et al., 2012). This may be related to trans-
signaling and “Signal Transducers and Activators of Transcription” protein activation in renal 
tubular cells (Lee et al., 2012). 
Interestingly, strenuous unaccustomed exercise can result in muscle damage and 
consequently elevated circulating IL-6. (Philippou et al., 2009; Montain et al., 2000; Fortes et 
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al., 2013; Pedersen 2013). Thus, it is plausible that completing exercise in hot environments 
with muscle damage could generate a more severe pro-inflammatory response that induces 
kidney dysfunction typical of severe heat illness. The recent discovery of novel biomarkers of 
AKI offers more sensitive and specific method of investigating the kidney in experimental 
models of heat stress. One such biomarker, that has been used in a variety of AKI settings, is 
neutrophil gelatinase-associated lipocalin (NGAL) (Mishra et al., 2003; Mishra et al., 2004; 
Mishra et al., 2005; Mishra et al., 2006; Nickolas et al., 2008). Combined with traditional 
markers of kidney function, such as creatinine (Cr) filtration and urine output, a more 
complete understanding of the kidney’s stress response can be gained.  Therefore, the 
unknown contribution of the pro-inflammatory state resulting from muscle damage on kidney 
function during heat exposure can, for the first time, be investigated. 
Consequently the aim of this study was to investigate the effect of muscle damage and 
subsequent exercise in the heat on markers of kidney injury and function. It was hypothesized 
that following a bout of muscle damaging exercise, during subsequent exercise in a hot 
environment: 1) kidney injury biomarkers would be upregulated (e.g. increased urine and 
plasma NGAL concentrations); 2) kidney function would be reduced (e.g. plasma Cr 
concentration will be increased); and 3) that changes in circulating interleukin-6 and 
consequently biomarkers of kidney injury would be correlated with changes in kidney 
function. 
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4.3. MATERIALS AND METHODS 
 
Participants. The study was undertaken in accordance with the Declaration of Helsinki (2008) 
and the institutional ethics committee gave ethical approval. Recruitment occurred between 
January 2011 and August 2011. Potential participants who were aged between 18 to 30 years 
and recreationally active were approached via University and local sports clubs. Ten healthy 
Caucasian male subjects were successfully enrolled (mean age ± SD, 20 ± 2 years). All 
provided written consent and none had medical conditions, musculoskeletal injury, history of 
heat illness, or medication use (e.g. regular use of non-steroidal anti-inflammatory drugs) that 
precluded participation. Moreover, none of the subjects were heat-acclimatized or regularly 
participated in sports/activities that involved large eccentric movements of the legs (e.g. 
mountain running, weight lifting). A day prior to each trial, subjects avoided heavy 
unaccustomed exercise and consumption of alcohol or caffeine.  
Study Design. A counterbalanced crossover design was employed, with each participant 
performing exercise in the heat following a treatment that consisted of either muscle damage 
exercise (EIMD; running downhill on a -10% gradient treadmill) or exercise intensity-
matched but non-muscle damaging exercise (CON; running on +1% gradient treadmill; figure 
4.1). All subjects performed both treatments, in random-order, on separate occasions with a 
14-day washout period between treatments. Order of presentation of treatments was 
randomized by using on-line software (http://www.randomizer.org; Site Statistics, Social 
Psychology Network) with blinding to the identities and demographic details of all 
participants.  
Familiarization and Maximal Exercise Testing. At least one week prior to the first 
experimental trial, maximal oxygen uptake ( O2max) was assessed by a continuous 
incremental exercise test on a motor driven treadmill (Mercury 4.0, HP Cosmos, Nussdorf-
Traunstein, Germany). Participants ran initially at 8 km/h at a constant 1% gradient with the 
running speed increased by 2 km/h every three minutes. At 16 km/h the gradient was 
increased by 2.5% every three minutes until volitional exhaustion. During this entire period, 
oxygen uptake and carbon dioxide production were determined using an on-line breath-by-
breath system (Cortex Metalyser 3B, Biophysik, Leipzig, Germany). Using linear 
interpolation of the running speed versus O2 relationship, the speed eliciting 65% O2max 
was calculated.  Following a rest period of 15 minutes, a four minute speed verification test 
was conducted to identify the speed that would evoke 65% O2max whilst running at +1% and 
V
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-10% gradients. Running speed was adjusted to elicit 65% O2max and verified by 
concomitant measures of expired gas; thus ensuring exercise intensity was the same on both 
gradients in the experimental arms. 
 
Dietary Control. All participants had a standardized breakfast before the start of each trial 
(cereal bar; 2 kcal/kg body mass). Furthermore, subjects were requested to replicate the diet 
consumed 24 hours before the start of each treatment arm; this was confirmed through written 
diet diaries. Euhydration was achieved by subjects drinking 40 ml/kg nude body mass (Model 
705, Seca, Hamburg, Germany) of water during the 24 hours before a treatment arm, and 
consuming an additional 5 ml/kg nude body mass approximately 30 minutes before. To 
confirm euhydration, urine specific gravity was measured using a handheld refractometer 
(Atago Uricon-Ne refractometer, NSG Precision cells, New York, USA) on the initial urine 
sample on the day of study (Armstrong et al., 1998). 
Experimental Protocol (Treatment). For both EIMD and CON conditions, participants 
wore standardized clothing consisting of running shorts, socks and shoes and performed a 
V
.
Figure 4.1. Schematic detailing flow of study. Treatment (EIMD or CON) was performed at 20 
o
C. 
Heat stress was performed at 33 
o
C. Baseline, before heat stress and after heat stress denote sampling 
time points. EIMD, exercise-induced muscle damage arm; CON, control arm; NGAL, neutrophil 
gelatinase-associated lipocalin. 
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warm-up consisting of a three-minute walk on the treadmill at 5 km/h.  Depending on the 
treatment allocation, subjects then ran at their verified speed to elicit 65% O2max on either a 
-10% gradient treadmill (EIMD) or a +1% gradient treadmill (CON) in an ambient 
temperature of 20 °C and 40% relative humidity for 60 minutes. During this period, 
participants consumed water (2.5 ml/kg nude body mass) at 0, 15, 30 and 45 minutes. 
Following this exercise bout, subjects sat in ambient conditions for 30 minutes and a single 
bolus of water equivalent to 5 ml/kg nude body mass was administered.   
Heat stress.  Exercise in the heat was then completed, which involved running on the 
treadmill at a 1% gradient for 40 minutes at 65% O2max in an environmental chamber (Delta 
Environmental Systems, Chester, UK; figure 4.1.) maintained at a dry bulb temperature of 
33
o
C with 50% relative humidity. No fluids were provided during this bout. To conclude the 
trial, participants were provided with 30 ml/kg
 
body mass fluids to consume in the following 
21 hours.  
Kidney injury and function. To assess kidney injury, NGAL concentration in blood and 
urine was determined. To assess kidney function, plasma Cr concentration (filtration), urine 
volume, urine specific gravity (urine concentration), and fractional excretion of sodium 
(integrity of renal tubular reabsorptive function) were measured. Sampling time points are 
shown in figure 4.1. For micturition, participants were asked to maximize bladder emptying 
through double voiding. Urine volumes were collected at each time point using 24-hour urine 
containers to determine urine flow rate and to measure urinary specific gravity (see above).  
 
The fractional excretion of sodium was calculated as follows:  
 
[(sodiumurinary × creatinineplasma) ÷ (sodiumplasma x creatinineurinary)] × 100. 
 
Whole blood (lithium heparin, K2EDTA and serum) was taken from the antecubital vein 
using a 22-gauge needle and Vacutainer (BD, Oxford, UK). Serum tubes were left to stand for 
one hour before centrifugation. Blood samples were centrifuged for 10 minutes at 1500 g.  
Serum, plasma and urine aliquots were stored at -80 
o
C for subsequent biochemical analysis.  
Muscle damage and inflammation. As an indicator of muscle damage, plasma creatine 
kinase was measured at baseline and 24 hours post-treatment – a period where one could 
reasonably expect and elevation of creatine kinase from any muscle damage sustained during 
the protocol. Similar to the measurements of kidney function and injury, circulating plasma 
V
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IL-6 and tumor necrosis factor alpha (TNF-α) were measured at baseline and pre- and post-
heat stress as markers of inflammation (figure 4.1.).   
Biochemical Analyses. Enzyme-linked immunosorbent assays (ELISA) were performed 
for the following analytes using commercially-based kits as per kit instructions: plasma 
creatine kinase (EnzyChrom creatine kinase assay kit, BioAssay Systems, Hayward, USA); 
plasma IL-6 (Quantikine high sensitivity IL-6, HS600B, R&D Systems Europe, Abingdon, 
UK); plasma TNF-α (High Sensitivity TNF-α ELISA with Signal Amplification, eBioscience, 
Vienna, Austria) and plasma / urinary NGAL (NGAL Rapid ELISA kit, Bioporto, Gentofte, 
Denmark). Absorbances were read at a wavelength of 450 nm by a microplate reader 
(FLUOstar Omega, BMG Labtech GmbH, Ortenburg, Germany). Intra-assay coefficient of 
variation (CV) for creatine kinase, IL-6, TNF-α and NGAL (plasma/urine) were 3.8%, 5.3%, 
9.5% and 4.7/8.4%, respectively.  
Plasma and urinary Cr was measured by the Jaffe method on an Olympus AU2700 
automated analyzer (assay: OSR6178; Olympus, UK; Beckmann-Coulter, UK). Plasma and 
urine sodium was measured by an indirect ion selective electron probe on the same analyzer. 
For each biochemical analysis, all participant samples were assayed on the same plate. 
Urinary NGAL concentrations are presented as absolute values and corrected for urinary 
flow rates (NGAL ng/min).  This correction is an acceptable method to account for changes in 
urinary concentration and/or dilution. Although normalization of urinary NGAL to urinary Cr 
is commonly used in clinical and research settings to account for urinary concentration 
changes (cf. albumin:Cr ratio), its application in exercise models could be flawed. Marked 
reductions in glomerular filtration rate and tubular dysfunction occur during high-intensity 
exercise, and subsequently urinary creatinine excretion becomes a non-constant (Poortmans 
1984; Junglee et al., 2012). Thus, normalization against urinary flow rate was used instead 
(Waikar et al., 2010). All blood analytes were corrected for plasma volume shifts (Dill and 
Costill, 1974).
 
 
Exercise intensity.  To confirm energy expenditure was the same in both treatment arms, 
metabolic energy expenditure (M; W/m
2
) was determined by the following: oxygen 
consumption (VO2) during treadmill running was calculated from 60 seconds expired air 
samples collected into a Douglas bag which were analyzed for oxygen and carbon dioxide 
concentrations (SERVOPRO 1440 gas analyzer, Servomex, Crowborough, UK) and volume 
(Harvard Apparatus, Edenbridge, UK).  
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This, together with the respiratory exchange ratio (RER; VO2/VCO2), and body surface 
area (BSA) by the DuBois and DuBois (1916) method was used in the following equation:  
 
Metabolic energy expenditure (Watts) = (VO2 × (21166 × [0.23(RER) + 0.77]) / 60) / BSA 
 
Body temperature and hydration status. Core temperature was measured at each time 
point by a rectal thermistor inserted 12 cm beyond the anal sphincter (Henleys Medical 
Supplies Ltd, Herts, UK) and connected securely to a portable data logger (YSI model 4000A, 
YSI, Dayton, USA). 
Hydration status was assessed through nude body mass change and plasma volume 
change. The latter was determined by measurement of haemoglobin (β-Haemoglobin 
Hemocue AB photometer, Hemocue Ltd, Dronfield, UK) and haematocrit (Hawksley and 
sons Ltd, Sussex, UK) measured on whole blood in triplicate and then averaged for 
subsequent plasma volume shift calculations as described above.  
Statistical Analysis. Data for all dependent variables were examined for normality using 
histogram plots and Shapiro-Wilk tests. All data were found to be normally distributed except 
for urinary NGAL and flow rate corrections. Thus, mean ± SD are stated for all measures 
except for urinary NGAL where median {interquartile range} are presented. For the purposes 
of further statistical analysis, urinary data were successfully transformed to normality using a 
log10 function.  
For all dependent variables, EIMD and CON groups at pre-heat stress and post-heat stress 
were compared using parametric two-way repeated measures analysis of variance (group vs. 
time) with adjustments made to the degrees of freedom when assumptions of sphericity were 
violated. Post-hoc Bonferroni adjusted t-tests or Tukey’s tests were used as appropriate to 
follow up significant interactions.  
Mean differences and 95% confidence intervals between EIMD and CON groups at pre-
heat stress and post-heat stress were calculated for all measures. In the case of urinary NGAL 
and urinary NGAL flow rates, the Hodges and Lehman method was used to derive median 
differences and 95% confidence intervals between EIMD and CON. 
Plasma creatine kinase concentrations in EIMD and CON arms were compared at 
baseline and 24 hour post-treatment by two-tailed paired Student’s t-tests with Bonferroni 
correction. Mean energy expenditure in the EIMD and CON arms were compared during the 
respective treatment bout and during exercise in the heat by two-tailed paired Student’s t-tests 
with Bonferroni correction. 
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To determine the possible relationships between plasma IL-6, measures of renal function 
and biomarkers of kidney injury, bivariate Pearson’s correlations were performed on 
percentage change scores from baseline to post-heat stress. For all tests, statistical 
significance was accepted when P ≤ 0.05. SPSS version 18.0 (SPSS Inc., IBM, Chicago IL, 
USA) was used for all statistical analysis. 
For the primary outcome measure of NGAL, a power calculation revealed that six 
participants were needed per group to detect a smallest important change in means of 4.6 
ng/ml.  This value is the increase required to elevate urinary NGAL from the normal healthy 
population mean (5.3 ng/ml) to above the normal range (0.7-9.8 ng/ml) (NGAL, Bioporto 
Diagnostics).  This power calculation assumes a within subject error of 1.7 ng/ml, and allows 
for a 5 and 20% chance of making a Type I or Type II error, respectively (Hopkins 2006). 
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4.4. RESULTS 
 
All ten male participants (age 20 ± 2 years; height 176 ± 6 cms; O2max 59 ± 4 ml/kg/min) 
successfully completed both trials and there were no participant dropouts or complications 
due to heat illness.   
Urinary NGAL and Corrections for Urinary Flow Rate. The heat stress exercise bout 
elicited a rise in median urinary NGAL concentration following EIMD but not CON exercise 
(figure 4.2.). At post-heat stress, 8 of 10 individuals and 3 of 10 individuals, in EIMD and 
CON trials, respectively, demonstrated rises in urinary NGAL concentrations above the 
normal range,.   
Absolute urinary NGAL concentrations were also corrected for urinary flow rates, thus 
taking into account any alterations in urine production that may confound interpretation of 
raw values. Between pre- and post-heat stress, CON demonstrated a fall in urinary NGAL 
flow rate whereas EIMD exhibited a slight rise (baseline, pre-heat stress, post-heat stress for 
EIMD: 4.6 {2.5-5.6}, 10.3 {4.4, 11.7}, 12.4 {8.7, 19.2} ng/min; for CON: 9.4 {7.8-12.4}, 
19.7 {11.6, 29.0}, 8.5 {5.7, 11.7} ng/min). For these data there was a significant interaction 
(P = 0.002), but no main effects of time or group (P = 0.2 and 0.3, respectively).  Mean 
difference (EIMD – CON) and 95% confidence intervals for urinary NGAL flow rate between 
both groups were -0.3 [-0.6, -0.1] ng/min and 0.1 [0.007, 0.3] ng/min at pre-heat stress and 
post-heat stress, respectively.  
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Plasma NGAL. Between pre- and post-heat stress, there were increases in plasma NGAL 
concentrations that were more prominent in EIMD (figure 4.3).  
Plasma creatinine. Plasma Cr increased between pre-heat stress and post -heat stress in 
both groups, but more so for EIMD (figure 4.4). By post- heat stress, 5 out of 10 participants 
in EIMD met stage 1 of the Acute Kidney Injury Network (AKIN) criteria (plasma Cr rise of 
> 0.3 mg/dl from baseline), compared to 0 out of 10 participants in CON (Mehta et al., 2007). 
 
 
 
 
 
 
 
 
Figure 4.2.  Left panel: urinary neutrophil gelatinase-associated lipocalin (NGAL) at baseline, before 
(preHS) and after (postHS) heat stress for control (CON; clear boxes) and exercise induced muscle 
damage (EIMD; shaded boxes) groups. Data are presented as median (solid line in box), quartiles 
(boxes) and ranges (whiskers) given non-parametric data. Circles and small stars indicate outliers. 
Dotted horizontal line on y-axis indicates upper limit of normal range for urinary NGAL (9.8 ng/ml). 
For EIMD and CON groups, there was a significant interaction between pre- and postHS (P = 0.005).  
By post hoc test: *, significantly different from PreHS; †, significantly different from CON. Right 
panel: median difference and 95% confidence intervals between EIMD and CON for urinary NGAL at 
pre- and postHS.  A positive value indicates urinary NGAL was higher in the EIMD group.   
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Figure 4.3. Left panel: plasma neutrophil gelatinase-associated lipocalin (NGAL) at baseline, before 
(preHS) and after (postHS) heat stress for control (CON; dotted line) and muscle damage (EIMD; 
solid line) groups. Data are means (SD). Dotted horizontal grey line crossing y-axis indicates upper 
limit of plasma NGAL (106 ng/ml). For EIMD and CON groups, there was a significant interaction 
between pre- and postHS (P = 0.04). By post hoc test: *, significantly different from PreHS; 
‡ 
trend 
(P ≥ 0.05 but ≤ 0.1) for difference with CON. Right panel: mean difference and 95% confidence 
intervals between EIMD and CON for plasma NGAL at pre- and postHS. A positive value indicates 
plasma NGAL concentration was higher in the EIMD group. 
 
 
 
Figure 4.4. Left panel: plasma creatinine at baseline, before (preHS) and after (postHS) heat stress 
for control (CON; dotted line) and muscle damage (EIMD; solid line) groups. Data are means (SD). 
Dotted horizontal grey line crossing y-axis indicates upper limit of plasma creatinine (1.2 mg/dl). For 
EIMD and CON groups, there was a significant interaction between pre- and postHS (P = 0.005).  By 
post hoc test: 
*
, significantly different from PreHS; 
†
, significantly different from CON. Right panel: 
mean difference and 95% confidence intervals between EIMD and CON for plasma creatinine at pre- 
and postHS. A positive value indicates plasma creatinine was higher in the EIMD group. 
 
 
 96 
Urinary Volume, Flow Rate and Specific Gravity. Between pre- and post-heat stress, 
there was a reduction in urine volume that was more pronounced in EIMD, exhibiting 
significant main effect of time and group (P < 0.05 and P = 0.05, respectively), albeit no 
interaction (P = 0.9, table 4.1.).  
Urinary flow rate revealed a similar pattern. Between pre- and post-heat stress, urinary 
flow rate fell below the baseline value (table 4.1.). This reduction in flow rate was again more 
pronounced in EIMD with significant main effects for time and group (P = 0.001 and P = 
0.05, respectively), but no interaction (P = 0.7).  
Consistent with this, urine specific gravity rose between pre and post-heat stress in both 
groups but more so in EIMD (table 4.1.). During pre- and post-heat stress, there were 
significant main effects of time and group (P = 0.001 and P = 0.04, respectively) but no 
interaction (P = 0.2).  
Fractional Excretion of Sodium. Fractional excretion of sodium fell between pre- and 
post-heat stress but tended to fall more sharply in EIMD (table 4.1.), as evidenced by a main 
effect of time (P = 0.01), and a trend for a time x group interaction (P = 0.08). 
Muscle Damage and inflammation. As an indirect marker of muscle damage, plasma 
creatine kinase concentrations at baseline were similar in CON and EIMD (CON: 78 ± 58 IU 
vs. EIMD: 58 ± 29 IU; P = 0.1), suggesting that a sufficient wash out period had occurred. By 
24 hours post-treatment, plasma creatine kinase concentrations were significantly elevated in 
EIMD (CON, 119 ± 69 IU vs. EIMD, 250 ± 69 IU; P < 0.001) indicating that the protocol 
induced some muscle damage. This was corroborated by Delayed-onset muscle soreness 
scores 24 hours post-treatment (unpublished data). Mean difference (EIMD – CON) and 95% 
confidence intervals for plasma creatine kinase between both groups were -20 IU [-47, 7 IU] 
and 131 IU [89, 173 IU] at baseline and post-24 hours, respectively. 
Furthermore, at baseline plasma IL-6 was not different between groups (P = 0.4; table 
4.2). Between pre- and post-heat stress, IL-6 increased in both groups but this rise was greater 
in EIMD (time x group interaction, P = 0.005).  In contrast, there were no changes to plasma 
TNF-α between groups at baseline (P = 0.8, table 4.2) or at the pre- to post-heat stress interval 
(main effect of time P = 0.6; main effect of group: P = 0.5; interaction: P = 0.9). 
Exercise intensity. During treatment, both CON and EIMD exercise was conducted at the 
same exercise intensity with no difference in mean metabolic energy expenditure between 
treatments (CON: 504 ± 56) W/m
2
 vs. EIMD: 503 ± 57 W/m
2
; P = 0.9).  However, during 
exercise in the heat, mean metabolic energy expenditure was slightly higher in EIMD 
compared to CON, despite identical running speed and incline (CON: 522 ± 50 W/m
2
 vs. 
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EIMD: 556 ± 57 W/m
2
; P < 0.001). Mean difference (EIMD – CON) and 95% confidence 
intervals for mean metabolic energy expenditure between groups were -1 W/m
2
 [-15, 13 
W/m
2
] and 34 W/m
2
 [23, 45 W/m
2
] at pre-heat stress and post-heat stress, respectively. 
Body temperature and hydration status. Pre and post -heat stress, rectal core temperature 
was greater in EIMD compared to CON (table 4.2). There was a significant main effect of 
time and group (P < 0.001 and P = 0.007, respectively), but no interaction (P = 0.2).  
Nude body mass decreased between pre- and post-heat stress in both treatment arms 
(table 4.2). This decrement in body mass was similar for each treatment, hence there was a 
significant main effect for time but not for group (P < 0.05 and P = 0.8, respectively).  
Moreover, when body mass change between pre- and post-heat stress was calculated as a 
proxy for fluid balance there was no difference between EIMD and CON (body mass change 
EIMD: -0.79 ± 0.37) kg; CON: -0.78 ± 0.16 kg, P = 0.9). 
At baseline, plasma volume was estimated as 52.3 ± 3.1 and 51.8 ± 3.0 % of total blood 
volume, in CON and EIMD groups, respectively.  Plasma volume was not different between 
groups at pre-heat stress and post-heat stress (pre-heat stress: CON, 51.9 ± 3.6 % vs. EIMD: 
51.0 ± 3.3 %; post-heat stress: CON, 51.2 ± 3.1 % vs. EIMD, 51.0 ± 3.0 % of total blood 
volume). No main effects were observed for time (P = 0.6) or group (P = 0.4). 
Correlational Analyses. Plasma NGAL was negatively correlated with urine volume in 
EIMD (r = -0.65; P = 0.04) but not in CON (r = -0.04; P = 0.9), and plasma NGAL was 
positively correlated with urinary specific gravity in EIMD (r = 0.64; P = 0.05), but not in 
CON (r = 0.08; P = 0.8). Similarly, a trend existed for plasma NGAL to be correlated 
negatively with urinary flow rate in EIMD (r = -0.61; P = 0.06), but not in CON (r = -0.05; P 
= 0.9). Although no associations were noted between plasma IL-6 with markers of kidney 
function, plasma IL-6 was positively correlated with the biomarker of kidney injury, plasma 
NGAL, in EIMD (r = 0.88; P = 0.001).  Consistent with other measures, this association was 
not evident in CON (r = -0.06; P = 0.9). 
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 Group Baseline Before heat 
stress 
After heat 
stress 
Before heat stress: 
EIMD – CON 
After heat stress:  
EIMD – CON 
Urine volume  
(ml) 
EIMD 146 ± 105 269 ± 133
 † 
 88 ± 77
* †
 -93 [-253, 66] -81 [-24, -139] 
CON 156 ± 96 363 ± 175 169 ± 78
* 
Urine flow rate  
(ml/min) 
EIMD 3.4 ± 2.3 3.5 ± 1.9
 † 
1.1 ± 1.0
* † 
-1.3 [-3.3, 0.7] -1.0 [-1.7, -0.3] 
CON 3.2 ± 1.8 4.8 ± 2.2 2.0 ± 1.0
* 
Urinary specific 
gravity 
EIMD 1.011 ± 0.008 1.006 ± 0.004
 †
 1.012 ± 0.004
* †  
0.001 [-0.002, 0.046] 0.004 [0.001, 0.008] 
CON 1.010 ± 0.008 1.005 ± 0.004 1.008 ± 0.005
*
 
Fractional excretion 
of sodium (%) 
EIMD 0.39 ± 0.15 0.33 ± 0.16 0.13 ± 0.12
* 
0.04 [-0.08, 0.16] 
 
-0.08 [-0.18, 0.01] 
 CON 0.36 ± 0.12 0.29 ± 0.12 0.22 ± 0.19
* 
Table 4.1. Kidney function markers following exercise induced muscle damage or control exercise. Legend: Data are mean ± SD, and 
mean difference between groups [95% confidence interval]; EIMD, exercise-induced muscle damage; CON, control; by main effect: 
*
, 
significantly different from before heat stress; 
†
, significantly different from CON.   
 
 
 
 99 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Group Baseline Before heat 
stress 
After heat 
stress 
Before heat stress:  
EIMD – CON 
After heat stress:  
EIMD – CON 
Interleukin-6  
(pg/ml) 
EIMD 0.7 ± 0.5 2.8 ± 0.8
 † 
6.0 ± 1.9)
* † 
1.4 [0.6, 2.2] 3.2 [1.5, 5.0] 
CON 0.6 ± 0.3 1.4 ± 0.9 2.8 ± 1.8)
* 
Tumor necrosis factor 
alpha (pg/ml) 
EIMD 1.9 ± 0.2 2.0 ± 0.1 2.1 ± 0.4) 0.06 [-0.13, 0.24] 0.07 [-0.23, 0.37] 
CON 1.9 ± 0.1 2.0 ± 0.2 2.0 ± 0.3) 
Core temperature (
o
C) EIMD 37.0 ± 0.3 37.8 ± 0.2
 †
 39.5 ± 0.5
* †
 0.35 [0.05, 0.65] 0.67 [0.13, 1.22] 
CON 37.0 ± 0.4 37.5 ± 0.3 38.8 ± 0.7
* 
Nude body mass (kg) 
 
EIMD 70.1 ± 7.7 69.2 ± 7.5 68.4 ± 7.5
* 
-0.03 [-0.25, 0.19] 
 
-0.04 [-0.42, 0.33] 
 CON 69.8 ± 7.3 69.2 ± 7.3 68.4 ± 7.3
*
 
Table 4.2. Treatment responses following exercise induced muscle damage or control exercise. Legend: Data are mean ± SD, and 
mean difference between groups [95% confidence interval]; EIMD, exercise-induced muscle damage; CON, control; by main effect or 
by post-hoc test following significant interaction: 
*
, significantly different from before heat stress; 
†
, significantly different from CON.  
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4.5. DISCUSSION 
 
For the first time it has been shown that prior muscle damaging exercise and its consequent 
mild inflammatory response led to upregulation of a biomarker of kidney injury, NGAL, 
when performing exercise in the heat. Prior muscle damaging exercise also resulted in 
alterations to kidney function as evidenced by increased plasma Cr concentration (by 
approximately 20%), decreased urine volume and urine flow rate (by 50%), reduced fractional 
excretion of sodium (by 40%), and mildly increased urinary specific gravity, compared to 
control exercise. Once AKIN criteria for AKI were applied, half of the individuals in the 
muscle damage group met stage 1 criteria (plasma Cr > 0.3 mg/dl from baseline) compared to 
no individuals in the control exercise group.  Moreover, the reduced fractional excretion of 
sodium in the muscle-damaged group suggests increased Na-K-adenosine triphosphatase 
activity within renal tubules and therefore higher oxygen and energy demands (Katz 1988). 
These findings reveal that even modest muscle damage, as typically observed following 
unaccustomed exercise, combined with relatively mild exercise-heat exposure, induces kidney 
stress. 
Such vulnerability of the kidney is of particular relevance to exercise settings and 
occupations where arduous physical activity is performed in hot conditions. Of note, the 
functional changes seen in the participants did not represent a positive adaptation to 
dehydration. These changes occurred despite fluid intake being strictly controlled and 
matched between groups. Lending further support, hydration status and fluid balance were 
similar in the muscle-damaged state, as evidenced by near identical body mass and plasma 
volume changes. The counterbalanced crossover study design also controlled for potential 
AKI aggravators such as preceding infectious illnesses, dehydration, and use of non-steroidal 
anti-inflammatory agents (Leon and Helwig, 2010). Taking all of the above into account and 
noting that the study’s population comprised athletic individuals exhibiting a high degree of 
fitness (mean O2max: 59 ml/kg/min), it is plausible that even more profound changes in 
biomarker and kidney function may result in the field where a “perfect storm” of muscle 
damage-naïve individuals and multiple environmental stressors are present (Clarkson 2007).  
Thus, muscle damage should be considered a novel risk factor for AKI. 
Changes in plasma NGAL were correlated with altered kidney function (urinary volume, 
flow rate and specific gravity). Although such data may suggest a maladaptive role for 
NGAL, it is noteworthy that recent in-vitro studies of cell cultures exposed to heat-stress 
demonstrate that ectopic expression of NGAL may actually have a protective effect 
V
.
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(Roudenkar et al., 2009). The role of inflammatory cytokines also requires further 
investigation. The increase in both plasma IL-6 and plasma NGAL following muscle damage 
and the positive correlation between these biomarkers (r = 0.9, P = 0.001 in EIMD group), 
supports the argument that an acute phase response to inflammation from muscle-damaging 
exercise may lead to the observed kidney stress. However, a lack of a direct correlation 
between IL-6 and kidney function does not discount a relationship and may suggest mediation 
by other factors (Nechemia-Arbely et al. 2008; Leon and Helwig, 2010; Lee et al., 2011). 
Interestingly, TNF-α is unlikely to be a mediating factor due to the lack of change following 
muscle damaging or control exercise. Alternatively, it is possible that the muscle-damaging 
protocol used in this study did not produce an IL-6 response sufficient to be directly 
associated with alterations in kidney function. For example, elevations in plasma IL-6 are 
often seen in patients with severe sepsis and AKI, but these conditions usually feature 
concentrations several hundred-fold higher than those observed in the present study (Chawla 
et al., 2007; Liu et al., 2009; Payen et al., 2012).   
Apart from an inflammatory pathway, a reduction in kidney blood flow is another 
plausible mechanism for the NGAL and kidney function alterations observed.  Kidney injury, 
as indicated by elevations of biomarkers such as NGAL, has been observed in recent clinical 
studies of “pre-renal” (reduced kidney perfusion) AKI (Nejat et al., 2012). Pre-renal AKI is 
also known to be associated with heat stroke (Lin et al. 2003). Although not directly 
measured in the present study, the exercise protocol was of sufficient intensity (65% of 
O2max) to reduce kidney blood flow (Castenfors 1967a; Schrier 1967; Poortmans 1984; 
Junglee et al., 2012). The observed fall in urine production is also consistent with a reduction 
in kidney blood flow.  
From a practical standpoint, these findings suggest that clinicians should take note of 
individuals who complain of muscle soreness suggestive of muscle damage either before or 
after performing strenuous exercise in the heat, as they appear to be at greater risk of 
developing AKI. In the majority of cases such aberrations will resolve without sequelae. 
However, if this scenario was amplified and/or occurred as part of a “perfect storm” (as is 
often the case during heat illness), serious AKI is more likely (Clarkson 2007).  Currently, 
unstandardized protocols exist to check for AKI in the days following exertional 
rhabdomyolysis-associated muscle damage (Patel et al., 2009). The present results suggest 
that kidney injury may be induced much earlier. Hence, precautionary measures including 
serial AKI biomarker sampling may be helpful; particularly given that measurement of 
V
.
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traditional markers of kidney injury such as urine volume can be difficult to ascertain 
following exercise (Poortmans 1984; Clarkson 2007).  
It is recognized that although elevations of urine NGAL with muscle damaging exercise 
were eight-fold (to 15 ng/ml), with a highest observed value of 65 ng/ml (expected normal 
range of 0.7-9.8 ng/ml), and elevations of plasma NGAL were two-fold (to 109 ng/ml) with a 
highest observed value of 158 ng/ml (expected normal range of 37-106 ng/ml), these 
responses are lower than that used to define clinical AKI (typically 250 ng/ml) (Nechemia-
Arbely et al., 2008). It is important to note that it was not a study aim to induce and diagnose 
AKI. In fact, the interpretation of such sub-clinical elevations is not well-defined at present, 
but some have suggested they may indicate kidney stress or mild injury (Nickolas et al., 2008; 
Nejat et al., 2012). In the context of exercise-induced muscle damage, this interpretation is 
analogous to that of exercise-induced rises in troponin concentrations that have been 
suggested to be an indicator of mild cardiac stress and, possibly, sub-clinical damage 
following strenuous endurance activity (Shave et al., 2010).  
A key limitation of this study is whether the observed plasma NGAL elevations arose 
solely from the kidney, as other sources (e.g. respiratory epithelium, liver, heart) cannot be 
excluded (Chakraborty et al., 2012). Moreover, fresh urine was not microscopically examined 
for evidence of tubular damage (e.g. for granular casts and for leukocyte quantification), 
which can also influence urinary NGAL concentrations (Decavele et al., 2011). However, 
plasma elevations were associated with reductions in measures of kidney function, and 
urinary flow rates were consistent with increased urinary tubular excretion of NGAL in 
EIMD. Furthermore, the ELISA kit utilized in this study only detects monomeric urinary 
NGAL; indicating a predominantly tubular rather than leukocyte origin (Mårtensson et al., 
2012). In addition, the current findings are only applicable to a male population. Although the 
majority of heat stroke and / or acute kidney injury cases following heavy physical exertion 
are reported in this sex (Carter et al., 2005), it remains to be shown whether females 
demonstrate similar responses; a sex specific response could be hypothesised given that high 
oestrogen levels can afford a protective effect against muscle damage e.g. high oestrogen 
levels (Constatini et al., 2005). Finally, the use of NGAL in this study has provided useful 
mechanistic information to the evolution of kidney stress during exercise in the heat, but 
further study is need to determine whether NGAL yields superior sensitivity and / or 
specificity against more traditional measures such as plasma Cr in such settings. 
In conclusion, performing muscle damaging exercise prior to running in the heat results 
in a mild inflammatory response (as assessed by plasma IL-6), upregulation of a biomarker of 
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kidney injury suggesting kidney stress (as assessed by NGAL), and alterations to kidney 
function (as assessed by plasma Cr, urine production and fractional excretion of sodium). 
Hence, prior muscle damaging exercise should be considered as a novel risk factor for 
developing AKI when performing exercise in the heat. Further controlled studies are required 
to dissect other potential interacting risk factors such as prior non-steroidal anti-inflammatory 
drugs use and intravascular volume depletion. These may have an additive effect with muscle 
damage and result in clinically significant changes in NGAL concentrations and kidney 
function measures. This study also raises the intriguing and unanswered question as to 
whether acclimatizing naïve individuals to muscle damage can ameliorate the consequent 
inflammation, elevated AKI biomarkers and alterations in kidney function, since pre-
conditioning exercise reduces muscle damage through the repeated bout effect (Chen et al., 
2012).  
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CHAPTER 5 
 
INFUSION OF RECOMBINANT IL-6 IN HEALTHY HUMANS ELEVATES 
PLASMA NGAL CONCENTRATIONS WITHOUT A REDUCTION IN RENAL 
FUNCTION  
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5.1. ABSTRACT 
 
Interleukin-6 (IL-6) is believed to be an important cytokine in acute kidney injury (AKI). 
Whether IL-6 per se is able to influence an AKI biomarker (Neutrophil Gelatinase Associated 
Lipocalin, NGAL) and kidney function in healthy humans, is not known. Thus, a three-hour 
recombinant IL-6 infusion was administered to six males at a rate of 5 μg/h. Plasma IL-6, 
NGAL, creatinine (Cr), and cystatin C concentrations were measured at 0 hours, 0.5 hours, 3 
hours and post-infusion at 24 hours and 48 hours. Tympanic temperature was recorded at 0 
hours and 3 hours.  IL-6 concentrations were 0.7 {0.6, 1.2} {interquartile range} pg/ml at 0 
hours and peaked at 3 hours to 159.7 {114.6, 186.7} pg/ml. By 48 hours this fell to 8.2 {6.8, 
13.0} pg/ml (main effect of time, P < 0.001). Plasma NGAL concentrations were 24.3 (13.2) 
ng/ml at 0 hours and peaked at the end of the infusion at 3 hours to 70.6 (49.3) ng/ml. At 48 
hours, this fell to 31.7 (16.5) ng/ml (main effect of time, P = 0.025). Plasma Cr and cystatin C 
concentrations were unchanged. Tympanic temperature rose from 36.9 (0.2) 
0
C to 37.5 (0.6) 
0
C at 0 hours and 3 hours, respectively (P = 0.046). Plasma NGAL was positively correlated 
with tympanic temperature (r = 0.945, P = 0.004). Although IL-6 concentrations found in 
clinical models of AKI were achieved, elevations in plasma NGAL were below the range 
typically associated with AKI and no changes to renal function were evident. Overall, these 
findings suggest that IL-6 is able to modulate NGAL but is not per se responsible for AKI or 
kidney dysfunction, and that addtional physiological aberrations must be involved. 
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5.2. INTRODUCTION 
 
From a histological perspective, acute kidney injury (AKI) is typified by a pro-inflammatory 
environment (Bonventre and Zuk, 2004; Edelstein and Schrier, 2007). Following an insult 
that leads to injury of the renal vascular endothelium, there is recruitment of leukocyte subsets 
such as macrophages and neutrophils from the blood into the kidney interstitium (Friedewald 
and Rabb, 2004). Together with renal tubular cells, these release various vasoconstrictive 
mediators and pro-inflammatory cytokines that contribute to the disruption of kidney function 
through tubular injury and culminates in apoptosis (Edelstein and Schrier, 2003). Thus, 
cytokines play an important role in both the initiation and extension of inflammation in AKI 
(Lee et al., 2011).  
Interleukin-6 (IL-6) is a cytokine that is thought to play a significant pathogenic role as a 
mediator of AKI, possibly through trans-signalling and Signal Transducers and Activators of 
Transcription protein activation in renal tubular cells (Lee et al., 2011). In mouse models of 
ischemic AKI, there is a rapid but transient increase in IL-6 expression by podocytes (Kielar 
et al., 2005; Vannay et al., 2009). Also, in direct response to exogenous IL-6, podocytes 
produce neutrophil gelatinase-associated lipocalin (NGAL); a biomarker of kidney injury 
(Lee et al., 2012). Despite such findings, the experimental manipulation of IL-6 yields 
variable responses in different models of AKI. For example in ischemic AKI, the prognosis of 
IL-6 knock-out mice may not be different or even improved in comparison to wild type mice, 
but in cisplatin-induced AKI, IL-6 knock-outs fare worse (Patel et al., 2005; Klein et al., 
2008; Mitazaki et al., 2011). These disparities could be due to variable doses of insult, 
experimental time course and the definitions of AKI used, or be reflective of the pleiotropic 
role of IL-6 as a key immunomodulatory cytokine that is involved throughout the evolution of 
AKI; from the initial phases of an acute phase response to its reparatory stage and resolution 
(Hurst et al., 2001; Nechemia-Arbley et al., 2008). Indeed, the modulation of fever by IL-6 
through the synthesis of prostaglandin E2 in the hypothalamus is a well-studied example of its 
pleotropism (Netea et al., 2000). Mouse models suggest high core body temperatures can 
moderate severity and recovery of AKI: hyperthermia potentiating injury (Zager and 
Altschuld 1986). These effects are associated with, and may be influenced by, temperature-
induced changes in renal high-energy phosphate availability and oxidant stress during the 
ischaemic/post-ischaemic period in AKI (Zager et al., 1985).  
The above relationships could have importance in a real-world setting. Junglee et al. 
(2013) recently demonstrated that performing muscle damaging exercise prior to running in 
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the heat increased plasma IL-6 concentration, core body temperature, kidney stress (through a 
rise in plasma and urine NGAL concentrations), and renal dysfunction (through elevations in 
plasma creatinine and a fall in urine output) compared to non-muscle damaging exercise. 
Moreover, plasma IL-6 concentration was positively correlated with plasma NGAL 
concentration and the latter was correlated with markers of reduced renal function (such as 
reduced urine production). Thus, it is plausible that IL-6 is part of an acute phase response 
integral to the development of AKI associated with exertional heat injury. However, whether 
the release of IL-6 per se leads to kidney stress and altered kidney function could not be 
ascertained from this study, as there could be contributions and interactions from other 
physiological changes and inflammatory mediators during muscle damage. Additionally, 
muscle-damaging exercise only elevates IL-6 modestly in laboratory-based studies, whereas 
much higher IL-6 concentrations are associated with severe AKI (Simmons et al., 2004; 
Zarjou and Agarwal 2011). 
To provide further insight into the role of IL-6 in AKI, the objective of this study was to 
infuse recombinant IL-6 in healthy participants; allowing us to extend previous animal studies 
and also to experimentally confirm previous observations of a mechanistic role for IL-6 in 
AKI (Junglee et al., 2013). For obvious ethical reasons, elevations of plasma IL-6 to 
concentrations well below those associated with AKI were only sought. Thus, the study’s 
primary aims were to determine the effect of a recombinant IL-6 infusion upon markers of 
kidney stress (by evaluating plasma NGAL response) and kidney function (by evaluating 
plasma creatinine (Cr) and cystatin C responses). 
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5.3. MATERIALS AND METHODS 
 
Study design and participants. An observational cohort study design was employed. The 
study was undertaken in accordance with the Declaration of Helsinki (2008) and the 
institutional ethics committee gave ethical approval. Six healthy Danish Caucasian male 
participants were recruited (age 25 ± 5 (SD) years; height 181 ± 7 cms; weight 81 ± 10 kg). 
All provided written consent and none had chronic medical conditions, recent infective 
illness, heat illness / fever or medication use (e.g. regular use of non-steroidal anti-
inflammatory agents) that precluded participation. 
Recombinant interleukin-6 infusion. All participants were fasted from midnight prior to 
receiving a three-hour intravenous infusion of human recombinant IL-6 (Sandoz, Basle, 
Switzerland). This was delivered in 20% human albumin solution (xenalb20, Bio Products 
Laboratory, Hertfordshire, UK), at a rate of 5 μg/h in a volume of 25 ml/h, through an 18 
gauge venous catheter (BD medical, Albertslund, Denmark) inserted in the antecubital fossa 
of the non-dominant arm. The group was supervised at all times by a medically trained 
individual. Similar protocols have been used in previous human studies investigating the 
effect of IL-6 on cytokine recruitment and general metabolism, and a peak plasma IL-6 
concentration similar to that found in post-cardiopulmonary bypass associated-AKI (above 
100 pg/ml) can be achieved without significant side-effects (Nemet et al., 2006; Musleh et al., 
2009).  
Primary and secondary outcome measures. Primary outcome measures were taken during 
the recombinant IL-6 infusion (at 0 hours, 0.5 hours and 3 hours) and post-IL-6 infusion (at 
24 hours and 48 hours; figure 5.1.). These included biomarkers of kidney injury (plasma 
NGAL) and function (plasma Cr and cystatin C) obtained through sampling of whole blood 
(K2EDTA).  
Blood samples were centrifuged for 10 minutes at 1500 g and plasma aliquots were 
stored at -80 
o
C for subsequent analysis. To determine if any degree of AKI had occurred, 
Acute Kidney Injury Network (AKIN) criteria for AKI were used, with any rise in plasma Cr 
of ≥ 0.3 mg/dl or 1.5 or 2 times higher than baseline indicative of AKI (Ricci et al., 2011). 
Secondary outcome measures included heart rate (Omron M2, Omron Sante France, Rosny 
Sous Bois, France), blood pressure (Omron M2, Omron Sante France, Rosny Sous Bois, 
France) and tympanic temperature (Braun Thermoscan, Fredericksberg, Denmark) that were 
only recorded prior to and immediately after the infusion had ended (figure 5.1.). The same 
recorder took all measurements whilst participants rested supine. 
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Biochemical Analyses. Enzyme-linked immunosorbent assays (ELISA) were performed 
as per kit instructions for plasma IL-6 (High sensitivity ELISA kit, R&D systems 
Minneapolis, MN, USA), and plasma NGAL (NGAL Rapid ELISA kit, Bioporto, Gentofte, 
Denmark). Absorbances were read by a microplate reader at wavelengths of 450 and 490 nm 
for NGAL and IL-6 respectively (FLUOstar Omega, BMG Labtech GmbH, Ortenburg, 
Germany). Plasma Cr was measured by the Jaffe method on an Olympus AU2700 automated 
analyzer (assay: OSR6178; Olympus, UK; Beckmann-Coulter, UK). Plasma cystatin C was 
measured by nephelometry on a Roche Integra 400+ analyser (Roche Diagnostic Limited, 
West Sussex, UK). For each biochemical analysis, all participant samples were assayed on the 
same plate. Intra-assay coefficient of variation for IL-6, NGAL, Cr and cystatin C were 6%, 
5.5%, 5.2% and 0.9%, respectively.  
Statistical Analysis. Data for all dependent variables were examined for normality using 
histogram plots and Shapiro-Wilk tests. Plasma IL-6 and systolic blood pressure were not 
normally distributed but were successfully transformed using the log10 function for 
subsequent statistical tests. Thus, mean ± SD are presented for all measures except for IL-6 
and systolic blood pressure where median {interquartile range} are given. All time points 
were compared using parametric one-way repeated measures analysis of variance (time) with 
adjustments made to the degrees of freedom when assumptions of sphericity were violated. 
Figure 5.1. Schematic illustrating time points for primary and secondary measurements. The 
recombinant IL-6 infusion was given between 0 and 3 hours (h). All measurements were taken in the 
resting condition. 
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Planned comparisons were made between specific time points using paired t-tests. Paired t-
tests were also used to compare outcomes that were measured at 0 hours and 3 hours only 
(heart rate, blood pressure and temperature). 
To determine possible relationships between plasma IL6, plasma NGAL, measures of 
renal function (plasma Cr and cystatin C), heart rate, blood pressure and body temperature, 
bivariate Pearson’s correlations were performed on raw change scores of values from 0 to 3 
hours. SPSS version 18.0 was used for all statistical analyses (SPSS Inc., IBM, Chicago IL, 
USA) and statistical significance was accepted when P ≤ 0.05. 
For planned comparisons of the primary outcome measure of kidney injury (plasma 
NGAL) between specific time points, a power calculation revealed that 6 participants were 
needed to obtain 80% power with a type I error rate of 5% for a two sided paired samples t-
test to detect a smallest important change in means of 43 ng/ml (Hopkins 2006).  This value is 
the increase required to elevate plasma NGAL from the normal healthy population mean (63 
ng/ml) to above the normal range (37-106 ng/ml).  This power calculation used a SD of the 
difference scores of 10 ng/ml (Junglee et al., 2013). 
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5.4. RESULTS 
 
All six participants completed the study without significant side-effects from infusion of 
recombinant IL-6. 
Infusion of recombinant IL-6. Recombinant IL-6 concentrations were 0.7 {0.6, 1.2} pg/ml 
at 0 hours and peaked at 3 hours to 159.7 {114.6, 186.7} pg/ml. By 48 hours post-infusion 
this had reduced to 8.2 {6.8, 13.0} pg/ml (figure 5.2.). Overall, there was a significant effect 
of time (P < 0.001; planned comparisons, 0 to 0.5 hours: P < 0.001; 0 to 3 hours: P < 0.001; 0 
to 24 hours: P = 0.004; 0 to 48 hours P = 0.001; figure 5.2.). 
Plasma NGAL concentrations. Plasma NGAL concentrations were 24.3 ± 13.2 ng/ml at 0 
hours and peaked at the end of the infusion at 3 hours to 70.6 ± 49.3 ng/ml, thus representing 
a mean increase of 167% from baseline (figure 5.3.). By 48 hours, this had fallen to 31.7 ± 
16.5 ng/ml (figure 5.3.). There was a significant effect of time (P = 0.025; planned 
comparisons, 0 to 0.5 hours: P = 0.92; 0 to 3 hours: P = 0.027; 0 to 24 hours: P = 0.338; 0 to 
48 hours: P = 0.631; figure 5.3.).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 5.2. Effect of recombinant IL-6 infusion upon plasma IL-6 concentrations. Data are medians 
(thick lines) and ranges. Open circles and asterixes are outliers. There was a significant effect of time 
(P = 0.007). #, difference compared to 0 hours sample point by planned comparisons. 
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At no time point were mean plasma NGAL concentrations elevated more than the 
minimum important clinical difference. However, one individual reached a peak plasma 
NGAL concentration that was greater than the normal range of 37-106 ng/ml (135.5 ng/ml at 
3 hours). 
Plasma creatinine and cystatin C concentrations. Mean baseline plasma Cr was 0.86 ± 
0.28 mg/dl and did not exhibit any significant changes throughout the duration of the 
experiment (main effect of time: P = 0.465). Furthermore, no subject satisfied any stage of the 
AKIN criteria. Similarly, mean baseline plasma cystatin C was 0.75 ± 0.14 mg/l and did not 
change over time (main effect of time, P = 0.176). 
Heart rate, blood pressure and tympanic temperature. Heart rate was significantly 
elevated between 0 and 3 hours of the recombinant IL-6 infusion (P = 0.041; table 5.1.), as 
was tympanic temperature (P = 0.046; table 5.1.). In contrast, neither systolic nor diastolic 
blood pressure measurements changed significantly throughout the course of the infusion (P = 
0.576 and P = 0.562, respectively; table 5.1.).  
Figure 5.3. Effect of recombinant IL-6 infusion upon plasma NGAL concentrations. Data are means 
and standard deviations. Dotted line indicates upper limit of normal range for plasma NGAL (106 
ng/ml). There was a significant effect of time (P = 0.025).  #, difference compared to 0 hours sample 
point by planned comparisons. 
 113 
Correlational analyses. Plasma NGAL was positively correlated with tympanic 
temperature (r = 0.945, P = 0.004). However, there were no significant correlations between 
other dependent variables. 
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Secondary measurement  0 hours 3 hours 
Heart rate (bpm) 61 (7) 67 (6) 
* 
Systolic blood pressure (mmHg) 120 {3.75} 120 {0} 
Diastolic blood pressure (mmHg) 78 ± 8 75 ± 5 
Tympanic temperature (
0
C) 36.9 ± 0.2 37.5 ± 0.6 
* 
Table 5.1. Effect of recombinant IL-6 infusion upon heart rate, blood pressure and tympanic temperature 
at 0 hours and 3 hours. Legend: Data are mean ± SD except for systolic blood pressure (median 
{interquartile range}). 
*
, significantly different from 0 hours by paired t-test. 
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5.5. DISCUSSION 
 
This is the first study to isolate the relationships between IL-6, a biomarker of kidney injury 
(NGAL) and established measures of renal function (plasma Cr and cystatin C) in healthy 
humans. Through a safe infusion of recombinant IL-6, elevations of plasma IL-6 
concentrations were demonstrated in six healthy males that peaked by the end of the infusion 
at 3 hours. There were concomitant elevations in plasma NGAL concentrations, heart rate and 
tympanic temperature – all of which also peaked at 3 hours. Moreover, plasma NGAL was 
positively correlated to tympanic temperature. However, although IL-6 appeared to modulate 
NGAL, mean NGAL concentrations did not exceed the minimum important clinical 
difference (43 ng/ml) to elevate mean concentrations above normal range (107 ng/ml). 
Accordingly, with respect to renal function measurements, at a group level there were no 
changes in plasma Cr and cystatin C throughout the duration of study. 
This study yielded plasma IL-6 concentrations close to that found in models of ischaemic 
AKI from post-cardiopulmonary bypass (Liu et al., 2009; Musleh et al., 2009; Miklaszewska 
et al., 2013). It is the systemic inflammatory response generated by post-cardiopulmonary 
bypass that has led investigators to explore the role of humoral mediators in AKI. In a cohort 
of over one thousand patients who underwent post-cardiopulmonary bypass, the Perioperative 
Genetics and Safety Outcomes Study group found that an IL-6 polymorphism (-572C) 
demonstrated a strong association with kidney injury in Caucasian patients (P < 0.0001, > 
50% decrease in renal filtration when presenting together; Stafford-Smith et al., 2005). 
However, relevant to plasma IL-6 concentrations achieved in the present study, Musleh et 
al.(2009) revealed that patients undergoing coronary artery bypass grafting had post-operative 
plasma IL-6 concentrations greater than 100 pg/ml which, in turn, were associated with a risk 
of kidney dysfunction (defined as creatinine > 176 μmol/l or an increase of 62 μmol/l above 
the preoperative level; P < 0.017, Odds Ratio 1.3 and 95% Confidence Interval 1.0–1.7; 
Musleh et al., 2009). Other studies have noted much higher increases in plasma IL-6 
concentrations associated when severe kidney dysfunction requiring dialysis occurs (Gueret et 
al., 2009). 
In keeping with the aim of the study, the infusion of recombinant IL-6 herein was 
sufficient to achieve substantial elevations in circulating IL-6 concentrations and up-regulate 
a biomarker of kidney injury (NGAL). However, the latter was not increased to 
concentrations found in clinically-defined AKI e.g. > 250 pg/ml (NGAL, Bioporto 
Diagnostics). Such sub-clinical elevations in plasma NGAL have recently been proposed to 
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indicate milder degrees of kidney stress or injury such as pre-renal azotemia (Doi et al., 2012; 
Nejat et al., 2012).  Nonetheless, IL-6 failed to impact upon kidney function: neither plasma 
creatinine nor cystatin C were elevated at intervals of up to 48 hours (Chiou et al., 1975).  
The findings from this study may imply that kidney dysfunction is not provoked by IL-6 
per se and that there are other factors that contribute to its development and AKI (Bonventre 
and Zuk, 2004; Lee et al., 2011). For example, a critical reduction in renal blood flow in 
ischaemic AKI is likely to be the initiating factor in establishing a pro-inflammatory 
environment of numerous cytokines with potentially synergistic activity (Edelstein and 
Schrier, 2007). This is supported by the post-cardiopulmonary bypass model and in previous 
work where the effects of muscle damage-induced inflammation followed by exercise in the 
heat were investigated (Abu-Omar and Ratnatunga, 2006; Liu et al., 2009; Musleh et al., 
2009; Miklaszewska et al., 2013; Junglee et al., 2013). In the study by Junglee et al. (2013), 
subjects exercised at intensities where a marked reduction in renal blood flow was expected to 
occur (65% of maximal aerobic capacity). Thus, despite the comparatively lower endogenous 
IL-6 response (6.0 pg/ml) observed in that study, a higher mean plasma NGAL concentration 
(109 pg/ml) was induced that correlated with biomarkers of reduced kidney function (e.g. 
plasma NGAL and urine volume: r = -0.65; P = 0.04).  
Alternatively, when presented without other factors known to induce AKI, the infused IL-
6 concentrations may not have been sufficient to induce kidney dysfunction. For example, 
patients with severe sepsis and AKI harbour endogenous IL-6 concentrations of at least 
several hundred-fold higher compared to the present study (Simmons et al., 2004; Zaarjou 
and Agarwal, 2011). Moreover, in its role of treating solid tumours based on its ability of 
inducing cytotoxic T cell differentiation, recombinant IL-6 infusion rates higher than the 
present study (150 μg/h) have been responsible for elevations in blood Cr of up to three-times 
above baseline concentrations in one third of oncology patients (Mulé et al., 1992; Sosman et 
al., 1997). This observation implies that IL-6 exhibits a dose-related response in its ability to 
cause renal dysfunction. On the contrary, it is unclear if these previous observations were 
confounded by factors such as co-morbid disease states (e.g. chronic kidney disease), 
intercurrent acute illness, and/or the impact of malignancy-related cachexia upon Cr 
metabolism (Stevens and Levey, 2005). Nevertheless, if extended to the findings of the 
present study, it is plausible that higher IL-6 concentrations could have resulted in greater 
plasma NGAL elevations and possibly renal dysfunction.  
Aside from being a biomarker of kidney injury, NGAL also plays a role in cytoprotection 
against adverse environments (Roudkenar et al., 2009; Chakraborty et al., 2012). In one in-
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vitro study, cell cultures exposed to a temperature of 47
o
C demonstrated ectopic NGAL 
expression associated with an anti-apoptotic effect though increased rates of cell proliferation, 
suggesting that NGAL protected cells from heat toxicity (Roudkenar et al., 2009). The 
positive correlation of plasma NGAL with tympanic temperature in the present study hints at 
the potential function of NGAL up-regulation as a cytoprotective factor in conditions of heat 
stress; in this instance caused by the infusion of recombinant IL-6 (Netea et al., 2000). In 
AKI, a reno-protective function of NGAL is revealed when administration of exogenous 
recombinant NGAL in NGAL knock-out mice ameliorates ischemic AKI through inhibition 
of tubular cell apoptosis (Roudkenar et al., 2009).  
A key limitation of this study is the lack of urinary data. Reductions in urinary flow rates 
are part of current AKIN criteria for AKI (Ricci et al., 2011). Given the possibility that the 
elevations in plasma NGAL concentrations noted herein could signify a form of very mild 
AKI that Cr and cystatin C are insensitive to, corroborative evidence from urinary flow rates 
and other related biomarkers such as urinary NGAL concentrations, fractional excretion of 
solutes (e.g. sodium) and cytology may have been useful in this regard (Doi et al., 2012; 
Nejat et al., 2012; Perazella and Coca, 2012). However, in animal models where wild-type 
Sprague-Dawley rats were infused with 50 μg/h of human recombinant IL-6 and achieved 
plasma IL-6 concentrations of 10-120 pg/ml, there was no microalbuminuria and all had 
normal renal histology at autopsy (Karkar et al., 1997). Although not entirely comparable to 
the human model, it does call into question whether any changes to urinary measures would 
have occurred through the study intervention, especially when plasma NGAL elevations did 
not exceed the minimum important clinical difference.  Additonally, there was no control arm 
to determine whether a saline or albumin intravenous infusion alone could yield similar 
elevations in plasma NGAL concentrations. Finally, despite ease of use in a resting state, 
tympanic temperature readings can demonstrate lower accuracy and precision compared to 
other measurement sites and may be affected by ambient temperature (Binkley et al., 2002; 
Lawson et al., 2007). In the study by Junglee et al. (2013) rectal temperature was used, which 
although more invasive, is suited to continuous core body temperature measurement before 
and during physical activity. 
In summary, infusion of recombinant IL-6 in healthy humans that achieves peak plasma 
concentrations of around 150 pg/ml, leads to sub-clinical elevations of plasma NGAL without 
impacting upon renal function as measured by plasma Cr or cystatin C. Other factors or 
higher concentrations of plasma IL-6 could therefore be responsible for AKI. Although 
speculative, the up-regulation of NGAL through IL-6 and its association with body 
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temperature suggests a functional role of cytoprotection against heat stressed environments. 
Finally, the factors responsible for the large inter-individual response to plasma NGAL up-
regulation requires further investigation to understand their clinical implications. The genetic 
makeup of an individual may have some relevance here (Frederickson and Christensen, 
2003). 
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6.1. SUMMARY OF STUDIES 
 
This PhD sought to explore the acute effects of exercise upon the kidneys to make tenable 
links to pathological states such as AKI and CKD. This involved experimental in-vivo 
exercise models to simulate a “stressed” kidney. Such associations with their potential clinical 
implications have received minimal attention despite the increasing number of healthy 
individuals participating in extreme physical challenges (Draper et al., 2009).  
To summarise briefly, chapter 2 demonstrated that high-intensity exercise in the form of 
an 800 metre sprint resulted in increased urinary NGAL concentrations and coincident 
decreases in plasma NGAL concentrations, with both responses being independent from post-
exercise proteinuria. Moreover, an inverse relationship was noted between urinary volume 
and urinary NGAL concentrations; an observation that is also recognised in oliguric AKI.  
The systematic review in Chapter 3 found promise in post-exercise proteinuria as a 
predictor for CKD progression. Five studies (N = 351) that met inclusion criteria, examined 
prospective cohorts of Type I diabetics who were at risk of CKD. By combining the results of 
the primary outcome in four of these studies (N = 318), the presence of PeP was highly 
associated with elevated resting proteinuria at follow-up (χ2 test, P < 0.0001) and significantly 
increased likelihood of developing CKD (Odds Ratios: 2.3-52.0). Due to great variability and 
questionable validity in the interventions performing a meta-analysis was not possible. It was 
evident that exercise interventions need to be refined and standardised before applying to 
other at-risk CKD populations.  
In chapter 4, it was shown that a bout of muscle-damaging exercise established a pro-
inflammatory state evidenced by elevated plasma IL-6 concentrations. With subsequent 
endurance exercise in the heat, increased kidney stress as measured by elevated urinary 
NGAL and plasma Cr concentrations was discovered. Indeed, plasma Cr was sufficiently 
elevated to satisfy clincial criteria for AKI. Moreover, plasma IL-6 and plasma NGAL 
concentrations were positively correlated. 
Lastly, chapter 5 extended the findings of chapter 4 by isolating the role of pro-
inflammatory IL-6 in AKI. Through infusion of recombinant IL-6 in healthy males to achieve 
concentrations above 100 pg/ml, elevations in plasma NGAL were demonstrated but not to 
concentrations exhibited in AKI. In addition, there were no changes to plasma concentrations 
of other AKI biomarkers such as Cr or cystatin C. Overall, this suggests that IL-6 is able to 
modulate NGAL but per se is not responsible for AKI or kidney dysfunction. It is likely that 
additional physiological aberrations are needed.  
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6.2. FINDING COMMON GROUND - LINKING STUDY FINDINGS TOGETHER 
 
6.2.1. Use of novel kidney injury biomarkers in other studies of physical activity. How do the 
findings from chapter 2 and 4 add to the present literature? Chapter 2 represents the only 
investigation to-date into the response of AKI biomarkers to post-exercise proteinuria elicited 
by high-intensity exercise (800 metre sprint). Using an endurance-exercise protocol, study 4 
demonstrated for the first time that prior muscle damaging exercise followed by additional 
exercise in the heat, results in upregulation of NGAL and stressed kidney function.  
Overall, research in this area appears to be very scarce. At the current time, only two 
other groups have investigated the response of urine and plasma NGAL to exercise, albeit 
only in endurance exercise settings. Consistent with the findings from chapter 2 and 4, they 
have also demonstrated a trend for NGAL up-regulation following exercise.  
In a marathon study involving 25 participants, McCullough et al. (2011) recorded 
significant elevations in plasma NGAL (pre-marathon, 8 ± 4 ng/ml; to post-marathon, 47 ± 29 
ng/ml; P < 0.0001) and kidney injury molecule-1 (pre-marathon, 2.2 ± 1.5 ng/ml; to post-
marathon, 3.3 ± 1.7 ng/ml; P = 0.001). Similarly, Lippi et al. (2012) observed elevations in 
serum and urine NGAL of 1.6-fold and 7.7-fold, respectively, in 16 participants 20 minutes 
after completing a 60 km ultramarathon. As in chapter 2, they also noted attenuations in 
elevations in raw urinary NGAL concentrations when urine NGAL:Cr ratios were compared. 
Both groups, however, documented post-exercise increases in urinary NGAL greater than 
chapter 2 (peak median urinary NGAL 13 ng/ml), suggesting that endurance activity may 
place greater stress on renal physiology. This is somewhat contrary to the commonly accepted 
view that exercise-induced changes to renal physiology are primarily intensity rather than 
duration-driven.  
It should be noted that in the studies by Mccullough et al. (2011) and Lippi et al. (2012) 
there was no quantification of urine output. Therefore, aside from interpreting elevations as 
renal stress, they could also be viewed as a concentrating effect owing to potentially low-
urine outputs from exercise-induced anti-diuresis. Indeed, in chapter 2 that urinary NGAL 
concentrations were negatively correlated with urine volume (r = -0.701, P = 0.005). Further 
study into urinary biomarkers during physical exertion still needs to take these caveats into 
account to ensure correct interpretation. This is elaborated upon further in the next section. 
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6.2.2. Measurement of AKI biomarkers in urine. In the clinical environment, the measurement 
and interpretation of urinary AKI biomarkers remains a contentious issue (Waikar et al., 
2010). Urinary biomarkers can be interpreted as raw absolute values from spot sampling at a 
single timepoint (Nickolas et al., 2008). However, problems may occur when AKI with a 
polyuric state is seen and concentrations of biomarker appear to be reduced thus 
underestimating kidney injury. Conversely, in the more common situation of an AKI with 
oliguria, concentrations of biomarker may instead appear to be greatly elevated, even if 
production and excretion rates of the biomarker are constant. If a falling urine flow rate meets 
the AKI definition, a biomarker measurement in this setting may merely serve to amplify a 
true-positive result (Waikar et al., 2010).  
How may such interpretations carry-over into the post-exercise setting? In chapter 2 an 
inverse correlation between urine volume and absolute urinary NGAL concentrations was 
observed, which reached its peak at 25 minutes post-exercise. At the same time, urinary A:Cr 
ratios were also at their highest. Although, the oliguria in this study did not extend to the 
duration of Acute Kidney Injury Network (AKIN) criteria (e.g. stage 1: < 0.5mg/kg/hr for 6 
hours or more), physiologically, this could still be thought of as nephron stress at its peak 
with increased passage of plasma NGAL and albumin into the urine due to alterations in 
glomerular permeability. Additional measurement of known biomarkers of renal tubular stress 
that relate to inhibition or saturation of tubular reabsorption (e.g. β2-microglobulin, gamma 
glutamyl-transferase or alpha-1-antitripsin) could lend further support to this notion, and has 
already received some attention in the post-exercise setting (Ayca et al., 2006; Parikh et al., 
2010). Nevertheless, to avoid the issue of a concentrating effect through an oliguric state, 
there have been attempts to normalise against solutes excreted by the kidney. 
 
6.2.3. Normalisation against urinary creatinine. A recognised method of urinary biomarker 
interpretation involves normalisation against urinary Cr. Apart from its use in proteinuria 
quantification, urinary Cr normalisation is used to normalise a variety of other urinary 
analytes due to its ability to correct for changes in urinary dilution. This method relies upon 
the assumption of steady state excretion of Cr, which is likely in CKD, but is not the case in 
AKI and possibly the post-exercise setting (Waikar et al., 2010). To demonstrate this 
Tonomura et al. examined the influence of AKI induced by various high dose nephrotoxins 
upon urinary biomarker:Cr ratios using a murine model (Tonomura et al., 2010). By selecting 
lactate dehydrogenase and N-acetyl-beta-D-glucosaminidase as biomarkers of tubular injury, 
they discovered that correction by Cr could overestimate AKI, but that receiver-operator 
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curve analysis suggested this method exhibited a higher diagnostic power than correction by 
urine flow rates. In addition, where there was a constant urinary biomarker excretion, a 
decrease in urinary Cr clearance led to an increase in the biomarker:Cr ratio. They concluded 
that when using Cr correction the direction of alteration of the urinary biomarker 
concentrations and Cr should be considered. Goldstein has summarized this schematically 
(figure 6.1.). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In human studies such as those in chapter 2 and by Lippi et al. (2012), normalisation of 
urinary NGAL against urinary Cr appeared to attenuate rises compared to absolute urinary 
NGAL concentrations, although some of the subjects from the study in chapter 2 continued to 
show substantial rises in urinary NGAL:Cr. Taking these considerations into account, 
interpreting Cr normalisation in exercise settings could underestimate the degree of stress 
placed upon the kidney. Overall, these observations at least indicate some caution should be 
taken when using urinary Cr normalisation and should prompt further work in glomerular and 
tubular handling characteristics during dynamic instances. This could be refined further by 
Figure 6.1. When considering urinary biomarker:creatinine ratios, the change of excretion of both  
biomarker and creatinine should be known. As creatinine excretion is unstable in AKI, changes in the 
ratio cannot be determined unless the directional change of each is known. This would also apply to 
other dynamic setting such as post-exercise. AKI, acute kidney injury; ∆, change. Adapted from 
Goldstein 2010.  
 
 
 
 124 
incorporating the clinical variables known to affect Cr metabolism such as age, weight, sex, 
and ethnicity. 
 
6.2.4. Normalisation against urinary flow rates. Normalizing to the observed urinary flow 
rate at the time of urine sample collection to determine a biomarker excretion rate, or 
performing several timed collections of urinary biomarkers measurements could avoid some 
of the issues experienced through urinary Cr normalization. In chapter 4, absolute urinary 
NGAL concentrations were corrected for urinary flow rates. Between pre- and post-heat 
stress, non-muscle damaged individuals demonstrated a fall in urinary NGAL flow rate 
whereas muscle damaged individuals exhibited a slight rise (consistent with increased kidney 
stress during physical exertion in heat and muscle damage). 
The incorporation of urinary flow rate into NGAL measurements could be viewed as a 
more robust interpretation of biomarker values, as urine output is a well-established and 
validated biomarker of AKI (Ricci et al., 2007). Although achievable in the clinical setting 
from a recumbent patient with AKI or an experimental setting, how this may be accomplished 
in a real-world setting during physical activity is challenging and will involve consideration 
of logistic issues surrounding (multiple) sample collection and exercise-induced anti-diuresis. 
 
6.2.5. Normalisation against urinary osmolality and specific gravity. Correction of solutes 
based on urinary specific gravity or osmolality has been investigated in non-AKI settings. 
However, in AKI these two parameters undergo complex alterations due to renal tubular 
dysfunction with simultaneous reductions to GFR. This includes urinary dilution and altered 
concentrations of solutes such as glucose, sodium and potassium which appears to be more 
complex than urinary Cr handling. In short-term acute exercise of moderate intensity there is 
an increase in urine osmolality of around 40 mOsmols/KgH20, whilst at higher intensity 
exercise further decreases in tubular function may result (Freund et al., 1991). Therefore, it is 
essential that such dynamic interactions are probed in detail before deciding if these forms of 
adjustment can be helpful in the interpretation of biomarker concentrations in dynamic 
circumstances.  
 
6.2.6. A general interpretation of biomarker elevations during exercise. Regardless of the 
above considerations, when the findings in chapters 2, 4 and the other highlighted studies are 
interpreted together, it is reasonable to conclude that there is a common suggestion of mild 
kidney injury or stress that occurs during heavy exercise.  
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The Bioporto NGAL Rapid ELISA Kit used in the experiments herein considers a NGAL 
concentration cut-off of 250 ng/ml (in urine or plasma) to indicate the presence of a renal 
disorder, including AKI, without incurring the risk of an unacceptably high proportion of 
false positive diagnoses (NGAL Rapid ELISA, Bioporto, Gentofte, Denmark). The NGAL 
concentrations achieved in both urine and plasma in the controlled laboratory-based studies of 
this PhD could therefore be considered as within a sub-clinical range. Currently, interpretation 
at this level remains a grey area, although recent evidence suggests that this may represent a 
mild degree of kidney injury that equates to pre-renal AKI. In a study by Nejat et al. (2012), 
individuals with pre-renal AKI (defined as AKI that recovered within 48 hours, and with a 
fractional excretion of sodium of less than 1%) had greater median concentrations of several 
AKI biomarkers compared with no-AKI. Furthermore, Seibert et al. (2013) determined that 
urinary NGAL concentrations in pre-renal AKI patients (as defined by rapid response of renal 
function to volume repletion), were significantly higher than in healthy controls (pre-renal 
AKI: 64.8 ± 62.1 ng/ml; controls: 14.4 ± 8.3 ng/ml, P = 0.001). Hence, considering that the 
studies of this PhD involved healthy disease-free individuals and were performed in 
controlled experimental settings that did not set out to induce clinically-defined AKI, it is 
plausible that mild pre-kidney injury through tissue hypoperfusion accounts for the results 
found, as heavy intensity-based exercise is capable of reducing RBF up to 50% from baseline 
values (Walker et al., 1994). 
The contention that mild kidney injury occurs during heavy exercise is also is supported 
by two further observations from the experiments in chapter 4: 1) based on post-exercise 
serum creatinine measurements in chapter 4, McCullough et al. (2011) and Lippi et al. 
(2012), stage 1 AKIN criteria for AKI were met for at least 40% of participants in each study; 
and 2) there were concomitant changes in traditional urine physiology measurements such as 
reduced urine output / flow rate and increased specific gravity, implying stress in renal tubular 
transport. Together with measurement of novel biomarkers, this latter finding supports the 
idea of site-specific nephron stresses.  
 
6.2.7. Post-exercise proteinuria, NGAL and locations of nephron stress. The measurements of 
renal biomarkers in chapter 2 and 4 have provided insight into site-specific renal stress that 
occurs during exercise. It was originally hypothesised in chapter 2 that individuals who had 
higher concentrations of post-exercise proteinuria would also experience greater levels of 
renal stress as measured by an AKI biomarker. Although this hypothesis was not supported, 
as evidenced by the lack of a positive correlation between post-exercise proteinuria and 
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urinary NGAL concentrations, such discordance could instead reflect a difference in the 
locations of nephron stress i.e. urinary NGAL arising from tubules and albumin from 
glomerular leak. Indeed, in-vivo and in-vitro studies have clearly demonstrated that the vast 
majority of NGAL up-regulation in models of pre-renal AKI occurs within the proximal and 
distal tubules (figure 6.2.; Mishra et al., 2003).  
This observation is further supported by the findings from Chapter 4 that relate NGAL to 
altered renal tubular mechanisms during exercise. Here, there were higher concentrations of 
urine and plasma NGAL in the muscle-damaged group following heat stress with concomitant 
fall and rise in urine volume and specific gravity, respectively. Moreover, in the same group, 
plasma NGAL was negatively correlated with urine volume (r = -0.65; P = 0.04), positively 
correlated with urinary specific gravity in EIMD (r = 0.64; P = 0.05), and tended to be 
correlated negatively with urinary flow rate (r = -0.61; P = 0.06).  
Another possible reason for discordance between albuminuria and urinary NGAL elevations 
is that passage of albumin does not reflect nephron injury (i.e. glomerular basement 
membrane stress) in healthy people during an acute bout of exercise, but is merely represents 
a function of momentarily increased glomerular permeability. This is somewhat contrary to 
the situation in CKD where longstanding glomerular passage of albumin will eventually 
contribute to nephron injury, as protein overload in the renal tubules induces the release of 
cytokines, chemokines and growth factors (Abbate et al. 2006). This leads to abnormal 
interstitial accumulation of inflammatory cells, extracellular matrix collagen, fibronectin and 
other components that culminate in interstitial fibrosis, a pathological hallmark of CKD. 
Indeed, individuals with CKD show greater exercise-induced declines in GFR compared to 
Figure 6.2. Immunohistochemistry results on frozen sections of mouse kidneys at 3 and 12 hour reflow 
periods following experimentally-induced ischaemia using a vascular clamp. Induction of mouse kidney 
NGAL protein within tubules is demonstrated by cherry-red fluorescence when tissue samples were 
probed with a polyclonal antibody to NGAL. Con, sample obtained from control mice; G, glomerulus; 
HP, sample at 100× magnification (other panels are at 20× magnification). Adopted from Mishra et al., 
2003. 
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healthy controls and that post-exercise proteinuria may be exacerbated by exercise (e.g. in the 
nephrotic syndrome) (Bellingheri et al. 2008). Despite such findings, regular exercise in CKD 
does not appear to accelerate disease progression. In fact, exercise programs form an integral 
part of CKD management strategies. 
But how are the findings in chapter 3 accounted for? Here, acute exercise albuminuria 
was predictive of developing CKD in type 1 diabetics without nephropathy at baseline, with 
odds ratios between 2.3-52.0. Previous work showed that exhaustive exercise in type 1 
diabetics did not appear to provoke enhanced acute renal dysfunction compared to healthy 
controls, even when there was evidence of other diabetic complications such as retinopathy 
(Mauer et al. 1997). It could be that post-exercise proteinuria in this population instead 
indicates the development of subtle pathology over time which is specific to diabetics e.g. 
generalized endothelial dysfunction, which heralds the development of CKD.  
 
6.2.8. Evidence for renal inflammation during heavy physical activity. Chapter 4 explored IL-
6 as an inflammatory component of renal stress during heavy physical exertion. This was 
though a muscle-damaging protocol that, as previously demonstrated, successfully yielded 
supra-normal concentrations of pro-inflammatory IL-6, e.g. Nybo et al. (2002) performed an 
interventional study involving exercise in the heat and achieved IL-6 elevations with a pattern 
comparable to interventions in chapter 4 (figure 6.3.).  
The quantity of IL-6 release appears to be affected by both exercise intensity and duration 
(Mendham et al., 2011). Also, the type of exercise is relevant as eccentric (muscle damaging) 
contractions elicit a more inflammatory response, and hence greater increases in IL-6, than 
concentric contractions. Thus, in recent years, IL-6 has been coined a myokine (a cytokine 
secreted by and acting upon active muscle) and though several sources of IL-6 have been 
shown, contracting muscles contributes to most of the circulating IL-6 in response to exercise 
(Muñoz-Cánoves et al., 2013).  
Acute kidney injury is considered an inflammatory disorder and histologically this is 
evidenced by leukocyte recruitment and tubular injury. This environment is cytokine-rich and 
such molecules are believed to be important components of both the initiation and extension 
of kidney injury (Lee et al., 2012). In ischaemic AKI models, many pro-inflammatory 
cytokines / chemokines are found, including: IL-2, IL-6, IL-10, IL-18, CXCL1, granulocyte-
macrophage colony-stimulating factor, tumor growth factor-β, macrophage inflammatory 
protein-1, and monocyte chemoattractant protein-1 (Lee et al., 2011).  
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In chapter 4, the muscle-damaged group had higher plasma IL-6 concentrations and also 
exhibited greater levels of kidney stress (e.g. reduced urine flow and increased urinary 
specific gravity). These observations are supported by work from Sugama et al. (2013), who 
demonstrated significant raw and urinary flow-rate corrected elevations in urinary IL-6 in 14 
male triathletes following completion of a three-hour dualthon. They also showed similar 
elevations in other AKI-related cytokines (e.g. IL-2, IL-10 and interferon-γ) in the urine. In 
addition, and complementary to the findings of chapter 4, they applied AKIN AKI criteria to 
their cohort and found that “damaged individuals” (i.e. those who exhibited granular casts and 
those of renal tubular cells and therefore suggestive of renal injury) met stage I immediately, 
and 90 minutes, post-exercise based upon serum Cr concentration rises (increase ≥ 26 μmol/l 
within 48hrs or increase ≥ x 1.5 to x 1.9 of baseline serum Cr; figure 6.4.; Sugama et al. 2013). 
Figure 6.3. Arterial IL-6 concentrations at rest and during exercise during one hour on a cycle ergometer at 
a core temperature of 38
0
C (first bout) followed by a one hour rest period and then further exercise at 39.5
0
C 
(second bout). Both exercise trials were completed at a workload (170 ± 4 W) that corresponded to 50 % 
O2max. A similar pattern of plasma IL-6 rise was also seen in study 4. Data are mean values of 8 subjects. * 
Significantly different from the resting value (P < 0.05). Adopted from Nybo et al. 2002.  
 
 
 
V
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Interpreting these findings together suggests that during heavy exercise, the kidney (along 
with the active musculature) contributes to IL-6 synthesis and release, and plays a role in 
kidney stress or mild kidney injury. Indeed, urinary IL-6 has already been proposed as a 
biomarker of AKI in children undergoing cardiopulmonary-bypass surgery (Dennen et al., 
2010). However, can IL-6 by itself participate in kidney stress during strenuous physical 
activity? The following section will discuss this further. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.2.9. Can IL-6 per se lead to kidney injury? Given the evidence in the literature of IL-6 
participating in the evolution of AKI and the results of chapter 4 that showed a strong positive 
correlation between plasma IL-6 and an AKI biomarker (NGAL), chapter 5 investigated the 
propensity of IL-6 per se to cause kidney injury. To summarise, a recombinant IL-6 infusion 
at 5 μg/h in healthy individuals was able to up-regulate plasma NGAL but only to sub-clinical 
concentrations and without changes to plasma cr or cystatin C.  
There are a few plausable explanations for such outcomes. It could be that 
supraphysiological IL-6 concentrations result in a sub-clinical renal (tubular) injury, as 
indicated by elevated plasma NGAL but not reflected by filtration biomarkers. As discussed 
Figure 6.4. Changes in serum creatinine in fourteen male athletes before and at several time points 
following a 50km dualthon. The cohort was split into a damaged group (N = 7) consisting of individuals 
with renal tubular epithelium in their urine and a non-damaged group (N = 7) where this was absent. 
Damaged individuals met stage I AKIN AKI criteria immediately post-exercise and 90 minutes post-
exercise based upon serum creatinine concentrations elevations (0.54 mg/dl or 1.66-fold increase from 
baseline and 0.36 mg/dl or 1.44-fold rise from baseline, respectively). Legend: creatinine (Cr), pre-
exercise (Pre), immediately post-exercise (0 h), 1.5 hour post-exercise (1.5 h) and 3 hour post-exercise 
(3 h) are sampling points. Statistics: * P < 0.05, ** P < 0.01, † P < 0.1. Adopted from Sugama et al. 
2013. 
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above, recent evidence suggests that in the setting of kidney injury lower concentrations of 
NGAL (e.g. less than 250 ng/ml) may represent a milder injury that equates to pre-renal AKI 
(Seibert et al., 2013). Future studies should clarify this with concomitant urinary measures of 
renal injury. Alternatively, it could be that IL-6 merely modulates NGAL without sequalae. 
 However, infusions of IL-6 at a higher rate of 150 μg/h have been known to cause 
kidney injury (as defined by elevated blood Cr concentrations) when used to treat oncology 
patients with head and neck malignancy (Mulé et al., 1992; Sosman et al., 1997). Similarly, 
interleukin-2 (IL-2), another AKI-related cytokine, exhibits dose-limiting renal toxicity when 
used in the treatment of metastatic renal cell carcinoma and metastatic melanoma. More than 
90% of patients treated with intermediate or high-dose IL-2 showed some degree of acute 
renal dysfunction, inducing oliguria in over 60% of patients and grade 4 oliguria / anuria 
(defined as life-threatening consequences of kidney injury and/or dialysis indicated) in 10% 
(Poust et al., 2013). It should be noted that in these clinical setting, individuals had disease 
processes that could potentially sensitize them to the side-effects of cytokine therapies. 
Nevertheless, these observations imply that interleukin infusions possess a dose-response 
relationship and higher infusion rates could result in more profound elevations of plasma 
NGAL with simulatanous derangements to traditional kidney function measures. 
What could be the mechanism of cytokine-related renal injury? Interleukin-2 leads to 
intrarenal vasoconstriction, thought to be a result of abnormal renal prostaglandin synthesis. 
This, together with a vascular leak syndrome, is likely to contribute to acute tubular necrosis 
(Poust et al., 2013). Aside from individual cytokine-specific effects, high-dose interleukin 
infusions in general can lead to a rapid recruitment of numerous cytokines (“cytokine storm”), 
and the positive feedback reaction between cytokines and leukocytes establishes an 
inflammatory environment that stimulates AKI (Panelli et al., 2004; Otto et al., 2013). 
Therefore, despite the perceived importance of IL-6, it is more likely that an accumulation of 
numerous pro-inflammatory mediators rather than one particular cytokine contributes to AKI.  
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6.3. METHODS OF ASSESSING KIDNEY FUNCTION AND KIDNEY INJURY IN EXERCISE – CURRENT STATUS 
AND DEVELOPMENTS  
 
6.3.1. Measuring glomerular filtration rate during physical activity. A gold standard of GFR 
estimation involves the intravenous injection of an inert polysaccharide such as inulin or a 
contrast agent that possesses minimal renal tubular reabsorption and secretion and is, 
therefore, largely reflective of glomerular filtration. This could be considered an invasive 
method to determine GFR as it involves intravenous infusions which may be continuous and 
blood sampling at multiple time points to determine the rate of agent elimination from the 
blood.  
Although practically feasible in the sedentary subject, to make these assessments in 
individuals during dynamic situations such as exercise is more challenging. Consequently, 
there has been a trend in physiological studies to use equation-based estimated GFRs that do 
not require administration and sampling of an agent but only age, sex and a spot blood Cr 
measurement. Although convenient, such formulae have been principally developed in 
populations with CKD and should be used with caution in subjects having atypical 
anthropometric characteristics e.g. rugby players (Banfi et al., 2009). Also, the equations 
assume stable Cr metabolism (i.e. relatively constant rates of production and excretion) and 
this is unlikely when there is an abrupt change to GFR such as with exercise. Regardless of 
these drawbacks, this method continues to be widely used. 
Recently, a promising novel and more rapid method of real-time GFR estimation has 
been described using transcutaneously measured elimination kinetics of a fluorescent polymer 
(FITC-sinistrin), paired with a low-cost portable sensor that transcutaneously excites FITC-
sinistrin at 480 nm and detects the emitted light through the skin at 520 nm (Schreiber et al. 
2012). Radio-frequency transmission of data allows remote monitoring and real-time analysis 
of FITC-sinistrin excretion as a marker of GFR. Although only currently developed on 
murine models, this method has the potential of being an attractive, less invasive alternative 
for real-time GFR estimation that could be adapted to exercising individuals in a laboratory 
environment. As a proof-of-principle, comparative measurements of transcutaneous and 
plasma elimination kinetics of FITC-sinistrin demonstrated good agreement in a various 
murine models of kidney disease (Schreiber et al. 2012).  
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6.3.2. Measurement of urine output during exercise studies. In the emergency medical setting, 
measurement of urine production represents the most practical real-time measure of kidney 
function and features heavily in guidance for the management of AKI (cf. AKIN criteria for 
AKI). Nevertheless, measurement may not be straightforward for a number of reasons, 
including: lack of urine production, barriers to urinary tract catheterisation, poor recording of 
output. Even within the context of a controlled laboratory-based environment, measurement 
of urine output during exercise studies in humans can be challenging. This is important to 
consider for future studies into renal injury and function during exercise, as: 1) urine output is 
considered as a biomarker of kidney injury; and 2) accurate collection is important for 
subsequent determination of urinary biomarker concentrations and / or flow rates. 
Early physiological experiments conducted from the 1950s to 1970s commonly inserted 
urinary catheters per urethra into the bladder of subjects to facilitate real-time urine volume 
and rate calculation (Castenfors 1967a, Castenfors 1967b). Such a procedure could be 
considered as a “gold standard” for urinary volume or rate assessments, but in both males and 
females, insertion is not without risk as potential complications include infection, bleeding, 
urethral damage / scarring, and bladder spasm (Dellimore et al., 2013). This is in addition to 
the discomfort caused by catheter insertion that may in turn lead to less-than-optimal 
performance during intensity or duration-based exercise interventions. Such reasons, taken 
together with increasing ethical scrutiny for research in healthy humans, have made this 
technique less popular in mpre recent times (Resnik 2012).  
In the studies described in chapters 2 and 4, double voiding techniques were employed to 
maximise bladder emptying and obtain urine. However, residual urine volumes that were not 
excreted could potentially have carried-over into the next sampling time point. Thus, over- or 
underestimation of urine volume and flow rates may have occurred and confound biomarker 
excretion rates. A potential non-invasive method to resolve this issue is to perform bladder 
ultrasound scans that can provide an accurate estimation of urine volume within the bladder. 
Volume estimations computed by the Bardscan system correlate closely with the bladder 
volumes detected on urinary catheterization (r = 0.982, P = 0.016) (Abdel-Fattah and 
Barrington, 2005).  Different portable scanners are available that require very little training to 
use, but are not equally accurate nor provide the same level of clinical agreement. The 
accuracy and level of clinical agreement appears to be greatest when using a 3-D ultrasound 
system to calculate the bladder volume (Ghani et al., 2008). 
From a physiological perspective the magnitude, duration and rate of urine output during 
exercise are not readily predictable. Rising ADH concentrations are responsible for this fall in 
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urine output and once higher exercise intensities are approached there is a decrease in free-
water clearance. Even hyperhydration, prior to or during severe exercise, does not prevent the 
decrease in urine flow post-exercise (Refsum and Strömme 1975; Virvidakis et al., 1986). 
Although this cannot be avoided, it seems sensible to ensure that participants are well-
hydrated before performing strenuous physical activity. An acceptable limit of hydration can 
be assessed using a portable osmometer to check urine osmolality immediately prior to 
exercise, with a cut-off of less than 700 mOsmols/KgH20 being acceptable of an adequate 
hydration status (Sawka et al., 2007). 
 
6.3.3. Use of other molecular biomarkers of kidney injury during exercise. Of the numerous 
AKI molecular biomarkers available for clinical and research purposes, NGAL was chosen 
for use in this PhD as it has a rapidly growing evidence-base and is currently regarded as the 
most promising for routine clinical use. Irrespective of issues pertaining to interpretation, time 
of sampling and confounding factors (which are also common to other AKI biomarkers), to-
date, all clinical NGAL studies combined include more than 7000 patients (Hasse-Fielitz et 
al., 2014).  
As mentioned previously, the few studies investigating kidney injury during physical 
exertion have also chosen NGAL as a primary outcome measure. In their marathon cohort of 
25 athletes, McCullogh et al. (2011) also measured cystatin C and kidney-injury molecule 1. 
Although not strictly an AKI molecule, plasma cystatin C in this study exhibited parallel and 
similar mean concentration rises to plasma Cr.  Kidney injury molecule-1 (a transmembrane 
protein that is specifically up-regulated in dedifferentiated proximal tubule cells after 
ischaemic or nephrotoxic AKI), was also increased during the same period (baseline: 2.6 ± 
1.6 ng/ml; immediately post-race: 3.5 ± 1.6 ng/ml, P = 0.001; McCullogh et al., 2011).  
Measurement of an AKI biomarker panel may therefore serve to improve the sensitivity 
and specificity of AKI diagnosis, provide more information on site-specific kidney stresses 
and prognostication. However, it should be remembered that release kinetics of different 
biomarkers vary, which may influence their application. For example, in clinical studies, large 
and significant increases of kidney injury molecule-1 concentrations tend to occur 12 hours 
post-insult, whereas NGAL can be up-regulated as early as two hours from the time of insult 
(Mishra et al., 2003).  The modest kidney injury molecule-1 elevation immediately post-
marathon in the McCullough et al. (2011) study was made at a mean time of four hours, and 
so it could be perceived that assessment of this biomarker immediately following shorter 
duration intensity-based activity may not be sensitive enough to detect kidney stress. 
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Therefore, in addition to considering how molecular biomarker measurements should be 
interpreted (see section 6.2.), it is also likely that biomarker panels have to be tailored to the 
physical activity being investigated.  
It has been suggested that cystatin C represents a more precise measure of kidney disease 
compared to creatinine and should replace the latter as a biomarker of AKI, especially as 
cystatin C concentrations are less influenced by age, sex, race and muscle mass. Regardless of 
this, altered cystatin C concentrations (like increased albuminuria) in AKI can only be viewed 
as a function of glomerular permeability and do not directly indicate increased glomerular 
basement membrane stress or injury. Animal models of diabetic nephropathy have hinted at 
new biomarkers of glomerular injury that focus upon actual disruption of basement membrane 
elements responsible for the filtration process e.g. type IV collagen and laminin (Matheson et 
al., 2010). The urinary excretion of type IV collagen has been associated with glomerular 
injury and correlates with the urinary excretion of other components of the glomerular 
basement membrane including laminin (Yazawa et al., 2002). Further work is needed to 
define their role within clinical settings, but there is potential to refine AKI diagnosis 
alongside markers of tubular injury. However, it should be borne in mind that in the context 
of a post-exercise setting, such components of the glomerular basement membrane are also 
shared by muscle tissue breakdown and may therefore confound interpretation when there is 
suspicion of renal injury.  
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6.4. FUTURE DIRECTIONS AND CLINICAL IMPLICATIONS OF STUDY FINDINGS.  
 
6.4.1. The initiator of renal stress - determination of renal blood flow during physical activity. 
Although the last five to ten years has seen a dramatic rise in AKI molecular biomarker 
studies, there are still teething issues that are hampering their widespread use. In the clinical 
environment, their performance is driven by patient characteristics, co-morbid illness, the 
inciting kidney injury event, timings of measurement and selected thresholds for diagnosis. In 
this PhD, their application has provided greater insights into the mechanisms of renal stress 
and injury during heavy physical exertion. Nonetheless, there have been efforts to seek other 
physiological biomarkers that may indicate AKI and its earliest manifestations which could 
also be applied to exercise research. 
As discussed in chapter 1, heavy exercise results in incremental but pronounced 
reductions to renal blood flow. This is to the extent that vigorous activity (≥ 80% O2max) can 
result in renal plasma flow decreasing to 50% from baseline (Walker et al., 1994). This 
change to renal blood flow during exercise is likely to be the inciting stressor that contributes 
to subsequent alterations in renal physiology i.e. haematuria and proteinuria. Thus, it seems 
logical that pathophysiological changes to the renal microcirculation occur before cellular 
injury results in up-regulation of molecular biomarkers of AKI, such as NGAL. Renal blood 
flow quantification as a biomarker for acute renal injury is technically challenging - even in 
stationary patients and although surrogates such as renal plasma flow (chapter 1.1) can be 
assessed, this is resource dependent and time-consuming. Recently, several novel methods for 
assessing renal blood flow have been described and hold promise for future exercise study. 
 
6.4.1.1. Doppler ultrasound. Doppler ultrasound has so far received little consideration as a 
marker of RBF during exercise; mainly owing to a number of technical issues. Nonetheless, 
there are other surrogate measures of RBF that may be derived from Doppler and warrant 
further investigation into their applicability during exercise. These include the renal resistive 
index and gas-filled microbubble contrast-enhancement. The resistive index ((peak systolic 
velocity − end diastolic velocity) / peak systolic velocity)), assesses renal vascular resistance 
and a value of 0.70 is considered to be the upper threshold of normal resistive index in adults. 
In a study by Lerolle et al. (2006) involving a small cohort of patients with septic shock, the 
resistive index predicted the development of AKI five days after presentation (resistive index 
of 0.77 vs. 0.68 in AKI vs. non-AKI, respectively). Moreover, the resistive index was found 
V
.
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to be higher in patients with acute tubular necrosis (0.85) than in pre-renal AKI (0.67), and 
better than urinary biomarkers in the diagnosis of established AKI (Platt et al., 1991).  
Contrast-enhancement Doppler through intravenous injection of gas-filled microbubble 
particles is able to provide information of blood flow at the level of the capillary bed. Its use 
is well-established in the assessment of myocardial perfusion during echocardiography. In the 
kidney, there is good correlation between this methodology and RBF as determined by p-
aminohippuric acid clearances in porcine and canine models. In a prospective cohort trial, 
Kalantarinia et al. (2009b) showed that following a renal stressor in the form of a high-protein 
meal (1.5 g of chicken / kg body weight), there was a 42% increase in cortical blood flow and 
a 37% increase in blood velocity by using this technique. The authors also concluded that this 
technique was rapid, safe with a low rate of mild adverse events (about 5%).  
In terms of practicality, ultrasound offers portability and rapid result turnover but is 
heavily dependent on operator experience. Some of these characteristics are desirable if the 
above measures were to be used in the field to determine AKI risk in heavy physical activity. 
For example, assessing RBF in this manner may allow quantification of a “renal reserve” and 
provide an a priori estimation of AKI risk. 
 
6.4.1.2. Magnetic resonance imaging. Magnetic resonance imaging (MRI) may also be used 
to assess parenchymal renal blood flow. Blood Oxygen Level-Dependent MRI is a rapid and 
non-invasive method that relies upon paramagnetism to detect deoxyhaemaglobin that 
increases in proportion to oxygen consumption in renal tissues. For example, in a murine 
study, Juillard et al. (2004) demonstrated that this variation of MRI could noninvasively 
detect change in intra-renal oxygenation during an acute reduction of RBF due to unilateral 
renal artery stenosis.  
Application in kidney exercise physiology models also appears feasible. Using a custom 
MR-compatible cycloergometer, Taylor et al. (2002) revealed that blood flow to the digestive 
and renal circulations decreased from 2.1 +/- 0.5 l/min at rest to 1.6 +/- 0.7 l/min during 
exercise (P < 0.01), while infrarenal blood flow increased from 0.9 +/- 0.4 l/min at rest to 5.6 
+/- 1.1 l/min during exercise (P < 0.0005, figure 6.5.). Compared to Doppler ultrasound, use 
of MR cine phase-contrast techniques has the additional advantages of measuring spatial 
distributions of through-plane velocity over a cross section and allow concurrent 
quantification of flow rate, circumferentially resolved wall shear stress and lumen area.  
However, given the logistic and technical aspects involved in using MRI, this method is 
likely to remain a research tool in exercise physiology, albeit a powerful one. Other promising 
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techniques related to RBF estimation include measuring partial pressure of oxygen in the 
urine, which reflects oxygen tension within the medulla, and near-infra red spectroscopy 
(Leonhardt and Landes, 1963; Petrova and Mehta, 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.4.3. A multi-factorial model of renal injury following heavy exercise. Based upon the 
experimental work described in the preceding chapters, perturbations to kidney physiology 
during exercise cannot be regarded as merely “normal” adaptations, but should been viewed 
to represent physiological stress that rests on a scale of severity.  
At the less severe end of the spectrum, most changes to kidney physiology in response to 
low intensity and/or short-duration exercise are short-lived and likely to be clinically 
Figure 6.5.  Taylor et al. used a custom MR-compatible stationary cycle in a 0.5-T open magnet MR 
scanner with cine phase-contrast techniques to measure blood flow velocities in the inferior vena cava 
of young healthy subjects at rest and during upright dynamic lower limb exercise. Subjects were 
strapped to an upright seat in the open magnet to allow full range of leg motion while positioning the 
abdomen in the centre of the magnet for optimal imaging. The cycle was then positioned and its 
resistance was adjusted to promote comfortable pedaling and minimize abdomen movement that could 
affect image capture and quality. Adopted from Taylor et al. 2002. 
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inconsequential. This view should continue to be respected although more work is needed to 
determine if repeated high-intensity short-term activity resulting in renal aberrations puts 
individuals at risk of future harm e.g. CKD. However, at the more severe end of the spectrum, 
where activity is performed at higher levels of intensity and duration, the changes to 
physiology can be magnified and drift into a pathological state such as AKI and its clinical 
sequalae (figure 6.6.). The latter scenario is likely to involve a combination of environmental 
and individual-specific factors that interact together within a critical time-frame – the so-
called “perfect storm”.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapters 2 and 4 have only manipulated some of these (e.g. exercise intensity, exercise-
induced muscle damage and inflammation, heat-stressed environments) but other exist such 
as prior dehydration, clothing type, medicinal use (e.g. non-steroidal anti-inflammatory), 
myopathy, viral illnesses (respiratory tract infections) and body mass index (Adams et al., 
2012). Further experimental study is required to determine their individual and additive 
influences and temporal relationships. This may eventually allow for risk stratification to 
determine which phenotype(s) predispose to AKI following strenuous physical exertion. Such 
Figure 6.6. Schematic illustrating the potential mechanism of acute kidney injury through heavy 
physical exertion. In this setting, kidney injury is likely to exist on a scale of severity where milder 
activity only results in temporary phenomena such as haematuria and proteinuria. However, more 
strenuous activity of a higher intensity and longer duration, coupled with various adverse modifiable 
and non-modifiable factors increases the risk of developing significant AKI. It is at this point where 
“normal” physiological responses to exercise cross-over into a clinically-significant pathological state. 
AKI, acute kidney injury; NSAID, non-sterodial anti-inflammatory drug. 
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a tool, if reliable and rapidly applied, would be useful in large populations that perform heavy 
exercise in adverse settings on a regular basis e.g. athletes, soldiers, fire fighters, police. An 
example of this can be taken from work exploring risk factors for exertional heat illness; a 
condition that exhibits a spectrum of severity.  In a case-control study of 565 heat casualties 
during basic military training of Marine Corps (61 hospitalized (case subjects), 504 treated as 
outpatients (control subjects)), Hakre et al. (2004) determined risk factors for hospitalization 
using univariate and multivariate analyses, demographic, clinical, and laboratory factors. Of 
24 potential risk factors examined, 19 were significantly associated with hospitalization. 
Three clinical variables (disorientation, rectal temperature, and systolic blood pressure) and 
three laboratory variables (serum lactate dehydrogenase, potassium and Cr concentrations) 
were highly predictive for hospitalization in recruits with exertional heat illness. A simple 
scoring system using these six variables predicted hospitalization with 87% sensitivity, 91% 
specificity and a likelihood ratio of 9.7 (Hakre et al., 2004). In this model, it should be noted 
that half of the predictive variables were associated with kidney function (blood pressure, 
potassium and Cr), which highlights the importance of kidney health in heat illness. It is 
conceivable that the addition of other laboratory-measured parameters (e.g. biomarkers of 
kidney injury and cytokines) may improve the sensitivity and specificity of risk profiling. 
 
6.4.4. Wider applications of exercise testing for organ dysfunction or injury. Although further 
refinement is needed, the conclusions from chapter 3 should act as a catalyst for the 
development of a standardised exercise test for CKD prediction. There is good justification to 
pursue this area, especially given that exercise testing has already been successfully applied to 
determine risk in the assessment of coronary artery disease; typically through the combination 
of a graded treadmill exercise test (e.g. Bruce protocol) with a simultaneous 12-lead 
electrocardiogram to detect evidence of myocardial ischaemia (Gianrossi et al., 1989, 
Gibbons et al., 2002). This develops into a powerful diagnostic and prognostic tool when the 
results from such investigations are combined with O2max, haemodynamic responses to 
exercise, various forms of cardiovascular imaging and demographics. In the setting of 
coronary artery disease, the results of testing conclusions can be used to guide clinical 
decision-making in a number of situations, e.g. prediction of future cardiovascular events and 
the cardiovascular risk assessment for major surgical procedures. A similar scenario could be 
envisaged for post-exercise proteinuria positive in a CKD at-risk individual, with such 
information being used to dictate further investigations (e.g. renal biopsy) or secondary 
prevention measures (e.g. instigation of antihypertensive / antiproteinuric agents). 
V
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Apart from the heart, exercise testing for other organs has been performed to assess 
cardiovascular fitness in the context of other organ-specific disease states (e.g. chronic liver 
disease). Such information is then used to guide mortality or fitness for transplantation 
(Prentis et al., 2012). Yet interestingly, the idea of determining the direct physiological 
impact of cardiovascular testing (both in the short- and long-term) upon the “fitness” of  other 
organs (e.g. brain, liver, lungs and kidneys) and its implications has received relatively little 
attention. Recent evidence for cross-talk between organs during diseased states highlights the 
urgency to explore these potential interactions further. The cardiorenal syndrome illustrates 
this concept and highlights the functional interdependence between chronic heart and kidney 
failure to maintain homeostasis. This may occur through several putative pathways (figure 
6.7.; Ronco, 2010, Darabian et al., 2011).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Haapio et al. (2010) have explored this complex relationship at the molecular biomarker 
level using plasma NGAL as a biomarker of kidney injury in patients at-risk of cardiac 
disease who underwent elective nuclear stress perfusion imaging. They noted that patients 
with detectable concentrations of plasma NGAL demonstrated greater incremental changes in 
natriuretic peptides, had more segmental myocardial perfusion defects, higher end-diastolic 
and end-systolic volumes, and higher baseline levels of the cardiac injury biomarker troponin- 
I following imaging (Haapio et al., 2010). Although the authors stated such observations were 
only associations and did not extend to the directional nature of the relationships between 
Figure 6.7. Diagram summarising the key putative pathophysiological connections in the cardiorenal 
syndrome. Given the recent formal recognition of this syndrome, these potential routes of 
communication are now being investigated in more detail. RAAS, renin–angiotensin–aldosterone 
system; VD/VDR, vitamin D/vitamin D receptor. Adopted from Darabian et al. 2011. 
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renal and cardiac injury, they do provide credible evidence that in a disease model cardiac and 
renal function are intimately linked.  
Taking into account the discussion in chapter 1.2., these findings provide justification 
that cardio-renal relationships should be sought in healthy individuals undergoing strenuous 
endurance activity to elucidate the mechanisms by which physiological adaptations transgress 
into pathological states. McCullough et al. (2011) showed evidence of a cardiorenal 
syndrome in their marathon study that was manifested by transient right heart dilatation, 
elevations in blood brain natriuretic peptide and a transient decrease in renal filtration.  Such 
investigations could also provide a platform to investigate possible molecular cross-talk 
between other organs during physical activity. For example, in the critically ill, AKI can co-
exist with an acute lung injury and there is cross-talk which can involve a number of 
mechanisms including inflammatory cytokines, leukocytes, and induction of oxidative stress 
(Basu and Wheeler, 2013).  
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APPENDIX 1: EXAMPLES OF SEARCH STRATEGY TERMS USED IN 
CHAPTER 3 
 
OVID MEDLINE (R) and OVID MEDLINE IN PROCESS  
 
1. exp Exercise/ or exp Exercise Test/ 
2. proteinuria.mp. or exp Proteinuria/ 
3. albuminuria.mp. or exp Albuminuria/ 
4. 2 or 3 
5. 1 and 4 
6. chronic kidney disease.mp. or exp Renal Insufficiency, Chronic/ 
7. nephropathy.mp. 
8. 6 or 7 
9. 5 and 8 
10. exercise induced albuminuria.mp. 
11. exercise induced proteinuria.mp. 
12. post exercise proteinuria.mp. 
13. post-exercise albuminuria.mp. 
14. 10 or 11 or 12 or 13 
 
AMED 
 
1. exp Exercise/ 
2. exercise testing/ 
3. 1 or 2 
4. proteinuria.mp. 
5. albuminuria.mp. 
6. 4 or 5 
7. 3 and 6 
8. exp Kidney disease/ or chronic kidney disease.mp. or exp Kidney failure chronic/ 
9. nephropathy.mp. 
10. 8 or 9 
11. exercise induced proteinuria.mp. 
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12. post exercise proteinuria.mp. 
13. 7 and 10 
14. exercise induced albuminuria.mp. 
15. post exercise albuminuria.mp. 
 
EMBASE 
 
1. exp exercise test/ or exp exercise/ 
2. proteinuria.mp. or exp proteinuria/ 
3. albuminuria.mp. or exp proteinuria/ or exp albuminuria/ 
4. 2 or 3 
5. 1 and 4 
6. nephropathy.mp. 
7. chronic kidney disease.mp. or exp chronic kidney disease/ or exp chronic kidney failure/ 
8. 6 or 7 
9. 5 and 8 
10. post exercise albuminuria.mp. 
11. post exercise proteinuria.mp. 
12. exercise induced albuminuria.mp. 
13. exercise induced proteinuria.mp. 
14. 10 or 11 or 12 or 13 
 
PUBMED 
 
(((((EXERCISE OR EXERCISE TEST))) AND ((PROTEINURIA OR ALBUMINURIA)))) AND 
((CHRONIC KIDNEY DISEASE OR NEPHROPATHY)) OR 
(((EXERCISE INDUCED PROTEINURIA) OR EXERCISE INDUCED ALBUMINURIA) OR POST EXERCISE 
ALBUMINURIA) OR POST EXERCISE PROTEINURIA 
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COCHRANE LIBRARY 
 
ID SEARCH  
#1 EXERCISE INDUCED PROTEINURIA  
#2 EXERCISE INDUCED ALBUMINURIA  
#3 POST EXERCISE PROTEINURIA  
#4 POST EXERCISE ALBUMINURIA  
#5 #1 OR #2 OR #3 OR #4  
#6 EXERCISE OR EXERCISE TEST  
#7 PROTEINURIA OR ALBUMINURIA  
#8 #6 AND #7  
#9 CHRONIC KIDNEY DISEASE OR NEPHROPATHY  
#10 #8 AND #9 
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APPENDIX 2: OUTLINE OF QUADAS-2 CRITERIA AS USED IN CHAPTER 3 
 
DOMAIN PATIENT SELECTION   INDEX TEST  
REFERENCE 
STANDARD 
FLOW AND TIMING  
Description 
Describe methods of patient 
selection: Describe included 
patients (prior testing, 
presentation, intended use of 
index test and setting):  
Describe the index 
test and how it was 
conducted and 
interpreted:  
Describe the reference 
standard and how it was 
conducted and 
interpreted:  
Describe any patients who did not 
receive the index test(s) and/or 
reference standard or who were 
excluded from the 2x2 table (refer to 
flow diagram): Describe the time 
interval and any interventions between 
index test(s) and reference standard: 
Signalling questions 
(yes/no/unclear)
* 
Was a consecutive or 
random sample of patients 
enrolled? 
Were the index test 
results interpreted 
without knowledge 
of the results of the 
reference standard? 
Is the reference 
standard likely to 
correctly classify the 
target condition? 
Was there an appropriate interval 
between index test(s) and reference 
standard? 
Was a case-control design 
avoided? 
If a threshold was 
used, was it pre-
specified? 
Were the reference 
standard results 
interpreted without 
knowledge of the 
results of the index test? 
Did all patients receive a reference 
standard? 
Did the study avoid 
inappropriate exclusions? 
Did all patients receive the same 
reference standard? 
Were all patients included in the 
analysis? 
Risk of bias: 
High/low/unclear 
Could the selection of 
patients have introduced 
bias? 
Could the conduct or 
interpretation of the 
index test have 
introduced bias?       
Could the reference 
standard, its conduct, or 
its interpretation have 
introduced bias? 
Could the patient flow have introduced 
bias?  
Concerns regarding 
applicability: 
High/low/unclear 
Are there concerns that the 
included patients do not 
match the review question? 
Are there concerns 
that the index test, 
its conduct, or 
interpretation differ 
from the review 
question? 
Are there concerns that 
the target condition as 
defined by the reference 
standard does not match 
the review question? 
 
 
* Signalling questions allow reviewer to make an assessment of bias. Extra signalling   
   questions that are specific to the review question may be included if the reviewers believe    
   this can assist in assessment of risk of bias. 
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APPENDIX 3: STUDY SPECIFIC ANCHORING STATEMENTS TO ASSIST 
WITH RISK OF BIAS ASSESSMENT USING QUADAS-2 IN CHAPTER 3 
 
Domain 1: patient selection  
Risk of bias: could the selection of patients have introduced bias? (high, low, unclear)  
   
1.1 Was a consecutive or random sample of patients enrolled?  
 
If stated explicitly, consecutive or random sampling is least likely to be associated 
with bias. Importantly, investigators should have no choice to determine which 
patients are or are not included from the population under question. A higher risk of 
bias is possible with non-random sampling. Weighting: high risk of bias. 
 
1.2 Was a case-control design avoided?  
 
A high degree of bias is possible in case-control studies. A hospital-based case 
selection may behave differently from a community-based patient selection e.g. 
diabetic patients who are seen in hospital clinics could be sicker or more complex. 
Control populations should also be healthy and be representative of a non-disease 
population adjusted for age and sex. Also, if authors manipulate the cohort to increase 
or decrease the target condition e.g. adjust anti-proteinuric agents in diabetics to limit 
CKD progression, this may also increase bias. In a nested case-control study where 
subjects are systematically selected from a defined population, there is comparatively 
less bias. However, the latter may narrow the spectrum of patients who undergo the 
index (exercise) test. Weighting: high risk of bias. 
 
1.3 Did the study avoid inappropriate exclusions?  
 
Avoiding inappropriate exclusions may result in either over- or underestimating 
diagnostic accuracy. Specific appropriate exclusions include: recent exercise (in term 
of days) prior to testing, exercising in the presence of an intercurrent illness / fever / 
menstruation, or exercising with chronic conditions that may decompensate and limit 
a complete exercise test (e.g. ischaemic heart disease, chronic obstructive pulmonary 
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disease). If this is not stated or not made clear, the study will be rated as having a high 
risk of bias. Where exclusion criteria are made explicit in the methodology, the study 
will be deemed of low bias. Weighting: low risk of bias. 
   
1.4 Applicability: are there concerns that the included patients do not match the review  
question? (high, low, unclear)  
 
The subjects tested should be derived from a population of interest as defined by the 
review question. Studies where there is evidence of using very select populations for 
the purpose of generalisations (not if they are intended to represent a defined target 
population) or having a low external validity, will be classified as having a low 
applicability. 
   
Domain 2: index test  
Risk of bias: could the conduct or interpretation of the index test have introduced bias? (high, 
low, unclear)  
 
      2.1 Were the index test results interpreted without knowledge of the reference standard? 
 
Given the review question, it is expected that all studies would obtain the index test 
results (presence of post-exercise proteinuria) before assessing the reference standard 
(an objective measurement of CKD progression) at follow-up, preferably with 
blinding. Weighting: low risk of bias. 
 
      2.2 Were the index test thresholds pre-specified?  
 
It is recognised that the cut-off or threshold for exercise proteinuria varies depending 
upon the type of exercise, its intensity and duration. It is also generally accepted that 
exercise protocols involving a high intensity and short duration yield greatest the 
levels of proteinuria. Studies should aim for such protocols and qualify this by 
explicitly defining thresholds and using exercise tests that have been previously used 
by independent groups. However, it is recognised that different thresholds may be 
used in different populations but these should be justified clearly. If this is not clear or 
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the authors define the cut-off based on their own study data, the study is classified at a 
high risk of bias. Weighting: high risk of bias. 
 
    2.3  Were sufficient data on application given for the test to be repeated in an independent                
            study?  
 
In broad terms, this should include details of a validated measure of proteinuria, 
methods on excluding significant proteinuria at rest, steps taken to ensure adequate 
pre-hydration to maximise diuresis and details of exercise protocol: type of exercise, 
duration, how intensity was determined and when post-exercise proteinuria was 
determined. If a novel exercise test was used that has not been previously described in 
the literature, this should be detailed in full with evidence of validation.  Weighting: 
high risk of bias. 
   
      2.4 Applicability: are there concerns that the index test, its conduct, or interpretation  
            differ from the review question? (high, low, unclear)  
 
A poorly implemented or defined index test that also varies from the review question 
may have the potential to affect primary and secondary outcomes and therefore 
applicability. For example, if it is felt the exercise test lacked the ability to generate 
proteinuria, then the sensitivity or false negative rate could be affected. 
 
Domain 3: reference standard  
Risk of bias: could the reference standard, its conduct, or its interpretation have introduced 
bias? (high, low, unclear)  
   
      3.1 Is the reference standard likely to correctly classify the target condition?  
 
The reference standard for the purpose of this systematic review only relates to 
primary outcome measures. These should be directly related to CKD progression: 1. A 
proteinuria level above a well-established cut-off for significant proteinuria at rest 
(e.g. resting proteinuria greater than 3 mg/mmol (urinary A:Cr) or 30 mg/g (urinary 
P:Cr) or 21 ug/min (urinary albumin excretion rate)); or 2. an increased blood 
creatinine concentration of 25% from baseline and / or a drop in estimated GFR 
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category accompanied by a 25% or greater drop in estimated GFR from baseline. 
These are defined by previous independent studies and international consensus groups. 
The reference standard should also be assessed in a period of well-being and not 
where illness may confound measurements. Where this has not been clarified and / or 
a reference standard has not been evidenced or is not familiar to the reviewer, the 
study will be categorised as having bias.  Weighting: high risk of bias. 
 
      3.2 Were the reference standard results interpreted without knowledge of the results of the 
index test?  
 
Knowledge of the index test results (i.e. presence or absence of post-exercise 
proteinuria) are required to interpret the reference standard results. However, if 
patients were included in the primary outcome measure who had evidence of 
significant proteinuria at baseline prior to exercise testing (i.e. above the reference 
standard), this would put the study at a high risk of bias. Weighting: low risk of bias.  
 
      3.3 Was sufficient information on the reference standard measurement (method on the  
            assessment of CKD progression) given for it to be repeated in an independent study?  
 
It is expected that authors will have used established biomarkers of CKD progression 
(e.g. blood creatinine and / or proteinuria) as defined by the review question. Ideally 
these should be referenced. Additionally, details of the assay kits used should be stated 
in full and again this is expected. Methods for blood creatinine determination can vary 
across different laboratories with methods such as the Jaffe reaction or isotope 
dilution-mass spectrometry. If unconventional CKD biomarkers are applied and / or 
in-house assay kits are used, the study will possess a high risk of bias. Weighting: low 
risk of bias. 
   
3.4  Applicability: are there concerns that the target condition as defined by the reference
 standard does not match the review question? (high, low, unclear)  
 
As stated in 3.1, the reference standard should be derived from a well-established cut-
off for significant proteinuria at rest or elevations in blood creatinine / fall in estimated 
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GFR to indicate CKD as defined by previous independent studies or a consensus 
group. This should be applied consistently.  
   
Domain 4: patient flow and timing  
Risk of bias: could the patient flow have introduced bias? (high, low, unclear)  
   
      4.1 Was there an appropriate interval between the index test and reference standard?  
 
As per review question, assessment of the primary outcome should be performed at 
least three months following the index test. According to international guidance, this 
period is sufficient to assess whether a change of a CKD biomarker represents a 
progression of CKD. However, significant changes assessed at a timepoint shorter 
than three months would not be compatible with a CKD measurement. Periods longer 
than three months (e.g. years) are also acceptable, providing confounding factors are 
accounted for or controlled for, e.g. events that could affect the reference standard 
such as development of disease and introduction of disease modifying medications. 
Both instances would place a study at a high risk of bias. Ideally, treatment of the 
disease under investigation should change as little as possible during the follow-up 
period.  However, the authors recognise this may not be possible in actual practice. 
Weighting: high risk of bias. 
 
     4.2 Did all subjects receive the same reference standard?  
 
It is expected the same reference standard (limits and assays used) should be the same 
at baseline and follow-up. Any deviation from this e.g. change of assay kit used, 
places the study at a risk of bias. Weighting: low risk of bias. 
 
     4.3  Were all subjects included in the final analysis?  
 
Drop-out, subjects lost to follow up and missing data should be accounted for. There 
is a greater risk with studies whose follow-up period is greater than three months or 
extends to years. Attrition that is higher than expected (compared to other similar 
studies) should be treated as a high risk of bias. A cut-off of greater than 20% attrition 
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is defined as being high risk but this will be highly dependent on the number of 
subjects and length of follow-up. Weighting: low risk of bias. 
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